Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
GRCh38/hg38 5q21.3-33.2(chr5:106619588-156124387)x1	LOC129994433|LOC129994434|LOC129994435|LOC129994436|LOC129994437|LOC129994438|LOC129994439|LOC129994440|LOC129994441|LOC129994442|LOC129994443|LOC129994444|LOC129994445|LOC129994446|LOC129994447|LOC129994448|LOC129994449|LOC129994450|LOC129994451|LOC129994452|LOC129994453|LOC129994454|LOC129994455|LOC129994456|LOC129994457|LOC129994458|LOC129994459|LOC129994460|LOC129994461|LOC129994462|LOC129994463|LOC129994464|LOC129994465|LOC129994466|LOC129994467|LOC129994468|LOC129994469|LOC129994470|LOC129994471|LOC129994472|LOC129994473|LOC129994474|LOC129994475|LOC129994476|LOC129994477|LOC129994478|LOC129994479|LOC129994480|LOC129994481|LOC129994482|LOC129994483|LOC129994484|LOC129994485|LOC129994486|LOC129994487|LOC129994488|LOC129994489|LOC129994490|LOC129994491|LOC129994492|LOC129994493|LOC129994494|LOC129994495|LOC129994496|LOC129994497|LOC129994498|LOC129994499|LOC129994500|LOC129994501|LOC129994502|LOC129994503|LOC129994504|LOC129994505|LOC129994506|LOC129994507|LOC129994508|LOC129994509|LOC129994510|LOC129994511|LOC129994512|LOC129994513|LOC129994514|LOC129994515|LOC129994516|LOC129994517|LOC129994518|LOC129994519|LOC129994520|LOC129994521|LOC129994522|LOC129994523|LOC129994524|LOC129994525|LOC129994526|LOC129994527|LOC129994528|LOC129994529|LOC129994530|LOC129994531|LOC129994532|LOC129994533|LOC129994534|LOC129994535|LOC129994536|LOC129994537|LOC129994538|LOC129994539|LOC129994540|LOC129994541|LOC129994542|LOC129994543|LOC129994544|LOC129994545|LOC129994546|LOC129994547|LOC129994548|LOC129994549|LOC129994550|LOC129994551|LOC129994552|LOC129994553|LOC129994554|LOC129994555|LOC129994556|LOC129994557|LOC129994558|LOC129994559|LOC129994560|LOC129994561|LOC129994562|LOC129994563|LOC129994564|LOC129994565|LOC129994566|LOC129994567|LOC129994568|LOC129994569|LOC129994570|LOC129994571|LOC129994572|LOC129994573|LOC129994574|LOC129994575|LOC129994576|LOC129994577|LOC129994578|LOC129994579|LOC129994580|LOC129994581|LOC129994582|LOC129994583|LOC129994584|LOC129994585|LOC129994586|LOC129994587|LOC129994588|LOC129994589|LOC129994590|LOC129994591|LOC129994592|LOC129994593|LOC129994594|LOC129994595|LOC129994596|LOC129994597|LOC129994598|LOC129994599|LOC129994600|LOC129994601|LOC129994602|LOC129994603|LOC129994604|LOC129994605|LOC129994606|LOC129994607|LOC129994608|LOC129994609|LOC129994610|LOC129994611|LOC129994612|LOC129994613|LOC129994614|LOC129994615|LOC129994616|LOC129994617|LOC129994618|LOC129994619|LOC129994620|LOC129994621|LOC129994622|LOC129994623|LOC129994624|LOC129994625|LOC129994626|LOC129994627|LOC129994628|LOC129994629|LOC129994630|LOC129994631|LOC129994632|LOC129994633|LOC129994634|LOC129994635|LOC129994636|LOC129994637|LOC129994638|LOC129994639|LOC129994640|LOC129994641|LOC129994642|LOC129994643|LOC129994644|LOC129994645|LOC129994646|LOC129994647|LOC129994648|LOC129994649|LOC129994650|LOC129994651|LOC129994652|LOC129994653|LOC129994654|LOC129994655|LOC129994656|LOC129994657|LOC129994658|LOC129994659|LOC129994660|LOC129994661|LOC129994662|LOC129994663|LOC129994664|LOC129994665|LOC129994666|LOC129994667|LOC129994668|LOC129994669|LOC129994670|LOC129994671|LOC129994672|LOC129994673|LOC129994674|LOC129994675|LOC129994676|LOC129994677|LOC129994678|LOC129994679|LOC129994680|LOC129994681|LOC129994682|LOC129994683|LOC129994684|LOC129994685|LOC129994686|LOC129994687|LOC129994688|LOC129994689|LOC129994690|LOC129994691|LOC129994692|LOC129994693|LOC129994694|LOC129994695|LOC129994696|LOC129994697|LOC129994698|LOC129994699|LOC129994700|LOC129994701|LOC129994702|LOC129994703|LOC129994704|LOC129994705|LOC129994706|LOC129994707|LOC129994708|LOC129994709|LOC129994710|LOC129994711|LOC129994712|LOC129994713|LOC129994714|LOC129994715|LOC129994716|LOC129994717|LOC129994718|LOC129994719|LOC129994720|LOC129994721|LOC129994722|LOC129994723|LOC129994724|LOC129994725|LOC129994726|LOC129994727|LOC129994728|LOC129994729|LOC129994730|LOC129994731|LOC129994732|LOC129994733|LOC129994734|LOC129994735|LOC129994736|LOC129994737|LOC129994738|LOC129994739|LOC129994740|LOC129994741|LOC129994742|LOC129994743|LOC129994744|LOC129994745|LOC129994746|LOC129994747|LOC129994748|LOC129994749|LOC129994750|LOC129994751|LOC129994752|LOC129994753|LOC129994754|LOC129994755|LOC129994756|LOC129994757|LOC129994758|LOC129994759|LOC129994760|LOC129994761|LOC129994762|LOC129994763|LOC129994764|LOC129994765|LOC129994766|LOC129994767|LOC129994768|LOC129994769|LOC129994770|LOC129994771|LOC129994772|LOC129994773|LOC129994774|LOC129994775|LOC129994776|LOC129994777|LOC129994778|LOC129994779|LOC129994780|LOC129994781|LOC129994782|LOC129994783|LOC129994784|LOC129994785|LOC129994786|LOC129994787|LOC129994788|LOC129994789|LOC129994790|LOC129994791|LOC129994792|LOC129994793|LOC129994794|LOC129994795|LOC129994796|LOC129994797|LOC129994798|LOC129994799|LOC129994800|LOC129994801|LOC129994802|LOC129994803|LOC129994804|LOC129994805|LOC129994806|LOC129994807|LOC129994808|LOC129994809|LOC129994810|LOC129994811|LOC129994812|LOC129994813|LOC129994814|LOC129994815|LOC129994816|LOC129994817|LOC129994818|LOC129994819|LOC129994820|LOC129994821|LOC129994822|LOC129994823|LOC129994824|LOC129994825|LOC129994826|LOC129994827|LOC129994828|LOC129994829|LOC129994830|LOC129994831|LOC129994832|LOC129994833|LOC129994834|LOC129994835|LOC129994836|LOC129994837|LOC129994838|LOC129994839|LOC129994840|LOC129994841|LOC129994842|LOC129994843|LOC129994844|LOC129994845|LOC129994846|LOC129994847|LOC129994848|LOC129994849|LOC129994850|LOC129994851|LOC129994852|LOC129994853|LOC129994854|LOC129994855|LOC129994856|LOC129994857|LOC129994858|LOC129994859|LOC129994860|LOC129994861|LOC129994862|LOC129994863|LOC129994864|LOC129994865|LOC129994866|LOC129994867|LOC129994868|LOC129994869|LOC129994870|LOC129994871|LOC129994872|LOC129994873|LOC129994874|LOC129994875|LOC129994876|LOC129994877|LOC129994878|LOC129994879|LOC129994880|LOC129994881|LOC129994882|LOC129994883|LOC129994884|LOC129994885|LOC129994886|LOC129994887|LOC129994888|LOC129994889|LOC129994890|LOC129994891|LOC129994892|LOC129994893|LOC129994894|LOC129994895|LOC129994896|LOC129994897|LOC129994898|LOC129994899|LOC129994900|LOC129994901|LOC129994902|LOC129994903|LOC129994904|LOC129994905|LOC129994906|LOC129994907|LOC129994908|LOC129994909|LOC129994910|LOC129994911|LOC129994912|LOC129994913|LOC129994914|LOC129994915|LOC129994916|LOC129994917|LOC129994918|LOC129994919|LOC129994920|LOC129994921|LOC129994922|LOC129994923|LOC129994924|LOC129994925|LOC129994926|LOC129994927|LOC129994928|LOC129994929|LOC129994930|LOC129994931|LOC129994932|LOC129994933|LOC129994934|LOC129994935|LOC129994936|LOC129994937|LOC129994938|LOC129994939|LOC129994940|LOC129994941|LOC129994942|LOC129994943|LOC129994944|ABLIM3|ACSL6|ACSL6-AS1|ADAMTS19|ADAMTS19-AS1|ADRB2|AFAP1L1|AFF4|AFF4-DT|ALDH7A1|ANKHD1|ANKHD1-DT|ANKHD1-EIF4EBP3|ANXA6|AP3S1|APBB3|APC|ARAP3|ARHGAP26|ARHGAP26-AS1|ARHGAP26-IT1|ARHGEF37|ARL14EPL|ARSI|ATG12|ATOX1|ATOX1-AS1|BRD8|C5orf15|C5orf24|C5orf46|C5orf63|CAMK2A|CAMK4|CAMLG|CARINH|CARMN|CATSPER3|CCDC112|CCDC192|CCDC69|CCNI2|CD14|CD74|CDC23|CDC25C|CDC42SE2|CDKL3|CDKN2AIPNL|CDO1|CDX1|CEP120|CHSY3|CHSY3-AS1|CLMAT3|CNOT8|COMMD10|CSF1R|CSF2|CSNK1A1|CSNK1G3|CTB-1I21.1|CTB-99A3.1|CTNNA1|CTNNA1-AS1|CTXN3|CXCL14|CXXC5|CXXC5-AS1|CYSTM1|DCANP1|DCP2|DCTN4|DDX46|DELE1|DIAPH1|DIAPH1-AS1|DMXL1|DMXL1-DT|DNAJC18|DND1|DPYSL3|DTWD2|ECSCR|EFNA5|EGR1|EIF4EBP3|EPB41L4A|EPB41L4A-AS1|EPB41L4A-DT|EPIST|ETF1|FAM114A2|FAM13B|FAM13B-AS1|FAM170A|FAM53C|FAT2|FAXDC2|FBN2|FBXL17|FBXO38|FBXO38-DT|FCHSD1|FEM1C|FER|FGF1|FNIP1|FSTL4|FTMT|G3BP1|GALNT10|GDF9|GEMIN5|GFRA3|GLRA1|GM2A|GNPDA1|GPR151|GPX3|GRAMD2B|GRIA1|GRPEL2|GRPEL2-AS1|GRXCR2|HAND1|HARS1|HARS2|HBEGF|HDAC3|HINT1|HMGXB3|HMHB1|HNRNPA0|HSD17B4|HSPA4|HSPA9|HTR4|IGIP|IK|IL13|IL17B|IL3|IL4|IL5|IL9|IRF1|IRGM|ISOC1|JADE2|JAKMIP2|JAKMIP2-AS1|KCNN2|KCTD16|KDM3B|KIF20A|KIF3A|KIF4B|KLHL3|LARP1|LARS1|LEAP2|LECT2|LINC00992|LINC01023|LINC01170|LINC01470|LINC01843|LINC01844|LINC01848|LINC01861|LINC01933|LINC01950|LINC01957|LINC02039|LINC02147|LINC02148|LINC02200|LINC02201|LINC02208|LINC02214|LINC02215|LINC02216|LINC02240|LINC02863|LINC02900|LINC02999|LINCADL|LMNB1|LMNB1-DT|LOC100128966|LOC100652758|LOC101927023|LOC101927078|LOC101927190|LOC101927357|LOC101927421|LOC101927488|LOC101929719|LOC102467216|LOC102467217|LOC102467226|LOC105378230|LOC105379157|LOC105379176|LOC105379183|LOC105379192|LOC107198087|LOC107986453|LOC108178993|LOC108228201|LOC108281143|LOC108449898|LOC108660405|LOC109113859|LOC109113860|LOC109113862|LOC110121070|LOC110121082|LOC110121084|LOC110121107|LOC110121118|LOC110121171|LOC110121173|LOC110121194|LOC110121202|LOC110121271|LOC110121303|LOC111188152|LOC111188153|LOC111188154|LOC111188156|LOC111365180|LOC111429606|LOC111500310|LOC111828524|LOC112267934|LOC112997552|LOC112997553|LOC112997554|LOC112997555|LOC112997556|LOC112997557|LOC112997558|LOC112997559|LOC112997560|LOC112997561|LOC112997562|LOC112997563|LOC112997564|LOC112997565|LOC112997566|LOC112997567|LOC112997568|LOC112997569|LOC112997570|LOC114004387|LOC114004388|LOC114004389|LOC114004390|LOC116158522|LOC116158523|LOC116158524|LOC116158525|LOC116158526|LOC119407423|LOC120285837|LOC121079954|LOC121079955|LOC121079956|LOC121079957|LOC121079958|LOC121079959|LOC121079960|LOC121079961|LOC121079962|LOC121099701|LOC121099702|LOC121099703|LOC121099704|LOC121099705|LOC121099706|LOC121099707|LOC121099708|LOC121099709|LOC121099710|LOC121725211|LOC121725212|LOC121725213|LOC121725214|LOC121725215|LOC121725216|LOC121725217|LOC121740630|LOC121740631|LOC123497947|LOC123497948|LOC123497949|LOC123497950|LOC123497951|LOC123497953|LOC123497954|LOC123497955|LOC123497956|LOC123497958|LOC123497959|LOC123497960|LOC123497961|LOC123497962|LOC123497963|LOC123497964|LOC123497965|LOC123497966|LOC123497967|LOC123497968|LOC123497969|LOC123497970|LOC123497971|LOC123497972|LOC123497973|LOC123497974|LOC123497975|LOC123497976|LOC123497977|LOC123497978|LOC123522801|LOC123522802|LOC123522803|LOC123522804|LOC123522805|LOC123522806|LOC123566730|LOC123566731|LOC123566732|LOC123566733|LOC123566734|LOC123575580|LOC123575581|LOC123575582|LOC123575583|LOC123575584|LOC123575585|LOC123575586|LOC123575587|LOC123575588|LOC123575589|LOC123575590|LOC123575592|LOC123575593|LOC123575594|LOC123575595|LOC123575596|LOC123575597|LOC123575598|LOC123575599|LOC123575600|LOC123575601|LOC123575602|LOC123575603|LOC123575604|LOC123575605|LOC126807471|LOC126807472|LOC126807473|LOC126807474|LOC126807475|LOC126807476|LOC126807477|LOC126807478|LOC126807479|LOC126807480|LOC126807481|LOC126807482|LOC126807483|LOC126807484|LOC126807485|LOC126807486|LOC126807487|LOC126807488|LOC126807489|LOC126807490|LOC126807491|LOC126807492|LOC126807493|LOC126807494|LOC126807495|LOC126807496|LOC126807497|LOC126807498|LOC126807499|LOC126807500|LOC126807501|LOC126807502|LOC126807503|LOC126807504|LOC126807505|LOC126807506|LOC126807507|LOC126807508|LOC126807509|LOC126807510|LOC126807511|LOC126807512|LOC126807513|LOC126807514|LOC126807515|LOC126807516|LOC126807517|LOC126807518|LOC126807519|LOC126807520|LOC126807521|LOC126807522|LOC126807523|LOC126807524|LOC126807525|LOC126807526|LOC126807527|LOC126807528|LOC126807529|LOC126807530|LOC126807531|LOC126807532|LOC126807533|LOC126807534|LOC126807535|LOC126807536|LOC126807537|LOC126807538|LOC126807539|LOC126807540|LOC126807541|LOC126807542|LOC126807543|LOC126807544|LOC126807545|LOC126807546|LOC126807547|LOC126807548|LOC126807549|LOC126807550|LOC126807551|LOC126807552|LOC126807553|LOC126807554|LOC126807555|LOC126807556|LOC126807557|LOC126807558|LOC126807559|LOC126807560|LOC126807561|LOC126807562|LOC126807563|LOC126807564|LOC126807565|LOC126807566|LOC127814297|LOC128772274|LOC129389338|LOC129389339|LOC129389340|LOC129389341|LOC129389342|LOC129389343|LOC129389344|LOC129389345|LOC129389346|LOC129389347|LOC129389348|LOC129389349|LOC129389350|LOC129389351|LOC129389352|LOC129389353|LOC129389354|LOC129389355|LOC129389356|LOC129389357|LOC129389358|LOC129389359|LOC129389360|LOC129389361|LOC129389362|LOC129389363|LOC129389364|LOC129389365|LOC129389366|LOC129389367|LOC129389368|LOC129389369|LOC129389370|LOC129389371|LOC129389372|LOC129389373|LOC129389374|LOC129389375|LOC129389376|LOC129389377|LOC129389378|LOC129389379|LOC129389380|LOC129389381|LOC129389382|LOC129389383|LOC129389384|LOC129389385|LOC129389386|LOC129389387|LOC129389388|LOC129389389|LOC129389390|LOC129389391|LOC129389392|LOC129389393|LOC129389394|LOC129389395|LOC129389396|LOC129389397|LOC129389398|LOC129389399|LOC129389400|LOC129389401|LOC129994308|LOC129994309|LOC129994310|LOC129994311|LOC129994312|LOC129994313|LOC129994314|LOC129994315|LOC129994316|LOC129994317|LOC129994318|LOC129994319|LOC129994320|LOC129994321|LOC129994322|LOC129994323|LOC129994324|LOC129994325|LOC129994326|LOC129994327|LOC129994328|LOC129994329|LOC129994330|LOC129994331|LOC129994332|LOC129994333|LOC129994334|LOC129994335|LOC129994336|LOC129994337|LOC129994338|LOC129994339|LOC129994340|LOC129994341|LOC129994342|LOC129994343|LOC129994344|LOC129994345|LOC129994346|LOC129994347|LOC129994348|LOC129994349|LOC129994350|LOC129994351|LOC129994352|LOC129994353|LOC129994354|LOC129994355|LOC129994356|LOC129994357|LOC129994358|LOC129994359|LOC129994360|LOC129994361|LOC129994362|LOC129994363|LOC129994364|LOC129994365|LOC129994366|LOC129994367|LOC129994368|LOC129994369|LOC129994370|LOC129994371|LOC129994372|LOC129994373|LOC129994374|LOC129994375|LOC129994376|LOC129994377|LOC129994378|LOC129994379|LOC129994380|LOC129994381|LOC129994382|LOC129994383|LOC129994384|LOC129994385|LOC129994386|LOC129994387|LOC129994388|LOC129994389|LOC129994390|LOC129994391|LOC129994392|LOC129994393|LOC129994394|LOC129994395|LOC129994396|LOC129994397|LOC129994398|LOC129994399|LOC129994400|LOC129994401|LOC129994402|LOC129994403|LOC129994404|LOC129994405|LOC129994406|LOC129994407|LOC129994408|LOC129994409|LOC129994410|LOC129994411|LOC129994412|LOC129994413|LOC129994414|LOC129994415|LOC129994416|LOC129994417|LOC129994418|LOC129994419|LOC129994420|LOC129994421|LOC129994422|LOC129994423|LOC129994424|LOC129994425|LOC129994426|LOC129994427|LOC129994428|LOC129994429|LOC129994430|LOC129994431|LOC129994432|LOC129994945|LOC129994946|LOC129994947|LOC129994948|LOC129994949|LOC129994950|LOC129994951|LOC129994952|LOC129994953|LOC129994954|LOC129994955|LOC129994956|LOC129994957|LOC129994958|LOC129994959|LOC129994960|LOC129994961|LOC129994962|LOC129994963|LOC129994964|LOC129994965|LOC129994966|LOC129994967|LOC129994968|LOC129994969|LOC129994970|LOC129994971|LOC129994972|LOC129994973|LOC129994974|LOC129994975|LOC129994976|LOC129994977|LOC129994978|LOC129994979|LOC129994980|LOC129994981|LOC129994982|LOC129994983|LOC129994984|LOC129994985|LOC129994986|LOC129994987|LOC129994988|LOC129994989|LOC129994990|LOC129994991|LOC129994992|LOC129994993|LOC129994994|LOC129994995|LOC129994996|LOC129994997|LOC129994998|LOC129994999|LOC129995000|LOC129995001|LOC129995002|LOC129995003|LOC129995004|LOC129995005|LOC129995006|LOC129995007|LOC129995008|LOC129995009|LOC129995010|LOC129995011|LOC129995012|LOC129995013|LOC129995014|LOC129995015|LOC129995016|LOC129995017|LOC129995018|LOC129995019|LOC129995020|LOC129995021|LOC129995022|LOC129995023|LOC129995024|LOC129995025|LOC129995026|LOC129995027|LOC129995028|LOC129995029|LOC129995030|LOC129995031|LOC129995032|LOC129995033|LOC129995034|LOC129995035|LOC129995036|LOC129995037|LOC129995038|LOC129995039|LOC129995040|LOC129995041|LOC129995042|LOC129995043|LOC129995044|LOC129995045|LOC129995046|LOC129995047|LOC129995048|LOC129995049|LOC129995050|LOC129995051|LOC129995052|LOC129995053|LOC129995054|LOC129995055|LOC129995056|LOC129995057|LOC129995058|LOC129995059|LOC129995060|LOC129995061|LOC129995062|LOC129995063|LOC129995064|LOC129995065|LOC129995066|LOC129995067|LOC129995068|LOC129995069|LOC129995070|LOC129995071|LOC129995072|LOC129995073|LOC129995074|LOC129995075|LOC129995076|LOC129995077|LOC129995078|LOC129995079|LOC129995080|LOC129995081|LOC129995082|LOC129995083|LOC129995084|LOC129995085|LOC129995086|LOC129995087|LOC129995088|LOC129995089|LOC129995090|LOC129995091|LOC129995092|LOC129995093|LOC129995094|LOC129995095|LOC129995096|LOC129995097|LOC129995098|LOC129995099|LOC129995100|LOC129995101|LOC131768270|LOC132089162|LOC132089163|LOC132089164|LOC132089165|LOC132089166|LOC132089167|LOC132089168|LOC132089169|LOC132089170|LOC132089171|LOC132089172|LOC132089173|LOC132089174|LOC132089175|LOC132089176|LOC132089177|LOC132089178|LOC132089179|LOC132089180|LOC132089181|LOC132089182|LOC132089183|LOC132089184|LOC132089185|LOC132089186|LOC132089187|LOC132089188|LOC132089189|LOC132089190|LOC132089191|LOC132089192|LOC132089193|LOC132089194|LOC132089195|LOC132089196|LOC132089197|LOC132089198|LOC132089199|LOC132089200|LOC132089201|LOC132089202|LOC132089203|LOC132089204|LOC132089205|LOC132089206|LOC132089207|LOC132089208|LOC132089209|LOC132089210|LOC132089211|LOC132089212|LOC132089213|LOC132089214|LOC132089215|LOC132089216|LOC132089217|LOC132089218|LOC132089219|LOC132089220|LOC132089221|LOC132089222|LOC132089223|LOC132090732|LOC132090733|LOC132090734|LOC132090735|LOC132090736|LOC132090737|LOC132090738|LOC132090739|LOC132090740|LOC132090741|LOC132090742|LOC132090743|LOC132090744|LOC132090745|LOC132090746|LOC132090747|LOC132205961|LOC132205962|LOC285638|LOX|LRRTM2|LVRN|LYRM7|MACROH2A1|MALINC1|MAN2A1|MAN2A1-DT|MARCHF3|MARCOL|MATR3|MCC|MEGF10|MEIKIN|MFAP3|MGC32805|MINAR2|MIR12130|MIR1244-2|MIR1289-2|MIR1294|MIR1303|MIR143|MIR145|MIR3141|MIR3655|MIR3661|MIR378A|MIR378H|MIR3936|MIR3936HG|MIR4460|MIR4633|MIR5197|MIR548F3|MIR5692C1|MIR5706|MIR584|MIR6499|MIR6830|MIR6831|MIR874|MRPL22|MYOT|MYOZ3|MYOZ3-AS1|MZB1|NDFIP1|NDST1|NDST1-AS1|NDUFA2|NEUROG1|NME5|NMUR2|NR3C1|NREP|NREP-AS1|NRG2|P4HA2|P4HA2-AS1|PAIP2|PCBD2|PCDH1|PCDH12|PCDHA1|PCDHA10|PCDHA11|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHACT|PCDHB1|PCDHB1-AS1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHB16|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB8|PCDHB9|PCDHB@|PCDHG@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCYOX1L|PDE6A|PDGFRB|PDLIM4|PFDN1|PGGT1B|PHAX|PITX1|PITX1-AS1|PJA2|PKD2L2|PKD2L2-DT|PLAC8L1|POU4F3|PPARGC1B|PPIC|PPP2CA|PPP2CA-DT|PPP2R2B|PPP2R2B-IT1|PRDM6|PRDM6-AS1|PRELID2|PROB1|PRR16|PRRC1|PSD2|PSD2-AS1|PURA|RAD50|RAPGEF6|RBM22|RBM27|REEP2|REEP5|RELL2|RNF14|RPS14|SAP30L|SAP30L-AS1|SAR1B|SCGB3A2|SEC24A|SEMA6A|SEMA6A-AS1|SEMA6A-AS2|SEPTIN8|SGCD|SH3RF2|SH3TC2|SH3TC2-DT|SHROOM1|SIL1|SKP1|SLC12A2|SLC12A2-DT|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A46|SLC25A48|SLC25A48-AS1|SLC26A2|SLC27A6|SLC35A4|SLC36A1|SLC36A2|SLC36A3|SLC4A9|SLC6A7|SMAD5|SMAD5-AS1|SMIM3|SMIM32|SMIM33|SNCAIP|SNHG4|SNORA13|SNORA74A|SNORA74D|SNORD63|SNORD63B|SNX2|SNX24|SOWAHA|SPARC|SPATA24|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SPRY4-AS1|SPRY4-IT1|SRA1|SRFBP1|SRP19|STARD4|STARD4-AS1|STING1|STK32A|STK32A-AS1|SYNPO|TAF7|TCERG1|TCF7|TCOF1|TGFBI|TH2-LCR|TH2LCRR|TICAM2|TICAM2-AS1|TIFAB|TIGD6|TMCO6|TMED7|TMED7-TICAM2|TMEM232|TNFAIP8|TNIP1|TRIM36|TRPC7|TRPC7-AS1|TRPC7-AS2|TSLP|TSSK1B|TXNDC15|UBE2B|UBE2D2|UQCRQ|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR36|WDR55|WNT8A|WSPAR|YIPF5|YTHDC2|ZCCHC10|ZMAT2|ZNF300|ZNF474|ZNF474-AS1|ZNF475|ZNF608		See cases	VCV000059672	5	105955289 - 155551397	5	106619588 - 156124387	59672	74267			copy number loss		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 5q23.3-33.2(chr5:129847794-153353546)x3	ACSL6|ACSL6-AS1|ADRB2|AFAP1L1|AFF4|AFF4-DT|ANKHD1|ANKHD1-DT|ANKHD1-EIF4EBP3|ANXA6|APBB3|ARAP3|ARHGAP26|ARHGAP26-AS1|ARHGAP26-IT1|ARHGEF37|ARSI|ATOX1|ATOX1-AS1|BRD8|C5orf15|C5orf24|C5orf46|CAMK2A|CAMLG|CARINH|CARMN|CATSPER3|CCDC69|CCNI2|CD14|CD74|CDC23|CDC25C|CDC42SE2|CDKL3|CDKN2AIPNL|CDX1|CHSY3|CHSY3-AS1|CLMAT3|CSF1R|CSF2|CSNK1A1|CTB-1I21.1|CTB-99A3.1|CTNNA1|CTNNA1-AS1|CXCL14|CXXC5|CXXC5-AS1|CYSTM1|DCANP1|DCTN4|DDX46|DELE1|DIAPH1|DIAPH1-AS1|DNAJC18|DND1|DPYSL3|ECSCR|EGR1|EIF4EBP3|EPIST|ETF1|FAM13B|FAM13B-AS1|FAM53C|FAT2|FBXO38|FBXO38-DT|FCHSD1|FGF1|FNIP1|FSTL4|G3BP1|GDF9|GFRA3|GLRA1|GM2A|GNPDA1|GPR151|GPX3|GRPEL2|GRPEL2-AS1|GRXCR2|HARS1|HARS2|HBEGF|HDAC3|HINT1|HMGXB3|HMHB1|HNRNPA0|HSPA4|HSPA9|HTR4|IGIP|IK|IL13|IL17B|IL3|IL4|IL5|IL9|IRF1|IRGM|JADE2|JAKMIP2|JAKMIP2-AS1|KCTD16|KDM3B|KIF20A|KIF3A|KLHL3|LARS1|LEAP2|LECT2|LINC01470|LINC01843|LINC01844|LINC01933|LINC02863|LINC02900|LINC02999|LOC100128966|LOC100652758|LOC101929719|LOC105378230|LOC105379176|LOC105379183|LOC105379192|LOC107198087|LOC107986453|LOC108178993|LOC108281143|LOC108449898|LOC108660405|LOC109113859|LOC109113860|LOC109113862|LOC110121107|LOC110121118|LOC110121171|LOC110121202|LOC110121271|LOC111188152|LOC111188153|LOC111188154|LOC111188156|LOC111365180|LOC111429606|LOC111500310|LOC111828524|LOC112267934|LOC112997557|LOC112997558|LOC112997559|LOC112997560|LOC112997561|LOC112997562|LOC112997563|LOC112997564|LOC112997565|LOC112997566|LOC112997567|LOC112997568|LOC112997569|LOC114004387|LOC114004388|LOC114004389|LOC114004390|LOC116158522|LOC116158523|LOC116158524|LOC116158525|LOC119407423|LOC120285837|LOC121079960|LOC121079961|LOC121079962|LOC121099701|LOC121099702|LOC121099703|LOC121099704|LOC121099705|LOC121099706|LOC121099707|LOC121099708|LOC121099709|LOC121099710|LOC121725217|LOC121740630|LOC123497966|LOC123497967|LOC123497968|LOC123497969|LOC123497970|LOC123497971|LOC123497972|LOC123497973|LOC123497974|LOC123497975|LOC123497976|LOC123497977|LOC123497978|LOC123522801|LOC123522802|LOC123522803|LOC123522804|LOC123522805|LOC123522806|LOC123566730|LOC123566731|LOC123566732|LOC123566733|LOC123566734|LOC123575580|LOC123575581|LOC123575582|LOC123575583|LOC123575584|LOC123575585|LOC123575586|LOC123575587|LOC123575588|LOC123575589|LOC123575590|LOC123575592|LOC123575593|LOC123575594|LOC123575595|LOC123575596|LOC123575597|LOC123575598|LOC123575599|LOC123575600|LOC123575601|LOC123575602|LOC126807503|LOC126807504|LOC126807505|LOC126807506|LOC126807507|LOC126807508|LOC126807509|LOC126807510|LOC126807511|LOC126807512|LOC126807513|LOC126807514|LOC126807515|LOC126807516|LOC126807517|LOC126807518|LOC126807519|LOC126807520|LOC126807521|LOC126807522|LOC126807523|LOC126807524|LOC126807525|LOC126807526|LOC126807527|LOC126807528|LOC126807529|LOC126807530|LOC126807531|LOC126807532|LOC126807533|LOC126807534|LOC126807535|LOC126807536|LOC126807537|LOC126807538|LOC126807539|LOC126807540|LOC126807541|LOC126807542|LOC126807543|LOC126807544|LOC126807545|LOC126807546|LOC126807547|LOC126807548|LOC126807549|LOC126807550|LOC126807551|LOC126807552|LOC126807553|LOC126807554|LOC126807555|LOC126807556|LOC126807557|LOC126807558|LOC126807559|LOC126807560|LOC126807561|LOC127814297|LOC128772274|LOC129389362|LOC129389363|LOC129389364|LOC129389365|LOC129389366|LOC129389367|LOC129389368|LOC129389369|LOC129389370|LOC129389371|LOC129389372|LOC129389373|LOC129389374|LOC129389375|LOC129389376|LOC129389377|LOC129389378|LOC129389379|LOC129389380|LOC129389381|LOC129389382|LOC129389383|LOC129389384|LOC129389385|LOC129389386|LOC129389387|LOC129389388|LOC129389389|LOC129389390|LOC129389391|LOC129389392|LOC129389393|LOC129389394|LOC129389395|LOC129389396|LOC129389397|LOC129389398|LOC129389399|LOC129389400|LOC129389401|LOC129994532|LOC129994533|LOC129994534|LOC129994535|LOC129994536|LOC129994537|LOC129994538|LOC129994539|LOC129994540|LOC129994541|LOC129994542|LOC129994543|LOC129994544|LOC129994545|LOC129994546|LOC129994547|LOC129994548|LOC129994549|LOC129994550|LOC129994551|LOC129994552|LOC129994553|LOC129994554|LOC129994555|LOC129994556|LOC129994557|LOC129994558|LOC129994559|LOC129994560|LOC129994561|LOC129994562|LOC129994563|LOC129994564|LOC129994565|LOC129994566|LOC129994567|LOC129994568|LOC129994569|LOC129994570|LOC129994571|LOC129994572|LOC129994573|LOC129994574|LOC129994575|LOC129994576|LOC129994577|LOC129994578|LOC129994579|LOC129994580|LOC129994581|LOC129994582|LOC129994583|LOC129994584|LOC129994585|LOC129994586|LOC129994587|LOC129994588|LOC129994589|LOC129994590|LOC129994591|LOC129994592|LOC129994593|LOC129994594|LOC129994595|LOC129994596|LOC129994597|LOC129994598|LOC129994599|LOC129994600|LOC129994601|LOC129994602|LOC129994603|LOC129994604|LOC129994605|LOC129994606|LOC129994607|LOC129994608|LOC129994609|LOC129994610|LOC129994611|LOC129994612|LOC129994613|LOC129994614|LOC129994615|LOC129994616|LOC129994617|LOC129994618|LOC129994619|LOC129994620|LOC129994621|LOC129994622|LOC129994623|LOC129994624|LOC129994625|LOC129994626|LOC129994627|LOC129994628|LOC129994629|LOC129994630|LOC129994631|LOC129994632|LOC129994633|LOC129994634|LOC129994635|LOC129994636|LOC129994637|LOC129994638|LOC129994639|LOC129994640|LOC129994641|LOC129994642|LOC129994643|LOC129994644|LOC129994645|LOC129994646|LOC129994647|LOC129994648|LOC129994649|LOC129994650|LOC129994651|LOC129994652|LOC129994653|LOC129994654|LOC129994655|LOC129994656|LOC129994657|LOC129994658|LOC129994659|LOC129994660|LOC129994661|LOC129994662|LOC129994663|LOC129994664|LOC129994665|LOC129994666|LOC129994667|LOC129994668|LOC129994669|LOC129994670|LOC129994671|LOC129994672|LOC129994673|LOC129994674|LOC129994675|LOC129994676|LOC129994677|LOC129994678|LOC129994679|LOC129994680|LOC129994681|LOC129994682|LOC129994683|LOC129994684|LOC129994685|LOC129994686|LOC129994687|LOC129994688|LOC129994689|LOC129994690|LOC129994691|LOC129994692|LOC129994693|LOC129994694|LOC129994695|LOC129994696|LOC129994697|LOC129994698|LOC129994699|LOC129994700|LOC129994701|LOC129994702|LOC129994703|LOC129994704|LOC129994705|LOC129994706|LOC129994707|LOC129994708|LOC129994709|LOC129994710|LOC129994711|LOC129994712|LOC129994713|LOC129994714|LOC129994715|LOC129994716|LOC129994717|LOC129994718|LOC129994719|LOC129994720|LOC129994721|LOC129994722|LOC129994723|LOC129994724|LOC129994725|LOC129994726|LOC129994727|LOC129994728|LOC129994729|LOC129994730|LOC129994731|LOC129994732|LOC129994733|LOC129994734|LOC129994735|LOC129994736|LOC129994737|LOC129994738|LOC129994739|LOC129994740|LOC129994741|LOC129994742|LOC129994743|LOC129994744|LOC129994745|LOC129994746|LOC129994747|LOC129994748|LOC129994749|LOC129994750|LOC129994751|LOC129994752|LOC129994753|LOC129994754|LOC129994755|LOC129994756|LOC129994757|LOC129994758|LOC129994759|LOC129994760|LOC129994761|LOC129994762|LOC129994763|LOC129994764|LOC129994765|LOC129994766|LOC129994767|LOC129994768|LOC129994769|LOC129994770|LOC129994771|LOC129994772|LOC129994773|LOC129994774|LOC129994775|LOC129994776|LOC129994777|LOC129994778|LOC129994779|LOC129994780|LOC129994781|LOC129994782|LOC129994783|LOC129994784|LOC129994785|LOC129994786|LOC129994787|LOC129994788|LOC129994789|LOC129994790|LOC129994791|LOC129994792|LOC129994793|LOC129994794|LOC129994795|LOC129994796|LOC129994797|LOC129994798|LOC129994799|LOC129994800|LOC129994801|LOC129994802|LOC129994803|LOC129994804|LOC129994805|LOC129994806|LOC129994807|LOC129994808|LOC129994809|LOC129994810|LOC129994811|LOC129994812|LOC129994813|LOC129994814|LOC129994815|LOC129994816|LOC129994817|LOC129994818|LOC129994819|LOC129994820|LOC129994821|LOC129994822|LOC129994823|LOC129994824|LOC129994825|LOC129994826|LOC129994827|LOC129994828|LOC129994829|LOC129994830|LOC129994831|LOC129994832|LOC129994833|LOC129994834|LOC129994835|LOC129994836|LOC129994837|LOC129994838|LOC129994839|LOC129994840|LOC129994841|LOC129994842|LOC129994843|LOC129994844|LOC129994845|LOC129994846|LOC129994847|LOC129994848|LOC129994849|LOC129994850|LOC129994851|LOC129994852|LOC129994853|LOC129994854|LOC129994855|LOC129994856|LOC129994857|LOC129994858|LOC129994859|LOC129994860|LOC129994861|LOC129994862|LOC129994863|LOC129994864|LOC129994865|LOC129994866|LOC129994867|LOC129994868|LOC129994869|LOC129994870|LOC129994871|LOC129994872|LOC129994873|LOC129994874|LOC129994875|LOC129994876|LOC129994877|LOC129994878|LOC129994879|LOC129994880|LOC129994881|LOC129994882|LOC129994883|LOC129994884|LOC129994885|LOC129994886|LOC129994887|LOC129994888|LOC129994889|LOC129994890|LOC129994891|LOC129994892|LOC129994893|LOC129994894|LOC129994895|LOC129994896|LOC129994897|LOC129994898|LOC129994899|LOC129994900|LOC129994901|LOC129994902|LOC129994903|LOC129994904|LOC129994905|LOC129994906|LOC129994907|LOC129994908|LOC129994909|LOC129994910|LOC129994911|LOC129994912|LOC129994913|LOC129994914|LOC129994915|LOC129994916|LOC129994917|LOC129994918|LOC129994919|LOC129994920|LOC129994921|LOC129994922|LOC129994923|LOC129994924|LOC129994925|LOC129994926|LOC129994927|LOC129994928|LOC129994929|LOC129994930|LOC129994931|LOC129994932|LOC129994933|LOC129994934|LOC129994935|LOC129994936|LOC129994937|LOC129994938|LOC129994939|LOC129994940|LOC129994941|LOC129994942|LOC129994943|LOC129994944|LOC129994945|LOC129994946|LOC129994947|LOC129994948|LOC129994949|LOC129994950|LOC129994951|LOC129994952|LOC129994953|LOC129994954|LOC129994955|LOC129994956|LOC129994957|LOC129994958|LOC129994959|LOC129994960|LOC129994961|LOC129994962|LOC129994963|LOC129994964|LOC129994965|LOC129994966|LOC129994967|LOC129994968|LOC129994969|LOC129994970|LOC129994971|LOC129994972|LOC129994973|LOC129994974|LOC129994975|LOC129994976|LOC129994977|LOC129994978|LOC129994979|LOC129994980|LOC129994981|LOC129994982|LOC129994983|LOC129994984|LOC129994985|LOC129994986|LOC129994987|LOC129994988|LOC129994989|LOC129994990|LOC129994991|LOC129994992|LOC129994993|LOC129994994|LOC129994995|LOC129994996|LOC129994997|LOC129994998|LOC129994999|LOC129995000|LOC129995001|LOC129995002|LOC129995003|LOC129995004|LOC129995005|LOC129995006|LOC129995007|LOC129995008|LOC129995009|LOC129995010|LOC129995011|LOC129995012|LOC129995013|LOC129995014|LOC129995015|LOC129995016|LOC129995017|LOC129995018|LOC129995019|LOC129995020|LOC129995021|LOC129995022|LOC129995023|LOC129995024|LOC129995025|LOC129995026|LOC129995027|LOC129995028|LOC129995029|LOC129995030|LOC129995031|LOC129995032|LOC129995033|LOC129995034|LOC129995035|LOC129995036|LOC129995037|LOC129995038|LOC129995039|LOC129995040|LOC129995041|LOC129995042|LOC129995043|LOC129995044|LOC129995045|LOC129995046|LOC129995047|LOC129995048|LOC129995049|LOC129995050|LOC129995051|LOC129995052|LOC129995053|LOC129995054|LOC129995055|LOC129995056|LOC129995057|LOC129995058|LOC129995059|LOC129995060|LOC129995061|LOC129995062|LOC129995063|LOC131768270|LOC132089164|LOC132089165|LOC132089166|LOC132089167|LOC132089168|LOC132089169|LOC132089170|LOC132089171|LOC132089172|LOC132089173|LOC132089174|LOC132089175|LOC132089176|LOC132089177|LOC132089178|LOC132089179|LOC132089180|LOC132089181|LOC132089182|LOC132089183|LOC132089184|LOC132089185|LOC132089186|LOC132089187|LOC132089188|LOC132089189|LOC132089190|LOC132089191|LOC132089192|LOC132089193|LOC132089194|LOC132089195|LOC132089196|LOC132089197|LOC132089198|LOC132089199|LOC132089200|LOC132089201|LOC132089202|LOC132089203|LOC132089204|LOC132089205|LOC132089206|LOC132089207|LOC132089208|LOC132089209|LOC132089210|LOC132089211|LOC132089212|LOC132089213|LOC132089214|LOC132089215|LOC132089216|LOC132089217|LOC132089218|LOC132089219|LOC132089220|LOC132089221|LOC132089222|LOC132090733|LOC132090734|LOC132090735|LOC132090736|LOC132090737|LOC132090738|LOC132090739|LOC132090740|LOC132090741|LOC132090742|LOC132090743|LOC132090744|LOC132090745|LOC132090746|LOC132205961|LOC132205962|LRRTM2|LYRM7|MACROH2A1|MALINC1|MARCOL|MATR3|MEIKIN|MIR1289-2|MIR143|MIR145|MIR3655|MIR3661|MIR378A|MIR3936|MIR3936HG|MIR5197|MIR5692C1|MIR584|MIR6499|MIR6830|MIR6831|MIR874|MYOT|MYOZ3|MYOZ3-AS1|MZB1|NDFIP1|NDST1|NDST1-AS1|NDUFA2|NEUROG1|NME5|NMUR2|NR3C1|NRG2|P4HA2|P4HA2-AS1|PAIP2|PCBD2|PCDH1|PCDH12|PCDHA1|PCDHA10|PCDHA11|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHACT|PCDHB1|PCDHB1-AS1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHB16|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB8|PCDHB9|PCDHB@|PCDHG@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCYOX1L|PDE6A|PDGFRB|PDLIM4|PFDN1|PITX1|PITX1-AS1|PKD2L2|PKD2L2-DT|PLAC8L1|POU4F3|PPARGC1B|PPP2CA|PPP2CA-DT|PPP2R2B|PPP2R2B-IT1|PRELID2|PROB1|PSD2|PSD2-AS1|PURA|RAD50|RAPGEF6|RBM22|RBM27|REEP2|RELL2|RNF14|RPS14|SAR1B|SCGB3A2|SEC24A|SEPTIN8|SH3RF2|SH3TC2|SH3TC2-DT|SHROOM1|SIL1|SKP1|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A48|SLC25A48-AS1|SLC26A2|SLC35A4|SLC36A1|SLC36A2|SLC36A3|SLC4A9|SLC6A7|SMAD5|SMAD5-AS1|SMIM3|SMIM32|SMIM33|SNHG4|SNORA74A|SNORA74D|SNORD63|SNORD63B|SOWAHA|SPARC|SPATA24|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPOCK1|SPRY4|SPRY4-AS1|SPRY4-IT1|SRA1|STING1|STK32A|STK32A-AS1|SYNPO|TAF7|TCERG1|TCF7|TCOF1|TGFBI|TH2-LCR|TH2LCRR|TIFAB|TIGD6|TMCO6|TNIP1|TRPC7|TRPC7-AS1|TRPC7-AS2|TXNDC15|UBE2B|UBE2D2|UQCRQ|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR55|WNT8A|WSPAR|YIPF5|ZCCHC10|ZMAT2|ZNF300|ABLIM3		See cases	VCV000149858	5	129183487 - 152733106	5	129847794 - 153353546	149858	159609			copy number gain		Pathogenic	Sep 21, 2012	no assertion criteria provided							
GRCh38/hg38 5q23.3-33.2(chr5:130860928-155321811)x3	ABLIM3|ACSL6|ACSL6-AS1|ADRB2|AFAP1L1|AFF4|AFF4-DT|ANKHD1|ANKHD1-DT|ANKHD1-EIF4EBP3|ANXA6|APBB3|ARAP3|ARHGAP26|ARHGAP26-AS1|ARHGAP26-IT1|ARHGEF37|ARSI|ATOX1|ATOX1-AS1|BRD8|C5orf15|C5orf24|C5orf46|CAMK2A|CAMLG|CARINH|CARMN|CATSPER3|CCDC69|CCNI2|CD14|CD74|CDC23|CDC25C|CDC42SE2|CDKL3|CDKN2AIPNL|CDX1|CLMAT3|CNOT8|CSF1R|CSF2|CSNK1A1|CTB-1I21.1|CTB-99A3.1|CTNNA1|CTNNA1-AS1|CXCL14|CXXC5|CXXC5-AS1|CYSTM1|DCANP1|DCTN4|DDX46|DELE1|DIAPH1|DIAPH1-AS1|DNAJC18|DND1|DPYSL3|ECSCR|EGR1|EIF4EBP3|EPIST|ETF1|FAM114A2|FAM13B|FAM13B-AS1|FAM53C|FAT2|FAXDC2|FBXO38|FBXO38-DT|FCHSD1|FGF1|FNIP1|FSTL4|G3BP1|GALNT10|GDF9|GEMIN5|GFRA3|GLRA1|GM2A|GNPDA1|GPR151|GPX3|GRIA1|GRPEL2|GRPEL2-AS1|GRXCR2|HAND1|HARS1|HARS2|HBEGF|HDAC3|HINT1|HMGXB3|HMHB1|HNRNPA0|HSPA4|HSPA9|HTR4|IGIP|IK|IL13|IL17B|IL3|IL4|IL5|IL9|IRF1|IRGM|JADE2|JAKMIP2|JAKMIP2-AS1|KCTD16|KDM3B|KIF20A|KIF3A|KIF4B|KLHL3|LARP1|LARS1|LEAP2|LECT2|LINC01470|LINC01843|LINC01844|LINC01861|LINC01933|LINC02863|LINC02900|LINC02999|LOC100128966|LOC100652758|LOC101929719|LOC105378230|LOC105379176|LOC105379183|LOC105379192|LOC107198087|LOC107986453|LOC108178993|LOC108228201|LOC108281143|LOC108449898|LOC108660405|LOC109113859|LOC109113860|LOC109113862|LOC110121107|LOC110121118|LOC110121171|LOC110121202|LOC110121271|LOC111188152|LOC111188153|LOC111188154|LOC111188156|LOC111365180|LOC111429606|LOC111500310|LOC111828524|LOC112267934|LOC112997558|LOC112997559|LOC112997560|LOC112997561|LOC112997562|LOC112997563|LOC112997564|LOC112997565|LOC112997566|LOC112997567|LOC112997568|LOC112997569|LOC112997570|LOC114004387|LOC114004388|LOC114004389|LOC114004390|LOC116158522|LOC116158523|LOC116158524|LOC116158525|LOC116158526|LOC119407423|LOC120285837|LOC121079960|LOC121079961|LOC121079962|LOC121099701|LOC121099702|LOC121099703|LOC121099704|LOC121099705|LOC121099706|LOC121099707|LOC121099708|LOC121099709|LOC121099710|LOC121725217|LOC121740630|LOC121740631|LOC123497966|LOC123497967|LOC123497968|LOC123497969|LOC123497970|LOC123497971|LOC123497972|LOC123497973|LOC123497974|LOC123497975|LOC123497976|LOC129994906|LOC129994907|LOC129994908|LOC129994909|LOC129994910|LOC129994911|LOC129994912|LOC129994913|LOC129994914|LOC129994915|LOC129994916|LOC129994917|LOC129994918|LOC129994919|LOC129994920|LOC129994921|LOC129994922|LOC129994923|LOC129994924|LOC129994925|LOC129994926|LOC129994927|LOC129994928|LOC129994929|LOC129994930|LOC129994931|LOC129994932|LOC129994933|LOC129994934|LOC129994935|LOC129994936|LOC129994937|LOC129994938|LOC129994939|LOC129994940|LOC129994941|LOC129994942|LOC129994943|LOC129994944|LOC129994945|LOC129994946|LOC129994947|LOC129994948|LOC129994949|LOC129994950|LOC129994951|LOC129994952|LOC129994953|LOC129994954|LOC129994955|LOC129994956|LOC129994957|LOC129994958|LOC129994959|LOC129994960|LOC129994961|LOC129994962|LOC129994963|LOC129994964|LOC129994965|LOC129994966|LOC129994967|LOC129994968|LOC129994969|LOC129994970|LOC129994971|LOC129994972|LOC129994973|LOC129994974|LOC129994975|LOC129994976|LOC129994977|LOC129994978|LOC129994979|LOC129994980|LOC129994981|LOC129994982|LOC129994983|LOC129994984|LOC129994985|LOC129994986|LOC129994987|LOC129994988|LOC129994989|LOC129994990|LOC129994991|LOC129994992|LOC129994993|LOC129994994|LOC129994995|LOC129994996|LOC129994997|LOC129994998|LOC129994999|LOC129995000|LOC129995001|LOC129995002|LOC129995003|LOC129995004|LOC129995005|LOC129995006|LOC129995007|LOC129995008|LOC129995009|LOC129995010|LOC129995011|LOC129995012|LOC129995013|LOC129995014|LOC129995015|LOC129995016|LOC129995017|LOC129995018|LOC129995019|LOC129995020|LOC129995021|LOC129995022|LOC129995023|LOC129995024|LOC129995025|LOC129995026|LOC129995027|LOC129995028|LOC129995029|LOC129995030|LOC129995031|LOC129995032|LOC129995033|LOC129995034|LOC129995035|LOC129995036|LOC129995037|LOC129995038|LOC129995039|LOC129995040|LOC129995041|LOC129995042|LOC129995043|LOC129995044|LOC129995045|LOC129995046|LOC129995047|LOC129995048|LOC129995049|LOC129995050|LOC129995051|LOC129995052|LOC129995053|LOC129995054|LOC129995055|LOC129995056|LOC129995057|LOC129995058|LOC129995059|LOC129995060|LOC129995061|LOC129995062|LOC129995063|LOC129995064|LOC129995065|LOC129995066|LOC129995067|LOC129995068|LOC129995069|LOC129995070|LOC129995071|LOC129995072|LOC129995073|LOC129995074|LOC129995075|LOC129995076|LOC129995077|LOC129995078|LOC129995079|LOC129995080|LOC129995081|LOC129995082|LOC129995083|LOC129995084|LOC129995085|LOC129995086|LOC129995087|LOC129995088|LOC129995089|LOC129995090|LOC129995091|LOC129995092|LOC129995093|LOC129995094|LOC129995095|LOC129995096|LOC129995097|LOC129995098|LOC129995099|LOC129995100|LOC131768270|LOC132089164|LOC132089165|LOC132089166|LOC132089167|LOC132089168|LOC132089169|LOC132089170|LOC132089171|LOC132089172|LOC132089173|LOC132089174|LOC132089175|LOC132089176|LOC132089177|LOC132089178|LOC132089179|LOC132089180|LOC132089181|LOC132089182|LOC132089183|LOC132089184|LOC132089185|LOC132089186|LOC132089187|LOC132089188|LOC132089189|LOC132089190|LOC132089191|LOC132089192|LOC132089193|LOC132089194|LOC132089195|LOC132089196|LOC132089197|LOC132089198|LOC132089199|LOC132089200|LOC132089201|LOC132089202|LOC132089203|LOC132089204|LOC132089205|LOC132089206|LOC132089207|LOC132089208|LOC132089209|LOC132089210|LOC132089211|LOC132089212|LOC132089213|LOC132089214|LOC132089215|LOC132089216|LOC132089217|LOC132089218|LOC132089219|LOC132089220|LOC132089221|LOC132089222|LOC132089223|LOC132090733|LOC132090734|LOC132090735|LOC132090736|LOC132090737|LOC132090738|LOC132090739|LOC132090740|LOC132090741|LOC132090742|LOC132090743|LOC132090744|LOC132090745|LOC132090746|LOC132090747|LOC132205961|LOC132205962|LRRTM2|LYRM7|MACROH2A1|MALINC1|MARCOL|MATR3|MEIKIN|MFAP3|MIR1289-2|MIR1294|MIR1303|MIR143|MIR145|MIR3141|MIR3655|MIR3661|MIR378A|MIR378H|MIR3936|MIR3936HG|MIR5197|MIR5692C1|MIR584|MIR6499|MIR6830|MIR6831|MIR874|MRPL22|MYOT|MYOZ3|MYOZ3-AS1|MZB1|NDFIP1|NDST1|NDST1-AS1|NDUFA2|NEUROG1|NME5|NMUR2|NR3C1|NRG2|P4HA2|P4HA2-AS1|PAIP2|PCBD2|PCDH1|PCDH12|PCDHA1|PCDHA10|PCDHA11|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHACT|PCDHB1|PCDHB1-AS1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHB16|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB8|PCDHB9|PCDHB@|PCDHG@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCYOX1L|PDE6A|PDGFRB|PDLIM4|PFDN1|PITX1|PITX1-AS1|PKD2L2|PKD2L2-DT|PLAC8L1|POU4F3|PPARGC1B|PPP2CA|PPP2CA-DT|PPP2R2B|PPP2R2B-IT1|PRELID2|PROB1|PSD2|PSD2-AS1|PURA|RAD50|RAPGEF6|RBM22|RBM27|REEP2|RELL2|RNF14|RPS14|SAP30L|SAP30L-AS1|SAR1B|SCGB3A2|SEC24A|SEPTIN8|SH3RF2|SH3TC2|SH3TC2-DT|SHROOM1|SIL1|SKP1|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A48|SLC25A48-AS1|SLC26A2|SLC35A4|SLC36A1|SLC36A2|SLC36A3|SLC4A9|SLC6A7|SMAD5|SMAD5-AS1|SMIM3|SMIM32|SMIM33|SNHG4|SNORA74A|SNORA74D|SNORD63|SNORD63B|SOWAHA|SPARC|SPATA24|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPOCK1|SPRY4|SPRY4-AS1|SPRY4-IT1|SRA1|STING1|STK32A|STK32A-AS1|SYNPO|TAF7|TCERG1|TCF7|TCOF1|TGFBI|TH2-LCR|TH2LCRR|TIFAB|TIGD6|TMCO6|TNIP1|TRPC7|TRPC7-AS1|TRPC7-AS2|TXNDC15|UBE2B|UBE2D2|UQCRQ|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR55|WNT8A|WSPAR|YIPF5|ZCCHC10|ZMAT2|ZNF300|LOC123497977|LOC123497978|LOC123522801|LOC123522802|LOC123522803|LOC123522804|LOC123522805|LOC123522806|LOC123566730|LOC123566731|LOC123566732|LOC123566733|LOC123566734|LOC123575580|LOC123575581|LOC123575582|LOC123575583|LOC123575584|LOC123575585|LOC123575586|LOC123575587|LOC123575588|LOC123575589|LOC123575590|LOC123575592|LOC123575593|LOC123575594|LOC123575595|LOC123575596|LOC123575597|LOC123575598|LOC123575599|LOC123575600|LOC123575601|LOC123575602|LOC123575603|LOC123575604|LOC123575605|LOC126807505|LOC126807506|LOC126807507|LOC126807508|LOC126807509|LOC126807510|LOC126807511|LOC126807512|LOC126807513|LOC126807514|LOC126807515|LOC126807516|LOC126807517|LOC126807518|LOC126807519|LOC126807520|LOC126807521|LOC126807522|LOC126807523|LOC126807524|LOC126807525|LOC126807526|LOC126807527|LOC126807528|LOC126807529|LOC126807530|LOC126807531|LOC126807532|LOC126807533|LOC126807534|LOC126807535|LOC126807536|LOC126807537|LOC126807538|LOC126807539|LOC126807540|LOC126807541|LOC126807542|LOC126807543|LOC126807544|LOC126807545|LOC126807546|LOC126807547|LOC126807548|LOC126807549|LOC126807550|LOC126807551|LOC126807552|LOC126807553|LOC126807554|LOC126807555|LOC126807556|LOC126807557|LOC126807558|LOC126807559|LOC126807560|LOC126807561|LOC126807562|LOC126807563|LOC127814297|LOC128772274|LOC129389362|LOC129389363|LOC129389364|LOC129389365|LOC129389366|LOC129389367|LOC129389368|LOC129389369|LOC129389370|LOC129389371|LOC129389372|LOC129389373|LOC129389374|LOC129389375|LOC129389376|LOC129389377|LOC129389378|LOC129389379|LOC129389380|LOC129389381|LOC129389382|LOC129389383|LOC129389384|LOC129389385|LOC129389386|LOC129389387|LOC129389388|LOC129389389|LOC129389390|LOC129389391|LOC129389392|LOC129389393|LOC129389394|LOC129389395|LOC129389396|LOC129389397|LOC129389398|LOC129389399|LOC129389400|LOC129389401|LOC129994533|LOC129994534|LOC129994535|LOC129994536|LOC129994537|LOC129994538|LOC129994539|LOC129994540|LOC129994541|LOC129994542|LOC129994543|LOC129994544|LOC129994545|LOC129994546|LOC129994547|LOC129994548|LOC129994549|LOC129994550|LOC129994551|LOC129994552|LOC129994553|LOC129994554|LOC129994555|LOC129994556|LOC129994557|LOC129994558|LOC129994559|LOC129994560|LOC129994561|LOC129994562|LOC129994563|LOC129994564|LOC129994565|LOC129994566|LOC129994567|LOC129994568|LOC129994569|LOC129994570|LOC129994571|LOC129994572|LOC129994573|LOC129994574|LOC129994575|LOC129994576|LOC129994577|LOC129994578|LOC129994579|LOC129994580|LOC129994581|LOC129994582|LOC129994583|LOC129994584|LOC129994585|LOC129994586|LOC129994587|LOC129994588|LOC129994589|LOC129994590|LOC129994591|LOC129994592|LOC129994593|LOC129994594|LOC129994595|LOC129994596|LOC129994597|LOC129994598|LOC129994599|LOC129994600|LOC129994601|LOC129994602|LOC129994603|LOC129994604|LOC129994605|LOC129994606|LOC129994607|LOC129994608|LOC129994609|LOC129994610|LOC129994611|LOC129994612|LOC129994613|LOC129994614|LOC129994615|LOC129994616|LOC129994617|LOC129994618|LOC129994619|LOC129994620|LOC129994621|LOC129994622|LOC129994623|LOC129994624|LOC129994625|LOC129994626|LOC129994627|LOC129994628|LOC129994629|LOC129994630|LOC129994631|LOC129994632|LOC129994633|LOC129994634|LOC129994635|LOC129994636|LOC129994637|LOC129994638|LOC129994639|LOC129994640|LOC129994641|LOC129994642|LOC129994643|LOC129994644|LOC129994645|LOC129994646|LOC129994647|LOC129994648|LOC129994649|LOC129994650|LOC129994651|LOC129994652|LOC129994653|LOC129994654|LOC129994655|LOC129994656|LOC129994657|LOC129994658|LOC129994659|LOC129994660|LOC129994661|LOC129994662|LOC129994663|LOC129994664|LOC129994665|LOC129994666|LOC129994667|LOC129994668|LOC129994669|LOC129994670|LOC129994671|LOC129994672|LOC129994673|LOC129994674|LOC129994675|LOC129994676|LOC129994677|LOC129994678|LOC129994679|LOC129994680|LOC129994681|LOC129994682|LOC129994683|LOC129994684|LOC129994685|LOC129994686|LOC129994687|LOC129994688|LOC129994689|LOC129994690|LOC129994691|LOC129994692|LOC129994693|LOC129994694|LOC129994695|LOC129994696|LOC129994697|LOC129994698|LOC129994699|LOC129994700|LOC129994701|LOC129994702|LOC129994703|LOC129994704|LOC129994705|LOC129994706|LOC129994707|LOC129994708|LOC129994709|LOC129994710|LOC129994711|LOC129994712|LOC129994713|LOC129994714|LOC129994715|LOC129994716|LOC129994717|LOC129994718|LOC129994719|LOC129994720|LOC129994721|LOC129994722|LOC129994723|LOC129994724|LOC129994725|LOC129994726|LOC129994727|LOC129994728|LOC129994729|LOC129994730|LOC129994731|LOC129994732|LOC129994733|LOC129994734|LOC129994735|LOC129994736|LOC129994737|LOC129994738|LOC129994739|LOC129994740|LOC129994741|LOC129994742|LOC129994743|LOC129994744|LOC129994745|LOC129994746|LOC129994747|LOC129994748|LOC129994749|LOC129994750|LOC129994751|LOC129994752|LOC129994753|LOC129994754|LOC129994755|LOC129994756|LOC129994757|LOC129994758|LOC129994759|LOC129994760|LOC129994761|LOC129994762|LOC129994763|LOC129994764|LOC129994765|LOC129994766|LOC129994767|LOC129994768|LOC129994769|LOC129994770|LOC129994771|LOC129994772|LOC129994773|LOC129994774|LOC129994775|LOC129994776|LOC129994777|LOC129994778|LOC129994779|LOC129994780|LOC129994781|LOC129994782|LOC129994783|LOC129994784|LOC129994785|LOC129994786|LOC129994787|LOC129994788|LOC129994789|LOC129994790|LOC129994791|LOC129994792|LOC129994793|LOC129994794|LOC129994795|LOC129994796|LOC129994797|LOC129994798|LOC129994799|LOC129994800|LOC129994801|LOC129994802|LOC129994803|LOC129994804|LOC129994805|LOC129994806|LOC129994807|LOC129994808|LOC129994809|LOC129994810|LOC129994811|LOC129994812|LOC129994813|LOC129994814|LOC129994815|LOC129994816|LOC129994817|LOC129994818|LOC129994819|LOC129994820|LOC129994821|LOC129994822|LOC129994823|LOC129994824|LOC129994825|LOC129994826|LOC129994827|LOC129994828|LOC129994829|LOC129994830|LOC129994831|LOC129994832|LOC129994833|LOC129994834|LOC129994835|LOC129994836|LOC129994837|LOC129994838|LOC129994839|LOC129994840|LOC129994841|LOC129994842|LOC129994843|LOC129994844|LOC129994845|LOC129994846|LOC129994847|LOC129994848|LOC129994849|LOC129994850|LOC129994851|LOC129994852|LOC129994853|LOC129994854|LOC129994855|LOC129994856|LOC129994857|LOC129994858|LOC129994859|LOC129994860|LOC129994861|LOC129994862|LOC129994863|LOC129994864|LOC129994865|LOC129994866|LOC129994867|LOC129994868|LOC129994869|LOC129994870|LOC129994871|LOC129994872|LOC129994873|LOC129994874|LOC129994875|LOC129994876|LOC129994877|LOC129994878|LOC129994879|LOC129994880|LOC129994881|LOC129994882|LOC129994883|LOC129994884|LOC129994885|LOC129994886|LOC129994887|LOC129994888|LOC129994889|LOC129994890|LOC129994891|LOC129994892|LOC129994893|LOC129994894|LOC129994895|LOC129994896|LOC129994897|LOC129994898|LOC129994899|LOC129994900|LOC129994901|LOC129994902|LOC129994903|LOC129994904|LOC129994905		See cases	VCV000057483	5	130196621 - 154701371	5	130860928 - 155321811	57483	72078			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 5q32-35.3(chr5:149714592-181272151)x3	ATOX1-AS1|ATP10B|C5orf52|C5orf58|CAMK2A|CLMAT3|CREBRF|CSF1R|CTC-338M12.4|ERGIC1|F12|FAM153B|G3BP1|GFPT2|GPX3|GRIA1|HAVCR2|HMMR|HMMR-AS1|HNRNPAB|IRGM|ITK|LARP1|LCP2|LINC01470|LINC01484|LINC01485|LINC01933|LINC01938|LINC01942|LINC02143|LINC02159|LINC01947|LINC01951|LINC01962|LINC02202|LINC02222|LINC02227|LOC129995237|LOC129995238|LOC129995239|LOC129995242|LOC129995243|LOC129995233|LOC129995234|LOC129995235|LOC129995236|KCNIP1|KCNIP1-AS1|KCNIP1-OT1|KIAA1191|KIF4B|KCNMB1|LOC129995244|LOC129995245|LOC129995246|LINC00847|LINC01187|LINC01202|LINC01366|LINC01411|LOC129995240|LOC129995241|LINC01574|LINC01845|LINC01847|GRK6|HAVCR1|GMCL2|GPRIN1|GRM6|HAND1|LINC01861|LINC01932|HEIH|HIGD2A|HK3|HMGXB3|HNRNPH1|FAM193B|FAM200C|FAM153A|FAT2|FAXDC2|FBLL1|HRH2|IL12B|GABRP|GALNT10|GARIN3|GEMIN5|IL12B-AS1|INSYN2B|GLRA1|CLTB|CPEB4|CPLX2|LINC01944|CANX|CBY3|CDX1|CLINT1|CLK4|CYFIP2|DBN1|CNOT6|CNOT8|COL23A1|DCTN4|EFCAB9|EIF4E1B|GM2A|FABP6|FABP6-AS1|FAF2|ARL10|ARSI|ATOX1|FAM114A2|ATP6V0E1|B4GALT7|BTNL3|BTNL8|BTNL9|C1QTNF2|C5orf47|ANXA6|BNIP1|BOD1|CCDC69|CCNG1|CCNJL|CD74|CDHR2|ADAM19|ADAMTS2|ADRA1B|DDX41|DOCK2|DOK3|DRD1|DUSP1|EBF1|FBXW11|FGF18|FGFR4|FLT4|FNDC9|FOXI1|GABRA1|GABRA6|GABRA6-AS1|GABRB2|GABRG2|LOC129995247|LOC129995248|LOC129995249|LOC129995250|LOC129995251|LOC129995252|LOC129995253|LOC129995254|LOC129995255|LOC129995256|LOC129995257|LOC129995258|LOC129995259|LOC129995260|LOC129995261|LOC129995262|LOC129995263|LOC129995264|LOC129995265|LOC129995266|LOC129995267|LOC129995268|LOC129995269|LOC129995270|LOC129995271|LOC129995272|LOC129995273|LOC129995274|LOC129995275|LOC129995276|LOC129995277|LOC129995278|LOC129995279|LOC129995280|LOC129995281|LOC129995282|LOC129995283|LOC129995284|LOC129995285|LOC129995286|LOC129995287|LOC129995288|LOC129995289|LOC129995290|LOC129995291|LOC129995292|LOC129995293|LOC129995294|LOC129995295|LOC129995296|LOC129995297|LOC129995298|LOC129995299|LOC129995300|LOC129995301|LOC129995302|LOC129995303|LOC129995304|LOC129995305|LOC129995306|LOC129995307|LOC129995308|LOC129995309|LOC129995310|LOC129995311|LOC129995312|LOC129995313|LOC129995314|LOC129995315|LOC129995316|LOC129995317|LOC129995318|LOC129995319|LOC129995320|LOC129995321|LOC129995322|LOC129995323|LOC129995324|LOC129995325|LOC129995326|LOC129995327|LOC129995328|LOC129995329|LOC129995330|LOC129995331|LOC129995332|LOC129995333|LOC129995334|LOC129995335|LOC129995336|LOC129995337|LOC129995338|LOC129995339|LOC129995340|LOC129995341|LOC129995342|LOC129995343|LOC129995344|LOC129995345|LOC129995346|LOC129995347|LOC129995348|LOC129995349|LOC129995350|LOC129995351|LOC129995352|LOC129995353|LOC129995354|LOC129995355|LOC129995356|LOC129995357|LOC129995358|LOC129995359|LOC129995360|LOC129995361|LOC129995362|LOC129995363|LOC129995364|LOC129995365|LOC129995366|LOC129995367|LOC129995368|LOC129995369|LOC129995370|LOC129995371|LOC129995372|LOC129995373|LOC129995374|LOC129995375|LOC129995376|LOC129995377|LOC129995378|LOC129995379|LOC129995380|LOC129995381|LOC129995382|LOC129995383|LOC129995384|LOC129995385|LOC129995386|LOC129995387|LOC129995388|LOC129995389|LOC129995390|LOC129995391|LOC129995392|LOC129995393|LOC129995394|LOC129995395|LOC129995396|LOC129995397|LOC129995398|LOC129995399|LOC129995400|LOC129995401|LOC129995402|LOC129995403|LOC129995404|LOC129995405|LOC129995406|LOC129995407|LOC129995408|LOC129995409|LOC129995410|LOC129995411|LOC129995412|LOC129995413|LOC129995414|LOC129995415|LOC129995416|LOC129995417|LOC129995418|LOC129995419|LOC129995420|LOC129995421|LOC129995422|LOC129995423|LOC129995424|LOC129995425|LOC129995426|LOC129995427|LOC129995428|LOC129995429|LOC129995430|LOC129995431|LOC129995432|LOC129995433|LOC129995434|LOC129995435|LOC129995436|LOC129995437|LOC129995438|LOC129995439|LOC129995440|LOC129995441|LOC129995442|LOC129995443|LOC129995444|LOC129995445|LOC129995446|LOC129995447|LOC129995448|LOC129995449|LOC129995450|LOC129995451|LOC129995452|LOC129995453|LOC129995454|LOC129995455|LOC129995456|LOC129995457|LOC129995458|LOC129995459|LOC129995460|LOC129995461|LOC129995462|LOC129995463|LOC129995464|LOC129995465|LOC129995466|LOC129995467|LOC129995468|LOC129995469|LOC129995470|LOC129995471|LOC129995472|LOC129995473|LOC129995474|LOC129995475|LOC129995476|LOC129995477|LOC129995478|LOC129995479|LOC129995480|LOC129995481|LOC129995482|LOC129995483|LOC129995484|LOC129995485|LOC129995486|LOC129995487|LOC129995488|LOC129995489|LOC129995490|LOC129995491|LOC129995492|LOC129995493|LOC129995494|LOC129995495|LOC129995496|LOC129995497|LOC129995498|LOC129995499|LOC129995500|LOC129995501|LOC129995502|LOC129995503|LOC129995504|LOC129995505|LOC129995506|LOC129995507|LOC129995508|LOC129995509|LOC129995510|LOC129995511|LOC129995512|LOC129995513|LOC129995514|LOC129995515|LOC129995516|LOC132089189|LOC132089190|LOC132089191|LOC132089192|LOC132089193|LOC132089194|LOC132089195|LOC132089196|LOC132089197|LOC132089198|LOC132089199|LOC132089200|LOC132089201|LOC132089202|LOC132089203|LOC132089204|LOC132089205|LOC132089206|LOC132089207|LOC132089208|LOC132089209|LOC132089210|LOC132089211|LOC132089212|LOC132089213|LOC132089214|LOC132089215|LOC132089216|LOC132089217|LOC132089218|LOC132089219|LOC132089220|LOC132089221|LOC132089222|LOC132089223|LOC132089224|LOC132089225|LOC132089226|LOC132089227|LOC132089228|LOC132089230|LOC132090739|LOC132090740|LOC132090741|LOC132090742|LOC132090743|LOC132090744|LOC132090745|LOC132090746|LOC132090747|LOC132090748|LOC132205961|LOC132205962|LSM11|LTC4S|MAML1|MAPK9|MAT2B|MED7|MFAP3|MGAT1|MGAT4B|MIR103A1|MIR103B1|MIR10523|MIR12118|MIR12125|MIR1229|MIR1271|MIR1294|MIR1303|MIR146A|MIR218-2|MIR3141|MIR3142|MIR3142HG|MIR340|MIR378A|MIR378E|MIR378H|MIR3912|MIR4281|MIR4634|MIR4638|MIR5003|MIR585|MIR6499|MIR8056|MIR8089|MRNIP|MRNIP-DT|MRPL22|MSANTD5|MSX2|MXD3|MYOZ3|MYOZ3-AS1|N4BP3|NDST1|NDST1-AS1|NEURL1B|NHP2|NIPAL4|NIPAL4-DT|NKX2-5|NMUR2|NOP16|NPM1|NSD1|NSG2|NUDCD2|OR2V1|OR2V2|OR2Y1|PANK3|PDE6A|PDGFRB|PDLIM7|PFN3|PHYKPL|PPARGC1B|PPP1R2B|PRELID1|PROP1|PRR7|PRR7-AS1|PTTG1|PWWP2A|RAB24|RACK1|RANBP17|RARS1|RASGEF1C|RBM22|RGS14|RMND5B|RNF130|RNF145|RNF44|RPL26L1|RPL26L1-AS1|RPS14|RUFY1|RUFY1-AS1|SAP30L|SAP30L-AS1|SCGB3A1|SFXN1|SGCD|SH3PXD2B|SIMC1|SLC26A2|SLC34A1|SLC36A1|SLC36A2|SLC36A3|SLC6A7|SLIT3|SLIT3-AS1|SLIT3-AS2|SLU7|SMIM23|SMIM3|SNCB|SNORA70J|SNORA74B|SNORD95|SNORD96A|SOX30|SPARC|SPATA31J1|SPDL1|SQSTM1|STC2|STK10|SYNPO|TBC1D9B|TCOF1|TENM2|TENM2-AS1|TENM2-AS3|THG1L|THOC3|THOC3-AS1|TIGD6|TIMD4|TLX3|TMED9|TNIP1|TRA-TGC3-1|TRIM41|TRIM52|TRIM52-AS1|TRIM7|TRIM7-AS2|TRK-CTT2-2|TRK-CTT2-3|TRL-AAG1-1|TRL-AAG1-2|TRL-AAG1-3|TRL-AAG2-1|TRP-TGG3-1|TRT-TGT6-1|TRV-AAC1-2|TRV-AAC1-3|TRV-AAC1-4|TRV-AAC2-1|TRV-CAC1-2|TRV-CAC1-3|TRV-CAC1-4|TRV-CAC1-5|TSPAN17|TTC1|UBLCP1|UBTD2|UIMC1|UNC5A|WWC1|ZFP2|ZFP62|ZNF300|ZNF346|ZNF354A|ZNF354B|ZNF354C|ZNF454|ZNF454-DT|ZNF879|LINC02995|LINC03000|LMAN2|LOC100128059|LOC100128340|LOC100288254|LOC100289470|LOC100502572|LOC100652758|LOC100996385|LOC101927908|LOC101928093|LOC102546299|LOC102724551|LOC105377730|LOC105377753|LOC105377763|LOC105378230|LOC105980006|LOC105980008|LOC108004526|LOC108228201|LOC109279841|LOC110120620|LOC110120643|LOC110120714|LOC110120747|LOC110120777|LOC110120965|LOC110120995|LOC110120998|LOC110121000|LOC110121027|LOC110121041|LOC110121211|LOC110121241|LOC110121272|LOC110121284|LOC111188152|LOC111188153|LOC111188154|LOC111188156|LOC111429606|LOC111500319|LOC111556140|LOC111828524|LOC112997568|LOC112997569|LOC112997570|LOC112997571|LOC112997572|LOC112997574|LOC112997575|LOC112997576|LOC112997577|LOC112997578|LOC112997579|LOC112997580|LOC112997581|LOC112997582|LOC112997583|LOC112997584|LOC114004391|LOC116158526|LOC116158527|LOC116158528|LOC116158530|LOC116158531|LOC116158532|LOC116158533|LOC116158534|LOC116158535|LOC116158536|LOC121099710|LOC121099711|LOC121099712|LOC121099713|LOC121099714|LOC121099715|LOC121099716|LOC121099717|LOC121099718|LOC121740630|LOC121740631|LOC121740632|LOC121740633|LOC121740634|LOC121740635|LOC123575590|LOC123575592|LOC123575593|LOC123575594|LOC123575595|LOC123575596|LOC123575597|LOC123575598|LOC123575599|LOC123575600|LOC123575601|LOC123575602|LOC123575603|LOC123575604|LOC123575605|LOC123575606|LOC123575607|LOC123575608|LOC123575609|LOC123575610|LOC123575611|LOC123575612|LOC123575614|LOC123575615|LOC123575616|LOC123575617|LOC123575618|LOC123575619|LOC123575620|LOC123575621|LOC123575622|LOC123575623|LOC123575624|LOC123575625|LOC123575626|LOC123575627|LOC123575628|LOC123575629|LOC123575630|LOC123575631|LOC123575632|LOC123575633|LOC123575634|LOC123575635|LOC123575636|LOC123575637|LOC123575638|LOC123575639|LOC123575640|LOC123575641|LOC126807551|LOC126807552|LOC126807553|LOC126807554|LOC126807555|LOC126807556|LOC126807557|LOC126807558|LOC126807559|LOC126807560|LOC126807561|LOC126807562|LOC126807563|LOC126807564|LOC126807565|LOC126807566|LOC126807567|LOC126807568|LOC126807569|LOC126807570|LOC126807571|LOC126807572|LOC126807573|LOC126807574|LOC126807575|LOC126807576|LOC126807577|LOC126807578|LOC126807579|LOC126807580|LOC126807581|LOC126807582|LOC126807583|LOC126807584|LOC126807585|LOC126807586|LOC126807587|LOC126807588|LOC126807589|LOC126807590|LOC126807591|LOC126807592|LOC126807593|LOC126807594|LOC126807595|LOC126807596|LOC126807597|LOC126807598|LOC126807599|LOC126807600|LOC126807601|LOC126807602|LOC126807603|LOC126807604|LOC126807605|LOC126807606|LOC126807607|LOC126807608|LOC126807609|LOC126807610|LOC126807611|LOC126807612|LOC126807613|LOC126807614|LOC126807615|LOC126807616|LOC126807617|LOC126807618|LOC126807619|LOC126807620|LOC126807621|LOC126807622|LOC126807623|LOC126807624|LOC126807625|LOC126807626|LOC126807627|LOC126807628|LOC126807629|LOC126807630|LOC126807631|LOC126807632|LOC126807633|LOC128772274|LOC128966623|LOC129389395|LOC129389396|LOC129389397|LOC129389398|LOC129389399|LOC129389400|LOC129389401|LOC129389402|LOC129389403|LOC129389404|LOC129389405|LOC129389406|LOC129389407|LOC129389408|LOC129389409|LOC129389410|LOC129389411|LOC129389412|LOC129389413|LOC129389414|LOC129389415|LOC129389416|LOC129389417|LOC129389418|LOC129389419|LOC129389420|LOC129389421|LOC129389422|LOC129994966|LOC129994967|LOC129994968|LOC129994969|LOC129994970|LOC129994971|LOC129994972|LOC129994973|LOC129994974|LOC129994975|LOC129994976|LOC129994977|LOC129994978|LOC129994979|LOC129994980|LOC129994981|LOC129994982|LOC129994983|LOC129994984|LOC129994985|LOC129994986|LOC129994987|LOC129994988|LOC129994989|LOC129994990|LOC129994991|LOC129994992|LOC129994993|LOC129994994|LOC129994995|LOC129994996|LOC129994997|LOC129994998|LOC129994999|LOC129995000|LOC129995001|LOC129995002|LOC129995003|LOC129995004|LOC129995005|LOC129995006|LOC129995007|LOC129995008|LOC129995009|LOC129995010|LOC129995011|LOC129995012|LOC129995013|LOC129995014|LOC129995015|LOC129995016|LOC129995017|LOC129995018|LOC129995019|LOC129995020|LOC129995021|LOC129995022|LOC129995023|LOC129995024|LOC129995025|LOC129995026|LOC129995027|LOC129995028|LOC129995029|LOC129995030|LOC129995031|LOC129995032|LOC129995033|LOC129995034|LOC129995035|LOC129995036|LOC129995037|LOC129995038|LOC129995039|LOC129995040|LOC129995041|LOC129995042|LOC129995043|LOC129995044|LOC129995045|LOC129995046|LOC129995047|LOC129995048|LOC129995049|LOC129995050|LOC129995051|LOC129995052|LOC129995053|LOC129995054|LOC129995055|LOC129995056|LOC129995057|LOC129995058|LOC129995059|LOC129995060|LOC129995061|LOC129995062|LOC129995063|LOC129995064|LOC129995065|LOC129995066|LOC129995067|LOC129995068|LOC129995069|LOC129995070|LOC129995071|LOC129995072|LOC129995073|LOC129995074|LOC129995075|LOC129995076|LOC129995077|LOC129995078|LOC129995079|LOC129995080|LOC129995081|LOC129995082|LOC129995083|LOC129995084|LOC129995085|LOC129995086|LOC129995087|LOC129995088|LOC129995089|LOC129995090|LOC129995091|LOC129995092|LOC129995093|LOC129995094|LOC129995095|LOC129995096|LOC129995097|LOC129995098|LOC129995099|LOC129995100|LOC129995101|LOC129995102|LOC129995103|LOC129995104|LOC129995105|LOC129995106|LOC129995107|LOC129995108|LOC129995109|LOC129995110|LOC129995111|LOC129995112|LOC129995113|LOC129995114|LOC129995115|LOC129995116|LOC129995117|LOC129995118|LOC129995119|LOC129995120|LOC129995121|LOC129995122|LOC129995123|LOC129995124|LOC129995125|LOC129995126|LOC129995127|LOC129995128|LOC129995129|LOC129995130|LOC129995131|LOC129995132|LOC129995133|LOC129995134|LOC129995135|LOC129995136|LOC129995137|LOC129995138|LOC129995139|LOC129995140|LOC129995141|LOC129995142|LOC129995143|LOC129995144|LOC129995145|LOC129995146|LOC129995147|LOC129995148|LOC129995149|LOC129995150|LOC129995151|LOC129995152|LOC129995153|LOC129995154|LOC129995155|LOC129995156|LOC129995157|LOC129995158|LOC129995159|LOC129995160|LOC129995161|LOC129995162|LOC129995163|LOC129995164|LOC129995165|LOC129995166|LOC129995167|LOC129995168|LOC129995169|LOC129995170|LOC129995171|LOC129995172|LOC129995173|LOC129995174|LOC129995175|LOC129995176|LOC129995177|LOC129995178|LOC129995179|LOC129995180|LOC129995181|LOC129995182|LOC129995183|LOC129995184|LOC129995185|LOC129995186|LOC129995187|LOC129995188|LOC129995189|LOC129995190|LOC129995191|LOC129995192|LOC129995193|LOC129995194|LOC129995195|LOC129995196|LOC129995197|LOC129995198|LOC129995199|LOC129995200|LOC129995201|LOC129995202|LOC129995203|LOC129995204|LOC129995205|LOC129995206|LOC129995207|LOC129995208|LOC129995209|LOC129995210|LOC129995211|LOC129995212|LOC129995213|LOC129995214|LOC129995215|LOC129995216|LOC129995217|LOC129995218|LOC129995219|LOC129995220|LOC129995221|LOC129995222|LOC129995223|LOC129995224|LOC129995225|LOC129995226|LOC129995227|LOC129995228|LOC129995229|LOC129995230|LOC129995231|LOC129995232		See cases	VCV000058118	5	149094155 - 180699152	5	149714592 - 181272151	58118	72713			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.*73A>G	PDGFRB		not provided	VCV001221159	5	149495253	5	150115690	1221159	1211556	rs2229562	NC_000005.10:150115689:T:C	single nucleotide variant	3 prime UTR variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.*40del	PDGFRB		not provided	VCV001207572	5	149495286	5	150115723	1207572	1197340	rs745433929	NC_000005.10:150115722:GGGGGGG:GGGGGG	Deletion	3 prime UTR variant	Likely benign	Aug 4, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.*39C>G	PDGFRB		not provided	VCV001182989	5	149495287	5	150115724	1182989	1171373	rs2229561	NC_000005.10:150115723:G:C	single nucleotide variant	3 prime UTR variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.*39C>A	PDGFRB		not provided	VCV001180277	5	149495287	5	150115724	1180277	1169094	rs2229561	NC_000005.10:150115723:G:T	single nucleotide variant	3 prime UTR variant	Benign	Mar 20, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3297G>A (p.Ala1099=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|not provided	VCV000748062	5	149495350	5	150115787	748062	749342	rs376978985	NC_000005.10:150115786:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.3296C>T (p.Ala1099Val)	PDGFRB	A1035V, A1099V, A938V	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002153423	5	149495351	5	150115788	2153423	1882285		NC_000005.10:150115787:G:A	single nucleotide variant	missense variant	Likely benign	May 3, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3295G>A (p.Ala1099Thr)	PDGFRB	A1035T, A1099T, A938T	not provided	VCV001312455	5	149495352	5	150115789	1312455	1301837	rs2113879949	NC_000005.10:150115788:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3292C>T (p.Arg1098Trp)	PDGFRB	R1098W, R937W, R1034W	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001379023	5	149495355	5	150115792	1379023	86684	rs267600485	NC_000005.10:150115791:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3288G>A (p.Ala1096=)	PDGFRB		Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002140980	5	149495359	5	150115796	2140980	1875478		NC_000005.10:150115795:C:T	single nucleotide variant	synonymous variant	Benign	Sep 2, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3287C>T (p.Ala1096Val)	PDGFRB	A1032V, A935V, A1096V	Myofibromatosis, infantile, 1|Inborn genetic diseases|not provided|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000707132	5	149495360	5	150115797	707132	691784	rs114435947	NC_000005.10:150115796:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.3279G>T (p.Gly1093=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001959422	5	149495368	5	150115805	1959422	2019556		NC_000005.10:150115804:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3276G>A (p.Ser1092=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001537825	5	149495371	5	150115808	1537825	1650104	rs774197688	NC_000005.10:150115807:C:T	single nucleotide variant	synonymous variant	Benign	Nov 18, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3275C>T (p.Ser1092Leu)	PDGFRB	S931L, S1028L, S1092L	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Inborn genetic diseases	VCV001975317	5	149495372	5	150115809	1975317	2026724		NC_000005.10:150115808:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.3274T>A (p.Ser1092Thr)	PDGFRB	S1092T, S1028T, S931T	Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002930856	5	149495373	5	150115810	2930856	3083926		NC_000005.10:150115809:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3270G>A (p.Pro1090=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000767571	5	149495377	5	150115814	767571	698920	rs183852315	NC_000005.10:150115813:C:T	single nucleotide variant	synonymous variant	Benign	Dec 31, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3269C>T (p.Pro1090Leu)	PDGFRB	P1026L, P1090L, P929L	PDGFRB-related disorder	VCV003347709	5	149495378	5	150115815	3347709	3506063		NC_000005.10:150115814:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	no assertion criteria provided							
NM_002609.4(PDGFRB):c.3263dup (p.Leu1089fs)	PDGFRB	L1089fs, L928fs, L1025fs	Inborn genetic diseases	VCV002265559	5	149495383 - 149495384	5	150115820 - 150115821	2265559	2249780		NC_000005.10:150115820:T:TT	Duplication	frameshift variant	Uncertain significance	Jan 16, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3256_3257insCGGAGC (p.Glu1085_Leu1086insProGlu)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis	VCV001999371	5	149495390 - 149495391	5	150115827 - 150115828	1999371	2057305		NC_000005.10:150115827:GCTC:GCTCCGGCTC	Insertion	inframe_insertion	Uncertain significance	Sep 13, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3252A>G (p.Pro1084=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|not provided|not specified|Myeloproliferative disorder, chronic, with eosinophilia|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000258779	5	149495395	5	150115832	258779	251818	rs246388	NC_000005.10:150115831:T:C	single nucleotide variant	synonymous variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.3250C>G (p.Pro1084Ala)	PDGFRB	P1084A, P1020A, P923A	Inborn genetic diseases	VCV003305494	5	149495397	5	150115834	3305494	3470357		NC_000005.10:150115833:G:C	single nucleotide variant	missense variant	Uncertain significance	May 20, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3246G>A (p.Pro1082=)	PDGFRB		PDGFRB-related disorder	VCV003043773	5	149495401	5	150115838	3043773	3210964		NC_000005.10:150115837:C:T	single nucleotide variant	synonymous variant	Likely benign	May 30, 2019	no assertion criteria provided							
NM_002609.4(PDGFRB):c.3241G>A (p.Glu1081Lys)	PDGFRB	E1081K, E1017K, E920K	Parkinsonian disorder|Basal ganglia calcification, idiopathic, 4	VCV000523454	5	149495406	5	150115843	523454	513955	rs1554107047	NC_000005.10:150115842:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2017	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3205G>A (p.Glu1069Lys)	PDGFRB	E1069K, E908K, E1005K	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002924697	5	149495442	5	150115879	2924697	3092935		NC_000005.10:150115878:C:T	single nucleotide variant	missense variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3204C>T (p.Asp1068=)	PDGFRB		not provided|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV000767315	5	149495443	5	150115880	767315	698921	rs141511317	NC_000005.10:150115879:G:A	single nucleotide variant	synonymous variant	Likely benign	May 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.3196C>A (p.Pro1066Thr)	PDGFRB	P1002T, P1066T, P905T	not provided	VCV001312456	5	149495451	5	150115888	1312456	1301838	rs2113880271	NC_000005.10:150115887:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3187C>A (p.Pro1063Thr)	PDGFRB	P999T, P902T, P1063T	Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002930991	5	149495460	5	150115897	2930991	3084061		NC_000005.10:150115896:G:T	single nucleotide variant	missense variant	Likely benign	Aug 23, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3181G>A (p.Asp1061Asn)	PDGFRB	D900N, D1061N, D997N	Inborn genetic diseases|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002056802	5	149495466	5	150115903	2056802	2109505		NC_000005.10:150115902:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 4, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.3165C>T (p.Ser1055=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002035755	5	149495482	5	150115919	2035755	2093672		NC_000005.10:150115918:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 30, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3161C>G (p.Thr1054Ser)	PDGFRB	T1054S, T893S, T990S	not provided	VCV001306923	5	149495486	5	150115923	1306923	1295872	rs900848864	NC_000005.10:150115922:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3154G>A (p.Val1052Ile)	PDGFRB	V1052I, V891I, V988I	Inborn genetic diseases	VCV003416456	5	149495493	5	150115930	3416456	3578972		NC_000005.10:150115929:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3149A>G (p.Asn1050Ser)	PDGFRB	N1050S, N889S, N986S	Inborn genetic diseases	VCV002318256	5	149495498	5	150115935	2318256	2313642		NC_000005.10:150115934:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3145C>T (p.Leu1049=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis	VCV002200482	5	149495502	5	150115939	2200482	1930917		NC_000005.10:150115938:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3139T>C (p.Ser1047Pro)	PDGFRB	S1047P, S983P, S886P	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Inborn genetic diseases	VCV002057474	5	149495508	5	150115945	2057474	2116631		NC_000005.10:150115944:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.3138-11C>G	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV002108125	5	149495520	5	150115957	2108125	2163298		NC_000005.10:150115956:G:C	single nucleotide variant	intron variant	Likely benign	Aug 24, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3138-28C>T	PDGFRB		not provided	VCV001263033	5	149495537	5	150115974	1263033	1252942	rs75732095	NC_000005.10:150115973:G:A	single nucleotide variant	intron variant	Benign	Feb 28, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3138-60T>C	PDGFRB		not provided	VCV001693084	5	149495569	5	150116006	1693084	1685524	rs77607501	NC_000005.10:150116005:A:G	single nucleotide variant	intron variant	Likely benign	Dec 22, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3138-91A>G	PDGFRB		not provided	VCV001186363	5	149495600	5	150116037	1186363	1176587	rs138324883	NC_000005.10:150116036:T:C	single nucleotide variant	intron variant	Likely benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3138-97C>T	PDGFRB		not provided	VCV001296913	5	149495606	5	150116043	1296913	1286703	rs12655077	NC_000005.10:150116042:G:A	single nucleotide variant	intron variant	Benign	Feb 28, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3138-115C>T	PDGFRB		not provided	VCV001209500	5	149495624	5	150116061	1209500	1197341	rs76993887	NC_000005.10:150116060:G:A	single nucleotide variant	intron variant	Likely benign	Mar 24, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3138-261C>T	PDGFRB		not provided	VCV001241268	5	149495770	5	150116207	1241268	1230804	rs165979	NC_000005.10:150116206:G:A	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+226G>A	PDGFRB		not provided	VCV001255044	5	149496955	5	150117392	1255044	1244976	rs76537636	NC_000005.10:150117391:C:T	single nucleotide variant	intron variant	Benign	Apr 4, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+73GC[10]	PDGFRB		not provided	VCV001223064	5	149497090 - 149497091	5	150117527 - 150117528	1223064	1212173	rs148754488	NC_000005.10:150117527:GCGCGCGCGCGCGCGCGC:GCGCGCGCGCGCGCGCGCGC	Microsatellite	intron variant	Benign	Sep 29, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+73GC[5]	PDGFRB		not provided	VCV002443375	5	149497091 - 149497098	5	150117528 - 150117535	2443375	2417112		NC_000005.10:150117527:GCGCGCGCGCGCGCGCGC:GCGCGCGCGC	Microsatellite	intron variant	Likely benign	May 25, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+73GC[8]	PDGFRB		not provided	VCV001300442	5	149497091 - 149497092	5	150117528 - 150117529	1300442	1290727	rs148754488	NC_000005.10:150117527:GCGCGCGCGCGCGCGCGC:GCGCGCGCGCGCGCGC	Microsatellite	intron variant	Likely benign	Apr 2, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+87G>A	PDGFRB		not provided	VCV001232986	5	149497094	5	150117531	1232986	1223399	rs56764942	NC_000005.10:150117530:C:T	single nucleotide variant	intron variant	Benign	Dec 18, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+86C>T	PDGFRB		not provided	VCV001341627	5	149497095	5	150117532	1341627	1332876	rs530614215	NC_000005.10:150117531:G:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+70_3137+83del	PDGFRB		not provided	VCV001194182	5	149497098 - 149497111	5	150117535 - 150117548	1194182	1183601	rs1459034030	NC_000005.10:150117534:CGCGCGCGCGCACAC:C	Deletion	intron variant	Likely benign	Dec 18, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+72_3137+81del	PDGFRB		not provided	VCV001526365	5	149497100 - 149497109	5	150117537 - 150117546	1526365	1517768	rs1369166054	NC_000005.10:150117536:CGCGCGCGCAC:C	Deletion	intron variant	Likely benign	Sep 22, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+70_3137+81del	PDGFRB		not provided	VCV001304962	5	149497100 - 149497111	5	150117537 - 150117548	1304962	1295237	rs1272539789	NC_000005.10:150117536:CGCGCGCGCACAC:C	Deletion	intron variant	Benign	Aug 18, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+81G>A	PDGFRB		not provided	VCV001301512	5	149497100	5	150117537	1301512	1291798	rs866649621	NC_000005.10:150117536:C:T	single nucleotide variant	intron variant	Likely benign	Apr 21, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+81G>C	PDGFRB		not provided	VCV001253174	5	149497100	5	150117537	1253174	1243117	rs866649621	NC_000005.10:150117536:C:G	single nucleotide variant	intron variant	Benign	Dec 18, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+68_3137+81del	PDGFRB		not provided	VCV001223366	5	149497100 - 149497113	5	150117537 - 150117550	1223366	1211187	rs144012098	NC_000005.10:150117536:CGCGCGCGCACACAC:C	Deletion	intron variant	Benign	Aug 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+80C>T	PDGFRB		not provided	VCV001180028	5	149497101	5	150117538	1180028	1169095	rs140531823	NC_000005.10:150117537:G:A	single nucleotide variant	intron variant	Likely benign	Nov 2, 2019	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.3137+64_3137+79del	PDGFRB		not provided	VCV001283159	5	149497102 - 149497117	5	150117539 - 150117554	1283159	1270868	rs749053408	NC_000005.10:150117538:CGCGCGCACACACACAC:C	Deletion	intron variant	Benign	Dec 18, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+68_3137+77del	PDGFRB		not provided	VCV001290363	5	149497104 - 149497113	5	150117541 - 150117550	1290363	1280191	rs1404982791	NC_000005.10:150117540:CGCGCACACAC:C	Deletion	intron variant	Benign	Nov 2, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+70_3137+77del	PDGFRB		not provided	VCV001283966	5	149497104 - 149497111	5	150117541 - 150117548	1283966	1273823	rs771624008	NC_000005.10:150117540:CGCGCACAC:C	Deletion	intron variant	Benign	May 18, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+72_3137+77del	PDGFRB		not provided	VCV001204077	5	149497104 - 149497109	5	150117541 - 150117546	1204077	1193565	rs879207452	NC_000005.10:150117540:CGCGCAC:C	Deletion	intron variant	Likely benign	Dec 18, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+75_3137+76insGT	PDGFRB		not provided	VCV001265742	5	149497105 - 149497106	5	150117542 - 150117543	1265742	1257365	rs1289430637	NC_000005.10:150117542:C:CAC	Insertion	intron variant	Benign	Dec 29, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+76C>T	PDGFRB		not provided	VCV001190878	5	149497105	5	150117542	1190878	1179978	rs112938568	NC_000005.10:150117541:G:A	single nucleotide variant	intron variant	Likely benign	Sep 23, 2019	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.3137+40TG[19]	PDGFRB		not provided	VCV001309114	5	149497107 - 149497108	5	150117544 - 150117545	1309114	1301142	rs3836743	NC_000005.10:150117544:CACACACACACACACACACACACACACACACACAC:CACACACACACACACACACACACACACACACACACACAC	Microsatellite	intron variant	Likely benign	May 1, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+74C>T	PDGFRB		not provided	VCV001281161	5	149497107	5	150117544	1281161	1271879	rs28368814	NC_000005.10:150117543:G:A	single nucleotide variant	intron variant	Benign	Aug 21, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+40TG[18]	PDGFRB		not provided	VCV001265344	5	149497107 - 149497108	5	150117544 - 150117545	1265344	1254811	rs3836743	NC_000005.10:150117544:CACACACACACACACACACACACACACACACACAC:CACACACACACACACACACACACACACACACACACAC	Microsatellite	intron variant	Benign	Aug 13, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+40TG[15]	PDGFRB		not provided	VCV001290674	5	149497108 - 149497111	5	150117545 - 150117548	1290674	1280502	rs3836743	NC_000005.10:150117544:CACACACACACACACACACACACACACACACACAC:CACACACACACACACACACACACACACACAC	Microsatellite	intron variant	Benign	Mar 22, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+71_3137+72insGC	PDGFRB		not provided	VCV001278492	5	149497109 - 149497110	5	150117546 - 150117547	1278492	1267073	rs10638773	NC_000005.10:150117546:C:CGC	Insertion	intron variant	Benign	Sep 22, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+68T>C	PDGFRB		not provided	VCV001221435	5	149497113	5	150117550	1221435	1210547	rs769968208	NC_000005.10:150117549:A:G	single nucleotide variant	intron variant	Benign	Sep 20, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+48T>C	PDGFRB		not provided	VCV001233927	5	149497133	5	150117570	1233927	1225593	rs41289061	NC_000005.10:150117569:A:G	single nucleotide variant	intron variant	Benign	Dec 25, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+15C>T	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis	VCV002061330	5	149497166	5	150117603	2061330	2124022		NC_000005.10:150117602:G:A	single nucleotide variant	intron variant	Likely benign	Apr 5, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+13G>T	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001645689	5	149497168	5	150117605	1645689	1652988	rs2113883431	NC_000005.10:150117604:C:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3137+10C>T	PDGFRB		PDGFRB-related disorder	VCV003029454	5	149497171	5	150117608	3029454	3189320		NC_000005.10:150117607:G:A	single nucleotide variant	intron variant	Likely benign	Jun 3, 2021	no assertion criteria provided							
NM_002609.4(PDGFRB):c.3137+4A>G	PDGFRB		Basal ganglia calcification, idiopathic, 4|not specified|Myeloproliferative disorder, chronic, with eosinophilia|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|not provided	VCV000258778	5	149497177	5	150117614	258778	251819	rs246391	NC_000005.10:150117613:T:C	single nucleotide variant	intron variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.3126C>A (p.Pro1042=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002045407	5	149497192	5	150117629	2045407	2103299		NC_000005.10:150117628:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3119G>T (p.Gly1040Val)	PDGFRB	G1040V, G879V, G976V	Myeloproliferative disorder, chronic, with eosinophilia|not provided|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000473406	5	149497199	5	150117636	473406	454815	rs149417689	NC_000005.10:150117635:C:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.3102C>T (p.Asp1034=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001585392	5	149497216	5	150117653	1585392	1627327	rs569140859	NC_000005.10:150117652:G:A	single nucleotide variant	synonymous variant	Benign	Aug 16, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3091G>A (p.Glu1031Lys)	PDGFRB	E1031K, E870K, E967K	not provided	VCV003252844	5	149497227	5	150117664	3252844	3411638		NC_000005.10:150117663:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3090C>T (p.Pro1030=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Myeloproliferative disorder, chronic, with eosinophilia|not specified|not provided|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000258777	5	149497228	5	150117665	258777	251820	rs2228440	NC_000005.10:150117664:G:A	single nucleotide variant	synonymous variant	Benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.3076C>T (p.Pro1026Ser)	PDGFRB	P865S, P962S, P1026S	not provided	VCV003384581	5	149497242	5	150117679	3384581	3543730		NC_000005.10:150117678:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3069C>T (p.Ile1023=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV001670396	5	149497249	5	150117686	1670396	1635761	rs2113883671	NC_000005.10:150117685:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 24, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3058G>A (p.Asp1020Asn)	PDGFRB	D859N, D956N, D1020N	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002046170	5	149497260	5	150117697	2046170	2096304		NC_000005.10:150117696:C:T	single nucleotide variant	missense variant	Likely benign	Jul 17, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3057C>T (p.Asn1019=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis	VCV002923793	5	149497261	5	150117698	2923793	3085980		NC_000005.10:150117697:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3044A>G (p.Asn1015Ser)	PDGFRB	N1015S, N854S, N951S	Inborn genetic diseases	VCV003416461	5	149497274	5	150117711	3416461	3578976		NC_000005.10:150117710:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3039G>A (p.Gln1013=)	PDGFRB		PDGFRB-related disorder	VCV003030461	5	149497279	5	150117716	3030461	3197694		NC_000005.10:150117715:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 10, 2020	no assertion criteria provided							
NM_002609.4(PDGFRB):c.3033C>T (p.Ala1011=)	PDGFRB		Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000712778	5	149497285	5	150117722	712778	721300	rs375836509	NC_000005.10:150117721:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 2, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3032C>A (p.Ala1011Asp)	PDGFRB	A850D, A947D, A1011D	Inborn genetic diseases	VCV002247821	5	149497286	5	150117723	2247821	2245016		NC_000005.10:150117722:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3030T>G (p.Thr1010=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001170638	5	149497288	5	150117725	1170638	1154963	rs182175304	NC_000005.10:150117724:A:C	single nucleotide variant	synonymous variant	Benign	Jan 26, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3029C>T (p.Thr1010Ile)	PDGFRB	T1010I, T849I, T946I	Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV001713491	5	149497289	5	150117726	1713491	1777386		NC_000005.10:150117725:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 25, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3026A>G (p.Tyr1009Cys)	PDGFRB	Y1009C, Y848C, Y945C	Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV002935583	5	149497292	5	150117729	2935583	3099256		NC_000005.10:150117728:T:C	single nucleotide variant	missense variant	Likely benign	Nov 18, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3018C>T (p.Ser1006=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002012023	5	149497300	5	150117737	2012023	2067400		NC_000005.10:150117736:G:A	single nucleotide variant	synonymous variant	Benign	Aug 17, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.3011C>T (p.Thr1004Ile)	PDGFRB	T1004I, T843I, T940I	not provided|Inborn genetic diseases	VCV001304018	5	149497307	5	150117744	1304018	1294293	rs770576414	NC_000005.10:150117743:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2997A>T (p.Arg999=)	PDGFRB		Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000712779	5	149497321	5	150117758	712779	721301	rs776113877	NC_000005.10:150117757:T:A	single nucleotide variant	synonymous variant	Likely benign	Dec 2, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2996G>C (p.Arg999Pro)	PDGFRB	R838P, R935P, R999P	not provided	VCV002499379	5	149497322	5	150117759	2499379	2477355		NC_000005.10:150117758:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2976G>A (p.Leu992=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV002059001	5	149497342	5	150117779	2059001	2106527		NC_000005.10:150117778:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 15, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2972G>A (p.Arg991His)	PDGFRB	R927H, R830H, R991H	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV000783158	5	149497346	5	150117783	783158	709731	rs75748462	NC_000005.10:150117782:C:T	single nucleotide variant	missense variant	Likely benign	Oct 11, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2971C>T (p.Arg991Cys)	PDGFRB	R991C, R830C, R927C	Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Inborn genetic diseases	VCV002065779	5	149497347	5	150117784	2065779	2118467		NC_000005.10:150117783:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 14, 2022	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.2970C>T (p.Ala990=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002139370	5	149497348	5	150117785	2139370	1875164		NC_000005.10:150117784:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2960G>A (p.Arg987Gln)	PDGFRB	R826Q, R923Q, R987Q	not provided|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000733483	5	149497358	5	150117795	733483	734934	rs35731372	NC_000005.10:150117794:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Nov 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2959C>T (p.Arg987Trp)	PDGFRB	R987W, R826W, R923W	not provided	VCV000039589	5	149497359	5	150117796	39589	48188	rs397509382	NC_000005.10:150117795:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2954T>C (p.Ile985Thr)	PDGFRB	I824T, I921T, I985T	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001505515	5	149497364	5	150117801	1505515	1437082	rs753367645	NC_000005.10:150117800:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2939G>A (p.Ser980Asn)	PDGFRB	S980N, S819N, S916N	not provided|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000576602	5	149497379	5	150117816	576602	562990	rs1561984983	NC_000005.10:150117815:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2938A>C (p.Ser980Arg)	PDGFRB	S980R, S819R, S916R	not specified	VCV000252609	5	149497380	5	150117817	252609	246977	rs879255377	NC_000005.10:150117816:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2015	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2927A>T (p.Glu976Val)	PDGFRB	E815V, E912V, E976V	not provided	VCV002430592	5	149497391	5	150117828	2430592	2404099		NC_000005.10:150117827:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2919G>A (p.Val973=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|not provided	VCV000785900	5	149497399	5	150117836	785900	709732	rs370594710	NC_000005.10:150117835:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2914C>A (p.Gln972Lys)	PDGFRB	Q972K, Q811K, Q908K	Inborn genetic diseases|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002281052	5	149497404	5	150117841	2281052	2270869		NC_000005.10:150117840:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2909A>C (p.Tyr970Ser)	PDGFRB	Y809S, Y970S, Y906S	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002015276	5	149497409	5	150117846	2015276	2068074		NC_000005.10:150117845:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2905-1G>T	PDGFRB		Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV002944704	5	149497414	5	150117851	2944704	3097993		NC_000005.10:150117850:C:A	single nucleotide variant	splice acceptor variant	Uncertain significance	Mar 24, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2905-3_2905-1del	PDGFRB		not provided	VCV001311429	5	149497414 - 149497416	5	150117851 - 150117853	1311429	1299486	rs2113884554	NC_000005.10:150117850:CTGCT:CT	Deletion	splice acceptor variant	Uncertain significance	Dec 12, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2905-8G>C	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002414151	5	149497421	5	150117858	2414151	1936782		NC_000005.10:150117857:C:G	single nucleotide variant	intron variant	Likely benign	Nov 22, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2905-8G>A	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001486244	5	149497421	5	150117858	1486244	1468721	rs201866603	NC_000005.10:150117857:C:T	single nucleotide variant	intron variant	Uncertain significance	Feb 13, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2905-19C>G	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002077459	5	149497432	5	150117869	2077459	2131517		NC_000005.10:150117868:G:C	single nucleotide variant	intron variant	Likely benign	Sep 9, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2905-259G>A	PDGFRB		not provided	VCV001281328	5	149497672	5	150118109	1281328	1270324	rs246392	NC_000005.10:150118108:C:T	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2904+246G>C	PDGFRB		not provided	VCV001258845	5	149498064	5	150118501	1258845	1247056	rs11740840	NC_000005.10:150118500:C:G	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2904+159C>T	PDGFRB		not provided	VCV001226608	5	149498151	5	150118588	1226608	1217862	rs246394	NC_000005.10:150118587:G:A	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2904+87G>A	PDGFRB		not provided	VCV001187624	5	149498223	5	150118660	1187624	1176588	rs150263966	NC_000005.10:150118659:C:T	single nucleotide variant	intron variant	Likely benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2904+75C>T	PDGFRB		not provided	VCV001314955	5	149498235	5	150118672	1314955	1305216	rs1432878	NC_000005.10:150118671:G:A	single nucleotide variant	intron variant	Likely benign	Apr 29, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2904+15G>A	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis	VCV002062302	5	149498295	5	150118732	2062302	2117575		NC_000005.10:150118731:C:T	single nucleotide variant	intron variant	Benign	Aug 8, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2890G>A (p.Glu964Lys)	PDGFRB	E803K, E900K, E964K	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV001010869	5	149498324	5	150118761	1010869	990798	rs747398617	NC_000005.10:150118760:C:T	single nucleotide variant	missense variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2889C>T (p.Gly963=)	PDGFRB		not provided|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV000771564	5	149498325	5	150118762	771564	698922	rs139623802	NC_000005.10:150118761:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2875G>A (p.Glu959Lys)	PDGFRB	E798K, E895K, E959K	PDGFRB-related disorder|not provided	VCV002444604	5	149498339	5	150118776	2444604	2418334		NC_000005.10:150118775:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2874C>T (p.Leu958=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001156895	5	149498340	5	150118777	1156895	1136674	rs773161073	NC_000005.10:150118776:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 5, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2872C>G (p.Leu958Val)	PDGFRB	L797V, L894V, L958V	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis	VCV000958188	5	149498342	5	150118779	958188	944491	rs1321037719	NC_000005.10:150118778:G:C	single nucleotide variant	missense variant	Likely benign	Mar 7, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2857C>A (p.Gln953Lys)	PDGFRB	Q792K, Q889K, Q953K	not provided	VCV001307686	5	149498357	5	150118794	1307686	1297634	rs1760044565	NC_000005.10:150118793:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2855C>G (p.Ser952Cys)	PDGFRB	S952C, S791C, S888C	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|not provided|PDGFRB-related disorder	VCV002059038	5	149498359	5	150118796	2059038	2116899		NC_000005.10:150118795:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2844G>A (p.Arg948=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|not provided	VCV000540601	5	149498370	5	150118807	540601	521357	rs55647240	NC_000005.10:150118806:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2811G>A (p.Met937Ile)	PDGFRB	M776I, M873I, M937I	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002051140	5	149498403	5	150118840	2051140	2111611		NC_000005.10:150118839:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2811G>T (p.Met937Ile)	PDGFRB	M776I, M873I, M937I	not provided	VCV001305189	5	149498403	5	150118840	1305189	1295464	rs751229604	NC_000005.10:150118839:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2799-83dup	PDGFRB		not provided	VCV001276357	5	149498497 - 149498498	5	150118934 - 150118935	1276357	1267525	rs5872159	NC_000005.10:150118934:T:TT	Duplication	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2798+271T>A	PDGFRB		not provided	VCV001260015	5	149498759	5	150119196	1260015	1249499	rs1864974	NC_000005.10:150119195:A:T	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2798+209G>A	PDGFRB		not provided	VCV001272773	5	149498821	5	150119258	1272773	1262238	rs3733676	NC_000005.10:150119257:C:T	single nucleotide variant	intron variant	Benign	Feb 28, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2798+196G>A	PDGFRB		not provided	VCV001211846	5	149498834	5	150119271	1211846	1201843	rs115096367	NC_000005.10:150119270:C:T	single nucleotide variant	intron variant	Likely benign	Mar 24, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2798+158del	PDGFRB		not provided	VCV001281908	5	149498872	5	150119309	1281908	1273135	rs3832325	NC_000005.10:150119308:GG:G	Deletion	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2798+10G>A	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002936374	5	149499020	5	150119457	2936374	3105811		NC_000005.10:150119456:C:T	single nucleotide variant	intron variant	Likely benign	Dec 15, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2798+8G>A	PDGFRB		PDGFRB-related disorder	VCV003349317	5	149499022	5	150119459	3349317	3508545		NC_000005.10:150119458:C:T	single nucleotide variant	intron variant	Uncertain significance	Jun 26, 2024	no assertion criteria provided							
NM_002609.4(PDGFRB):c.2791G>A (p.Asp931Asn)	PDGFRB	D770N, D867N, D931N	Inborn genetic diseases|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002228308	5	149499037	5	150119474	2228308	1936736		NC_000005.10:150119473:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 30, 2022	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.2756G>A (p.Arg919Gln)	PDGFRB	R758Q, R855Q, R919Q	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002028811	5	149499072	5	150119509	2028811	2085446		NC_000005.10:150119508:C:T	single nucleotide variant	missense variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2755C>T (p.Arg919Trp)	PDGFRB	R758W, R855W, R919W	not provided	VCV001335603	5	149499073	5	150119510	1335603	1326574	rs550187329	NC_000005.10:150119509:G:A	single nucleotide variant	missense variant	Likely benign	Dec 1, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2741A>G (p.Tyr914Cys)	PDGFRB	Y753C, Y850C, Y914C	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002194721	5	149499087	5	150119524	2194721	1932564		NC_000005.10:150119523:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2716G>C (p.Glu906Gln)	PDGFRB	E745Q, E842Q, E906Q	Inborn genetic diseases	VCV003210843	5	149499112	5	150119549	3210843	3375375		NC_000005.10:150119548:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2714C>T (p.Pro905Leu)	PDGFRB	P744L, P841L, P905L	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002423512	5	149499114	5	150119551	2423512	1945885		NC_000005.10:150119550:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2705C>T (p.Thr902Ile)	PDGFRB	T902I, T741I, T838I	not provided|Inborn genetic diseases|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis	VCV000423309	5	149499123	5	150119560	423309	406662	rs200865355	NC_000005.10:150119559:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 13, 2022	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.2698+1G>T	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis	VCV002122049	5	149499574	5	150120011	2122049	2173474		NC_000005.10:150120010:C:A	single nucleotide variant	splice donor variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2688C>G (p.Ile896Met)	PDGFRB	I735M, I896M, I832M	Inborn genetic diseases	VCV002231388	5	149499585	5	150120022	2231388	2227315		NC_000005.10:150120021:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2668G>C (p.Gly890Arg)	PDGFRB	G729R, G826R, G890R	Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV003242267	5	149499605	5	150120042	3242267	3401242		NC_000005.10:150120041:C:G	single nucleotide variant	missense variant	Uncertain significance		criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2667C>T (p.Phe889=)	PDGFRB		not provided|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002655905	5	149499606	5	150120043	2655905	2825398		NC_000005.10:150120042:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2655C>T (p.Asp885=)	PDGFRB		Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|not provided	VCV000712760	5	149499618	5	150120055	712760	721302	rs144234864	NC_000005.10:150120054:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2653G>A (p.Asp885Asn)	PDGFRB	D821N, D885N, D724N	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002202027	5	149499620	5	150120057	2202027	1934629		NC_000005.10:150120056:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2635C>A (p.Leu879Ile)	PDGFRB	L815I, L879I, L718I	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV002190056	5	149499638	5	150120075	2190056	1918805		NC_000005.10:150120074:G:T	single nucleotide variant	missense variant	Likely benign	Aug 22, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2627T>G (p.Phe876Cys)	PDGFRB	F715C, F812C, F876C	PDGFRB-related disorder	VCV003347861	5	149499646	5	150120083	3347861	3506214		NC_000005.10:150120082:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	no assertion criteria provided							
NM_002609.4(PDGFRB):c.2616G>A (p.Pro872=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000473405	5	149499657	5	150120094	473405	455595	rs148709288	NC_000005.10:150120093:C:T	single nucleotide variant	synonymous variant	Benign	Dec 6, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2601A>G (p.Leu867=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|not provided|Myeloproliferative disorder, chronic, with eosinophilia|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000258776	5	149499672	5	150120109	258776	251821	rs246395	NC_000005.10:150120108:T:C	single nucleotide variant	synonymous variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2588C>A (p.Thr863Asn)	PDGFRB	T702N, T863N, T799N	Inborn genetic diseases|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|not provided	VCV000948189	5	149499685	5	150120122	948189	923948	rs750896639	NC_000005.10:150120121:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 8, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.2587-5T>C	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV001533537	5	149499691	5	150120128	1533537	1530677	rs758524703	NC_000005.10:150120127:A:G	single nucleotide variant	intron variant	Benign	Oct 10, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2587-110C>T	PDGFRB		not provided	VCV001222671	5	149499796	5	150120233	1222671	1213068	rs41287106	NC_000005.10:150120232:G:A	single nucleotide variant	intron variant	Benign	Feb 7, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2587-297G>C	PDGFRB		not provided	VCV001216099	5	149499983	5	150120420	1216099	1206080	rs117267989	NC_000005.10:150120419:C:G	single nucleotide variant	intron variant	Likely benign	Oct 8, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2586+215G>A	PDGFRB		not provided	VCV001276444	5	149500236	5	150120673	1276444	1267612	rs193549	NC_000005.10:150120672:C:T	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2586+28G>A	PDGFRB		not provided	VCV001693085	5	149500423	5	150120860	1693085	1685525	rs116476231	NC_000005.10:150120859:C:T	single nucleotide variant	intron variant	Likely benign	Dec 22, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2586+20C>A	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002925007	5	149500431	5	150120868	2925007	3089786		NC_000005.10:150120867:G:T	single nucleotide variant	intron variant	Likely benign	Nov 15, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2586+20C>G	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002158757	5	149500431	5	150120868	2158757	1883739		NC_000005.10:150120867:G:C	single nucleotide variant	intron variant	Likely benign	Nov 15, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2586+13C>T	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001991199	5	149500438	5	150120875	1991199	2041240		NC_000005.10:150120874:G:A	single nucleotide variant	intron variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2566A>T (p.Asn856Tyr)	PDGFRB	N695Y, N792Y, N856Y	not provided	VCV002432540	5	149500471	5	150120908	2432540	2407794		NC_000005.10:150120907:T:A	single nucleotide variant	missense variant	Likely pathogenic	Jan 27, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2559G>A (p.Arg853=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002146269	5	149500478	5	150120915	2146269	1876874		NC_000005.10:150120914:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2557C>A (p.Arg853=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002147857	5	149500480	5	150120917	2147857	1877169		NC_000005.10:150120916:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 29, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2553C>G (p.Ile851Met)	PDGFRB	I690M, I787M, I851M	Inborn genetic diseases	VCV002256287	5	149500484	5	150120921	2256287	2246994		NC_000005.10:150120920:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2549A>G (p.Asp850Gly)	PDGFRB	D689G, D786G, D850G	not provided|Myofibromatosis, infantile, 1	VCV002434631	5	149500488	5	150120925	2434631	2405943		NC_000005.10:150120924:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2549A>T (p.Asp850Val)	PDGFRB	D850V, D689V, D786V	Infantile myofibromatosis	VCV000375681	5	149500488	5	150120925	375681	362520	rs1060499540	NC_000005.10:150120924:T:A	single nucleotide variant	missense variant	Pathogenic	Dec 1, 2016	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2548G>T (p.Asp850Tyr)	PDGFRB	D689Y, D786Y, D850Y	Myofibromatosis, infantile, 1	VCV003237207	5	149500489	5	150120926	3237207	3396332		NC_000005.10:150120925:C:A	single nucleotide variant	missense variant	Pathogenic	Apr 23, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2546_2548del (p.Arg849_Asp850delinsHis)	PDGFRB		Myofibromatosis, infantile, 1	VCV003233448	5	149500489 - 149500491	5	150120926 - 150120928	3233448	3392574		NC_000005.10:150120925:CTC:	Deletion	inframe_indel	Pathogenic	Apr 23, 2024	no assertion criteria provided							
NM_002609.4(PDGFRB):c.2546G>T (p.Arg849Leu)	PDGFRB	R688L, R785L, R849L	not provided	VCV003373572	5	149500491	5	150120928	3373572	3532761		NC_000005.10:150120927:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 29, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2528G>A (p.Cys843Tyr)	PDGFRB	C682Y, C779Y, C843Y	Inborn genetic diseases	VCV002491798	5	149500509	5	150120946	2491798	2464414		NC_000005.10:150120945:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2523G>A (p.Lys841=)	PDGFRB		not provided|Myeloproliferative disorder, chronic, with eosinophilia|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|not specified	VCV000286389	5	149500514	5	150120951	286389	270626	rs41287108	NC_000005.10:150120950:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2520C>T (p.Val840=)	PDGFRB		not provided	VCV000715118	5	149500517	5	150120954	715118	721303	rs371399585	NC_000005.10:150120953:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 9, 2017	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2502C>T (p.Ile834=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000707246	5	149500535	5	150120972	707246	691785	rs143375423	NC_000005.10:150120971:G:A	single nucleotide variant	synonymous variant	Benign	Jan 26, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2499C>A (p.Leu833=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001903082	5	149500538	5	150120975	1903082	1961160		NC_000005.10:150120974:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 24, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2493C>T (p.Asn831=)	PDGFRB		PDGFRB-related disorder	VCV003032356	5	149500544	5	150120981	3032356	3198278		NC_000005.10:150120980:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 10, 2023	no assertion criteria provided							
NM_002609.4(PDGFRB):c.2484G>A (p.Ala828=)	PDGFRB		not provided|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001570231	5	149500553	5	150120990	1570231	1623547	rs143342011	NC_000005.10:150120989:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2483C>A (p.Ala828Glu)	PDGFRB	A667E, A764E, A828E	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002096300	5	149500554	5	150120991	2096300	2146451		NC_000005.10:150120990:G:T	single nucleotide variant	missense variant	Pathogenic	Feb 11, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2483C>T (p.Ala828Val)	PDGFRB	A828V, A764V, A667V	Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001942408	5	149500554	5	150120991	1942408	2005141		NC_000005.10:150120990:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2476G>T (p.Asp826Tyr)	PDGFRB	D665Y, D762Y, D826Y	not provided	VCV003392579	5	149500561	5	150120998	3392579	3551658		NC_000005.10:150120997:C:A	single nucleotide variant	missense variant	Pathogenic	Jun 24, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2467G>A (p.Val823Ile)	PDGFRB	V662I, V759I, V823I	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis	VCV000958594	5	149500570	5	150121007	958594	944492	rs377442091	NC_000005.10:150121006:C:T	single nucleotide variant	missense variant	Likely benign	Dec 19, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2466C>T (p.Cys822=)	PDGFRB		not provided|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000715215	5	149500571	5	150121008	715215	721304	rs55830572	NC_000005.10:150121007:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jul 17, 2022	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.2464-3C>T	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV000572749	5	149500576	5	150121013	572749	562995	rs571983343	NC_000005.10:150121012:G:A	single nucleotide variant	intron variant	Uncertain significance	Aug 25, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2464-19C>G	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002923853	5	149500592	5	150121029	2923853	3086039		NC_000005.10:150121028:G:C	single nucleotide variant	intron variant	Benign	Dec 1, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2463+4C>T	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001386117	5	149500763	5	150121200	1386117	1361125	rs557338313	NC_000005.10:150121199:G:A	single nucleotide variant	intron variant	Uncertain significance	Jan 15, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2463C>T (p.Asn821=)	PDGFRB		not specified|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000287412	5	149500767	5	150121204	287412	271649	rs78336563	NC_000005.10:150121203:G:A	single nucleotide variant	synonymous variant	Benign	Jun 16, 2020	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2410G>A (p.Val804Met)	PDGFRB	V643M, V740M, V804M	not provided	VCV003371550	5	149500820	5	150121257	3371550	3530740		NC_000005.10:150121256:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2402T>C (p.Met801Thr)	PDGFRB	M640T, M801T, M737T	Basal ganglia calcification, idiopathic, 4	VCV000932040	5	149500828	5	150121265	932040	918933	rs1760125256	NC_000005.10:150121264:A:G	single nucleotide variant	missense variant	Uncertain significance	May 9, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2394A>C (p.Leu798=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002937686	5	149500836	5	150121273	2937686	3096166		NC_000005.10:150121272:T:G	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2386C>T (p.Pro796Ser)	PDGFRB	P732S, P635S, P796S	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002928117	5	149500844	5	150121281	2928117	3093738		NC_000005.10:150121280:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2384C>T (p.Ser795Phe)	PDGFRB	S634F, S731F, S795F	not provided	VCV001704875	5	149500846	5	150121283	1704875	1699407		NC_000005.10:150121282:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2380G>A (p.Glu794Lys)	PDGFRB	E633K, E794K, E730K	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|not provided	VCV002922854	5	149500850	5	150121287	2922854	3092400		NC_000005.10:150121286:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2379C>T (p.Asn793=)	PDGFRB		PDGFRB-related disorder	VCV003035485	5	149500851	5	150121288	3035485	3198794		NC_000005.10:150121287:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 1, 2019	no assertion criteria provided							
NM_002609.4(PDGFRB):c.2366C>T (p.Ala789Val)	PDGFRB	A628V, A725V, A789V	PDGFRB-related disorder	VCV002628796	5	149500864	5	150121301	2628796	2800513		NC_000005.10:150121300:G:A	single nucleotide variant	missense variant	Uncertain significance	May 20, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2365G>T (p.Ala789Ser)	PDGFRB	A628S, A789S, A725S	not provided	VCV000770059	5	149500865	5	150121302	770059	698923	rs190620156	NC_000005.10:150121301:C:A	single nucleotide variant	missense variant	Likely benign	Oct 18, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2362C>T (p.Arg788Ter)	PDGFRB	R788*, R627*, R724*	Inborn genetic diseases|not provided	VCV000520866	5	149500868	5	150121305	520866	511579	rs1320275282	NC_000005.10:150121304:G:A	single nucleotide variant	nonsense	Uncertain significance	Oct 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2360G>A (p.Cys787Tyr)	PDGFRB	C626Y, C787Y, C723Y	Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001480134	5	149500870	5	150121307	1480134	1364804	rs2113890060	NC_000005.10:150121306:C:T	single nucleotide variant	missense variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2345-18C>T	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002092740	5	149500903	5	150121340	2092740	2145483		NC_000005.10:150121339:G:A	single nucleotide variant	intron variant	Likely benign	Dec 18, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2345-112C>T	PDGFRB		not provided	VCV001212782	5	149500997	5	150121434	1212782	1202776	rs115895504	NC_000005.10:150121433:G:A	single nucleotide variant	intron variant	Likely benign	Apr 3, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2344+121T>C	PDGFRB		not provided	VCV001245242	5	149501322	5	150121759	1245242	1235195	rs79566483	NC_000005.10:150121758:A:G	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2335G>A (p.Val779Ile)	PDGFRB	V618I, V715I, V779I	not provided	VCV001319185	5	149501452	5	150121889	1319185	1309438	rs758890727	NC_000005.10:150121888:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2328T>A (p.Asp776Glu)	PDGFRB	D615E, D776E, D712E	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002089915	5	149501459	5	150121896	2089915	2155585		NC_000005.10:150121895:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2326G>A (p.Asp776Asn)	PDGFRB	D615N, D712N, D776N	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001009692	5	149501461	5	150121898	1009692	990799	rs751904503	NC_000005.10:150121897:C:T	single nucleotide variant	missense variant	Likely benign	Mar 30, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2298C>T (p.Ile766=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002924075	5	149501489	5	150121926	2924075	3082374		NC_000005.10:150121925:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 20, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2285A>G (p.Lys762Arg)	PDGFRB	K601R, K698R, K762R	Inborn genetic diseases	VCV003210842	5	149501502	5	150121939	3210842	3375374		NC_000005.10:150121938:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2281G>C (p.Val761Leu)	PDGFRB	V697L, V761L, V600L	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002939068	5	149501506	5	150121943	2939068	3100127		NC_000005.10:150121942:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2281G>A (p.Val761Ile)	PDGFRB	V697I, V600I, V761I	Inborn genetic diseases|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002262363	5	149501506	5	150121943	2262363	2258683		NC_000005.10:150121942:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 20, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.2280C>T (p.Asp760=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002031428	5	149501507	5	150121944	2031428	2079070		NC_000005.10:150121943:G:A	single nucleotide variant	synonymous variant	Benign	Jul 10, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2276G>A (p.Gly759Glu)	PDGFRB	G598E, G759E, G695E	Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV001965694	5	149501511	5	150121948	1965694	2024414		NC_000005.10:150121947:C:T	single nucleotide variant	missense variant	Benign	Apr 6, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2270T>C (p.Met757Thr)	PDGFRB	M596T, M757T, M693T	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001969146	5	149501517	5	150121954	1969146	2025284		NC_000005.10:150121953:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2269A>G (p.Met757Val)	PDGFRB	M757V, M693V, M596V	not provided	VCV000452509	5	149501518	5	150121955	452509	443722	rs933723345	NC_000005.10:150121954:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2268C>T (p.Asp756=)	PDGFRB		not provided|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000809827	5	149501519	5	150121956	809827	795660	rs56112987	NC_000005.10:150121955:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2252A>G (p.Tyr751Cys)	PDGFRB	Y590C, Y687C, Y751C	not provided	VCV003363990	5	149501535	5	150121972	3363990	3523199		NC_000005.10:150121971:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2243C>T (p.Ser748Leu)	PDGFRB	S587L, S684L, S748L	not provided|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002178345	5	149501544	5	150121981	2178345	1912222		NC_000005.10:150121980:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 22, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.2238C>T (p.Asp746=)	PDGFRB		Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000736581	5	149501549	5	150121986	736581	749343	rs555800957	NC_000005.10:150121985:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 7, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2235G>C (p.Lys745Asn)	PDGFRB	K584N, K681N, K745N	Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Inborn genetic diseases	VCV001432969	5	149501552	5	150121989	1432969	1493543	rs1760151971	NC_000005.10:150121988:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2233A>G (p.Lys745Glu)	PDGFRB	K584E, K681E, K745E	not provided	VCV001806545	5	149501554	5	150121991	1806545	1863551		NC_000005.10:150121990:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2212G>A (p.Gly738Ser)	PDGFRB	G577S, G674S, G738S	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001961687	5	149501575	5	150122012	1961687	2016656		NC_000005.10:150122011:C:T	single nucleotide variant	missense variant	Benign	Aug 5, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2208C>T (p.Ser736=)	PDGFRB		not provided|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV002418520	5	149501579	5	150122016	2418520	1944483		NC_000005.10:150122015:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2200G>A (p.Gly734Arg)	PDGFRB	G734R, G573R, G670R	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002195709	5	149501587	5	150122024	2195709	1926600		NC_000005.10:150122023:C:T	single nucleotide variant	missense variant	Likely benign	Mar 4, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2199C>T (p.Thr733=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000725390	5	149501588	5	150122025	725390	734935	rs192355633	NC_000005.10:150122024:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 21, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2191T>G (p.Ser731Ala)	PDGFRB	S667A, S570A, S731A	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002935862	5	149501596	5	150122033	2935862	3095651		NC_000005.10:150122032:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2184-7C>T	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002953404	5	149501610	5	150122047	2953404	3113505		NC_000005.10:150122046:G:A	single nucleotide variant	intron variant	Likely benign	Dec 20, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2184-89_2184-86del	PDGFRB		not provided	VCV001296890	5	149501689 - 149501692	5	150122126 - 150122129	1296890	1286680	rs56202461	NC_000005.10:150122125:CTCACTCAC:CTCAC	Microsatellite	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2184-148T>G	PDGFRB		not provided	VCV001272123	5	149501751	5	150122188	1272123	1262879	rs2304060	NC_000005.10:150122187:A:C	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2184-200G>A	PDGFRB		not provided	VCV001286098	5	149501803	5	150122240	1286098	1275937	rs17656204	NC_000005.10:150122239:C:T	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2183+122G>T	PDGFRB		not provided	VCV001187144	5	149502483	5	150122920	1187144	1176589	rs139968382	NC_000005.10:150122919:C:A	single nucleotide variant	intron variant	Likely benign	Jan 10, 2019	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2183+19G>A	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002938937	5	149502586	5	150123023	2938937	3099996		NC_000005.10:150123022:C:T	single nucleotide variant	intron variant	Likely benign	Nov 10, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2183+18A>G	PDGFRB		Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV002944901	5	149502587	5	150123024	2944901	3107857		NC_000005.10:150123023:T:C	single nucleotide variant	intron variant	Likely benign	Mar 6, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2176dup (p.Leu726fs)	PDGFRB	L565fs, L662fs, L726fs	PDGFRB-related disorder	VCV003344058	5	149502611 - 149502612	5	150123048 - 150123049	3344058	3505044		NC_000005.10:150123048:GGGGG:GGGGGG	Duplication	frameshift variant	Uncertain significance	Jun 21, 2024	no assertion criteria provided							
NM_002609.4(PDGFRB):c.2172C>T (p.Leu724=)	PDGFRB		not provided	VCV000728863	5	149502616	5	150123053	728863	734936	rs1377440487	NC_000005.10:150123052:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 24, 2017	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2170C>G (p.Leu724Val)	PDGFRB	L563V, L660V, L724V	not provided	VCV001708576	5	149502618	5	150123055	1708576	1706930		NC_000005.10:150123054:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2169G>T (p.Gly723=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001124751	5	149502619	5	150123056	1124751	1115665	rs961398213	NC_000005.10:150123055:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 2, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2164G>A (p.Val722Ile)	PDGFRB	V722I, V561I, V658I	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001960043	5	149502624	5	150123061	1960043	2016299		NC_000005.10:150123060:C:T	single nucleotide variant	missense variant	Likely benign	Sep 27, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2164G>T (p.Val722Phe)	PDGFRB	V658F, V722F, V561F	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000770053	5	149502624	5	150123061	770053	698924	rs142689325	NC_000005.10:150123060:C:A	single nucleotide variant	missense variant	Benign	Dec 19, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2163C>T (p.Pro721=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002195813	5	149502625	5	150123062	2195813	1926703		NC_000005.10:150123061:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 9, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2148C>T (p.Tyr716=)	PDGFRB		not provided	VCV000739686	5	149502640	5	150123077	739686	749344	rs1580798188	NC_000005.10:150123076:G:A	single nucleotide variant	synonymous variant	Likely benign	May 17, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2138C>T (p.Ala713Val)	PDGFRB	A552V, A649V, A713V	not provided	VCV003379607	5	149502650	5	150123087	3379607	3538783		NC_000005.10:150123086:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2137G>A (p.Ala713Thr)	PDGFRB	A713T, A649T, A552T	not specified	VCV000252608	5	149502651	5	150123088	252608	246978	rs371341863	NC_000005.10:150123087:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2015	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2136C>T (p.Ser712=)	PDGFRB		not specified	VCV003251490	5	149502652	5	150123089	3251490	3410289		NC_000005.10:150123088:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 5, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2129C>T (p.Pro710Leu)	PDGFRB	P549L, P646L, P710L	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Inborn genetic diseases	VCV002067349	5	149502659	5	150123096	2067349	2118742		NC_000005.10:150123095:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Sep 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2128C>T (p.Pro710Ser)	PDGFRB	P646S, P710S, P549S	Inborn genetic diseases	VCV002547962	5	149502660	5	150123097	2547962	2710342		NC_000005.10:150123096:G:A	single nucleotide variant	missense variant	Uncertain significance	May 17, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2126G>A (p.Arg709His)	PDGFRB	R709H, R548H, R645H	Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|not provided	VCV000194497	5	149502662	5	150123099	194497	191660	rs759436020	NC_000005.10:150123098:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 28, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.2123G>A (p.Arg708His)	PDGFRB	R547H, R708H, R644H	Inborn genetic diseases	VCV002368839	5	149502665	5	150123102	2368839	2365363		NC_000005.10:150123101:C:T	single nucleotide variant	missense variant	Likely benign	Jun 9, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2122C>T (p.Arg708Cys)	PDGFRB	R708C, R547C, R644C	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Inborn genetic diseases	VCV001961685	5	149502666	5	150123103	1961685	2016654		NC_000005.10:150123102:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 15, 2024	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.2119A>G (p.Lys707Glu)	PDGFRB	K546E, K643E, K707E	not provided	VCV001314128	5	149502669	5	150123106	1314128	1304389	rs2113892961	NC_000005.10:150123105:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2116G>A (p.Asp706Asn)	PDGFRB	D545N, D642N, D706N	not provided	VCV002573878	5	149502672	5	150123109	2573878	2738820		NC_000005.10:150123108:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2116G>T (p.Asp706Tyr)	PDGFRB	D642Y, D706Y, D545Y	Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001497821	5	149502672	5	150123109	1497821	1376341	rs770635073	NC_000005.10:150123108:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2115C>T (p.Ser705=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002158561	5	149502673	5	150123110	2158561	1883543		NC_000005.10:150123109:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 10, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2111A>G (p.His704Arg)	PDGFRB	H704R, H543R, H640R	Inborn genetic diseases	VCV002231329	5	149502677	5	150123114	2231329	2227256		NC_000005.10:150123113:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2094dup (p.Thr699fs)	PDGFRB	T538fs, T635fs, T699fs	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002951084	5	149502693 - 149502694	5	150123130 - 150123131	2951084	3109987		NC_000005.10:150123130:G:GG	Duplication	frameshift variant	Uncertain significance	Oct 28, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2084G>A (p.Arg695His)	PDGFRB	R631H, R534H, R695H	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002145401	5	149502704	5	150123141	2145401	1870345		NC_000005.10:150123140:C:T	single nucleotide variant	missense variant	Likely benign	Apr 21, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2083C>T (p.Arg695Cys)	PDGFRB	R695C, R631C, R534C	Cerebral palsy|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Basal ganglia calcification, idiopathic, 4|not provided	VCV000135650	5	149502705	5	150123142	135650	139368	rs138008832	NC_000005.10:150123141:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 5, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.2070G>A (p.Val690=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002924347	5	149502718	5	150123155	2924347	3092586		NC_000005.10:150123154:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2062G>C (p.Asp688His)	PDGFRB	D688H, D527H, D624H	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002953156	5	149502726	5	150123163	2953156	3114711		NC_000005.10:150123162:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2058C>T (p.Tyr686=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Inborn genetic diseases	VCV000738341	5	149502730	5	150123167	738341	749345	rs753622898	NC_000005.10:150123166:G:A	single nucleotide variant	synonymous variant	Likely benign	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2054G>A (p.Arg685His)	PDGFRB	R621H, R524H, R685H	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002187908	5	149502734	5	150123171	2187908	1921823		NC_000005.10:150123170:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2053C>T (p.Arg685Cys)	PDGFRB	R524C, R621C, R685C	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001164464	5	149502735	5	150123172	1164464	1154964	rs763239423	NC_000005.10:150123171:G:A	single nucleotide variant	missense variant	Benign	Oct 5, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2044G>A (p.Glu682Lys)	PDGFRB	E682K, E521K, E618K	Inborn genetic diseases	VCV002557803	5	149502744	5	150123181	2557803	2727210		NC_000005.10:150123180:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2029A>G (p.Ile677Val)	PDGFRB	I516V, I613V, I677V	not specified	VCV003063652	5	149502759	5	150123196	3063652	3223862		NC_000005.10:150123195:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2024G>A (p.Gly675Glu)	PDGFRB	G514E, G611E, G675E	PDGFRB-related disorder	VCV003347752	5	149502764	5	150123201	3347752	3495437		NC_000005.10:150123200:C:T	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	no assertion criteria provided							
NM_002609.4(PDGFRB):c.2024-74C>G	PDGFRB		not provided	VCV001192970	5	149502838	5	150123275	1192970	1183602	rs56388645	NC_000005.10:150123274:G:C	single nucleotide variant	intron variant	Likely benign	Apr 3, 2019	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.2024-295G>A	PDGFRB		not provided	VCV001281115	5	149503059	5	150123496	1281115	1271833	rs55943036	NC_000005.10:150123495:C:T	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2023+143C>T	PDGFRB		not provided	VCV001267712	5	149503670	5	150124107	1267712	1258048	rs2304061	NC_000005.10:150124106:G:A	single nucleotide variant	intron variant	Benign	Apr 3, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2023+16C>T	PDGFRB		Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV001905654	5	149503797	5	150124234	1905654	1955096		NC_000005.10:150124233:G:A	single nucleotide variant	intron variant	Likely benign	Jun 30, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2023+6G>A	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV002080271	5	149503807	5	150124244	2080271	2135504		NC_000005.10:150124243:C:T	single nucleotide variant	intron variant	Uncertain significance	Jan 15, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2023+5C>T	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV000540599	5	149503808	5	150124245	540599	520924	rs369842668	NC_000005.10:150124244:G:A	single nucleotide variant	intron variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2023+4C>G	PDGFRB		not provided	VCV002580842	5	149503809	5	150124246	2580842	2748428		NC_000005.10:150124245:G:C	single nucleotide variant	intron variant	Uncertain significance	Mar 19, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.2002T>A (p.Leu668Met)	PDGFRB	L507M, L604M, L668M	not provided	VCV003378375	5	149503834	5	150124271	3378375	3537554		NC_000005.10:150124270:A:T	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1998C>G (p.Asn666Lys)	PDGFRB	N666K, N602K, N505K	Infantile myofibromatosis	VCV000375556	5	149503838	5	150124275	375556	362366	rs864309711	NC_000005.10:150124274:G:C	single nucleotide variant	missense variant	Pathogenic	Dec 1, 2016	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1998C>A (p.Asn666Lys)	PDGFRB	N666K, N505K, N602K	Infantile myofibromatosis|Myofibromatosis, infantile, 1|not provided	VCV000218935	5	149503838	5	150124275	218935	215769	rs864309711	NC_000005.10:150124274:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1997A>G (p.Asn666Ser)	PDGFRB	N505S, N602S, N666S	See cases|Myeloproliferative disorder, chronic, with eosinophilia|not provided	VCV001686016	5	149503839	5	150124276	1686016	1678028	rs2113894766	NC_000005.10:150124275:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1996A>C (p.Asn666His)	PDGFRB	N666H, N505H, N602H	Inborn genetic diseases	VCV000208692	5	149503840	5	150124277	208692	205249	rs797044887	NC_000005.10:150124276:T:G	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1994T>C (p.Val665Ala)	PDGFRB	V665A, V504A, V601A	Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000495300	5	149503842	5	150124279	495300	213768	rs1554108211	NC_000005.10:150124278:A:G	single nucleotide variant	missense variant	Pathogenic	Nov 21, 2017	no assertion criteria provided							
NM_002609.4(PDGFRB):c.1990G>A (p.Val664Met)	PDGFRB	V503M, V600M, V664M	not provided	VCV002504737	5	149503846	5	150124283	2504737	2669704		NC_000005.10:150124282:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1989C>T (p.Asn663=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002922941	5	149503847	5	150124284	2922941	3092487		NC_000005.10:150124283:G:A	single nucleotide variant	synonymous variant	Benign	Apr 9, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1978C>A (p.Pro660Thr)	PDGFRB	P660T, P596T, P499T	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000055849	5	149503858	5	150124295	55849	70503	rs144050370	NC_000005.10:150124294:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1973T>C (p.Leu658Pro)	PDGFRB	L658P, L497P, L594P	Basal ganglia calcification, idiopathic, 4	VCV000039588	5	149503863	5	150124300	39588	48187	rs397509381	NC_000005.10:150124299:A:G	single nucleotide variant	missense variant	Pathogenic	Jan 8, 2013	no assertion criteria provided							
NM_002609.4(PDGFRB):c.1971C>T (p.His657=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV000766861	5	149503865	5	150124302	766861	698925	rs138486655	NC_000005.10:150124301:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 21, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1967G>C (p.Ser656Thr)	PDGFRB	S495T, S592T, S656T	not provided	VCV003383687	5	149503869	5	150124306	3383687	3542852		NC_000005.10:150124305:C:G	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1958A>G (p.Lys653Arg)	PDGFRB	K492R, K589R, K653R	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV002060920	5	149503878	5	150124315	2060920	2127487		NC_000005.10:150124314:T:C	single nucleotide variant	missense variant	Likely benign	Apr 29, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1950G>A (p.Ser650=)	PDGFRB		not provided	VCV002655906	5	149503886	5	150124323	2655906	2825399		NC_000005.10:150124322:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1947G>T (p.Met649Ile)	PDGFRB	M488I, M585I, M649I	not provided	VCV003365251	5	149503889	5	150124326	3365251	3524458		NC_000005.10:150124325:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1945A>G (p.Met649Val)	PDGFRB	M488V, M585V, M649V	not provided	VCV003363397	5	149503891	5	150124328	3363397	3522606		NC_000005.10:150124327:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1938A>G (p.Gln646=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002928141	5	149503898	5	150124335	2928141	3093762		NC_000005.10:150124334:T:C	single nucleotide variant	synonymous variant	Benign	Apr 17, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1913-10T>C	PDGFRB		PDGFRB-related disorder	VCV003030039	5	149503933	5	150124370	3030039	3201179		NC_000005.10:150124369:A:G	single nucleotide variant	intron variant	Likely benign	Feb 9, 2021	no assertion criteria provided							
NM_002609.4(PDGFRB):c.1913-10T>A	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002201438	5	149503933	5	150124370	2201438	1924975		NC_000005.10:150124369:A:T	single nucleotide variant	intron variant	Likely benign	Sep 29, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1913-16C>G	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002196788	5	149503939	5	150124376	2196788	1933324		NC_000005.10:150124375:G:C	single nucleotide variant	intron variant	Benign	Jan 29, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1912+175T>A	PDGFRB		not provided	VCV001231562	5	149504115	5	150124552	1231562	1220235	rs1077724	NC_000005.10:150124551:A:T	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1912+132A>G	PDGFRB		not provided	VCV001284216	5	149504158	5	150124595	1284216	1274072	rs1075846	NC_000005.10:150124594:T:C	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1912+85T>C	PDGFRB		not provided	VCV001327721	5	149504205	5	150124642	1327721	1318340	rs3889371	NC_000005.10:150124641:A:G	single nucleotide variant	intron variant	Likely benign	Jun 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1912+48G>T	PDGFRB		not provided	VCV001183171	5	149504242	5	150124679	1183171	1171374	rs56298464	NC_000005.10:150124678:C:A	single nucleotide variant	intron variant	Likely benign	Feb 12, 2020	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1912+32G>A	PDGFRB		not provided	VCV001199797	5	149504258	5	150124695	1199797	1190328	rs191619373	NC_000005.10:150124694:C:T	single nucleotide variant	intron variant	Likely benign	Mar 20, 2019	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1897G>A (p.Val633Ile)	PDGFRB	V472I, V569I, V633I	Inborn genetic diseases	VCV002213505	5	149504305	5	150124742	2213505	2201698		NC_000005.10:150124741:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1896C>T (p.Ala632=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV002085349	5	149504306	5	150124743	2085349	2136708		NC_000005.10:150124742:G:A	single nucleotide variant	synonymous variant	Benign	Mar 21, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1886T>C (p.Met629Thr)	PDGFRB	M629T, M468T, M565T	Inborn genetic diseases	VCV003210841	5	149504316	5	150124753	3210841	3375373		NC_000005.10:150124752:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1886T>G (p.Met629Arg)	PDGFRB	M468R, M565R, M629R	not provided	VCV001304309	5	149504316	5	150124753	1304309	1294584	rs1342136227	NC_000005.10:150124752:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1884G>A (p.Thr628=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV000767217	5	149504318	5	150124755	767217	698926	rs201518972	NC_000005.10:150124754:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 8, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1883C>T (p.Thr628Met)	PDGFRB	T564M, T628M, T467M	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002202658	5	149504319	5	150124756	2202658	1928309		NC_000005.10:150124755:G:A	single nucleotide variant	missense variant	Likely benign	Aug 8, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1872T>C (p.His624=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV000767318	5	149504330	5	150124767	767318	698927	rs141371542	NC_000005.10:150124766:A:G	single nucleotide variant	synonymous variant	Benign	Dec 11, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1854G>A (p.Thr618=)	PDGFRB		Myeloproliferative disorder, chronic, with eosinophilia|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|not provided	VCV000473404	5	149504348	5	150124785	473404	454742	rs56072663	NC_000005.10:150124784:C:T	single nucleotide variant	synonymous variant	Benign	Jan 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1853C>T (p.Thr618Met)	PDGFRB	T554M, T457M, T618M	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV001396032	5	149504349	5	150124786	1396032	1350811	rs139554380	NC_000005.10:150124785:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1842G>A (p.Val614=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002050781	5	149504360	5	150124797	2050781	2115126		NC_000005.10:150124796:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 18, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1822T>C (p.Ser608Pro)	PDGFRB	S447P, S608P, S544P	Inborn genetic diseases	VCV002237946	5	149504380	5	150124817	2237946	2232131		NC_000005.10:150124816:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1818C>T (p.Leu606=)	PDGFRB		Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000711863	5	149504384	5	150124821	711863	721305	rs199649903	NC_000005.10:150124820:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1810C>T (p.Arg604Cys)	PDGFRB	R604C, R443C, R540C	PDGFRB-related disorder|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001463139	5	149504392	5	150124829	1463139	1511576	rs541926152	NC_000005.10:150124828:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1808-48del	PDGFRB		not provided	VCV001207649	5	149504442	5	150124879	1207649	1197342	rs58779301	NC_000005.10:150124878:CC:C	Deletion	intron variant	Likely benign	May 20, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1808-177C>T	PDGFRB		not provided	VCV001190307	5	149504571	5	150125008	1190307	1179979	rs150827671	NC_000005.10:150125007:G:A	single nucleotide variant	intron variant	Likely benign	Apr 16, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1808-217A>C	PDGFRB		not provided	VCV001272219	5	149504611	5	150125048	1272219	1262975	rs73277731	NC_000005.10:150125047:T:G	single nucleotide variant	intron variant	Benign	Jun 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1807+186A>G	PDGFRB		not provided	VCV001252717	5	149504822	5	150125259	1252717	1242662	rs3733677	NC_000005.10:150125258:T:C	single nucleotide variant	intron variant	Benign	Mar 29, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1804del (p.Leu602fs)	PDGFRB	L441fs, L602fs, L538fs	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV001419345	5	149505011	5	150125448	1419345	1387024	rs771859820	NC_000005.10:150125447:G:	Deletion	frameshift variant	Uncertain significance	Aug 10, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1788G>A (p.Pro596=)	PDGFRB		not provided|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002655907	5	149505027	5	150125464	2655907	2825400		NC_000005.10:150125463:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1788G>T (p.Pro596=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002148360	5	149505027	5	150125464	2148360	1871148		NC_000005.10:150125463:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1777T>C (p.Trp593Arg)	PDGFRB	W432R, W529R, W593R	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000656806	5	149505038	5	150125475	656806	633635	rs770027941	NC_000005.10:150125474:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1776G>T (p.Thr592=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001992544	5	149505039	5	150125476	1992544	2059066		NC_000005.10:150125475:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1776G>A (p.Thr592=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001087623	5	149505039	5	150125476	1087623	1072541	rs367951719	NC_000005.10:150125475:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 18, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1775C>A (p.Thr592Lys)	PDGFRB	T528K, T431K, T592K	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002926108	5	149505040	5	150125477	2926108	3093043		NC_000005.10:150125476:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1775C>T (p.Thr592Met)	PDGFRB	T431M, T528M, T592M	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002923780	5	149505040	5	150125477	2923780	3085967		NC_000005.10:150125476:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1766A>G (p.Tyr589Cys)	PDGFRB	Y525C, Y428C, Y589C	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|not provided	VCV000863633	5	149505049	5	150125486	863633	830537	rs1760269359	NC_000005.10:150125485:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 31, 2024	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.1762C>T (p.Pro588Ser)	PDGFRB	P427S, P524S, P588S	not specified|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV002506282	5	149505053	5	150125490	2506282	2671237		NC_000005.10:150125489:G:A	single nucleotide variant	missense variant	Uncertain significance	May 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1761G>A (p.Leu587=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|not provided	VCV000540602	5	149505054	5	150125491	540602	520926	rs56078873	NC_000005.10:150125490:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1751C>G (p.Pro584Arg)	PDGFRB	P584R, P423R, P520R	Myeloproliferative disorder, chronic, with eosinophilia|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000217122	5	149505064	5	150125501	217122	213767	rs863224946	NC_000005.10:150125500:G:C	single nucleotide variant	missense variant	Pathogenic	Mar 28, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1734G>A (p.Glu578=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001638200	5	149505081	5	150125518	1638200	1560104	rs2113897064	NC_000005.10:150125517:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1716_1717insGAGCTGATCCGATGGAAGGTGATTGAGTCTGTG (p.Val572_Ser573insGluLeuIleArgTrpLysValIleGluSerVal)	PDGFRB		Infantile myofibromatosis	VCV000973195	5	149505098 - 149505099	5	150125535 - 150125536	973195	961572	rs1760270922	NC_000005.10:150125535:CACAGACTCAATCACCTTCCATCGGATC:CACAGACTCAATCACCTTCCATCGGATCAGCTCCACAGACTCAATCACCTTCCATCGGATC	Microsatellite	inframe_insertion	Pathogenic	Aug 10, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1714G>A (p.Val572Met)	PDGFRB	V411M, V508M, V572M	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001683596	5	149505101	5	150125538	1683596	1675527	rs2113897117	NC_000005.10:150125537:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1697_1702del (p.Trp566_Val568delinsLeu)	PDGFRB		Infantile myofibromatosis	VCV000375555	5	149505113 - 149505118	5	150125550 - 150125555	375555	362365	rs1060499543	NC_000005.10:150125549:CCTTCC:	Deletion	inframe_indel	Pathogenic	Dec 1, 2016	no assertion criteria provided							
NM_002609.4(PDGFRB):c.1700A>G (p.Lys567Arg)	PDGFRB	K406R, K503R, K567R	not provided	VCV002655908	5	149505115	5	150125552	2655908	2825401		NC_000005.10:150125551:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1699A>G (p.Lys567Glu)	PDGFRB	K567E, K503E, K406E	Myofibromatosis, infantile, 1	VCV000375237	5	149505116	5	150125553	375237	361944	rs1554108389	NC_000005.10:150125552:T:C	single nucleotide variant	missense variant	Pathogenic	Dec 1, 2016	no assertion criteria provided							
NM_002609.4(PDGFRB):c.1696T>C (p.Trp566Arg)	PDGFRB	W566R, W502R, W405R	Inborn genetic diseases|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|not provided	VCV000375682	5	149505119	5	150125556	375682	362521	rs1060499542	NC_000005.10:150125555:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 21, 2020	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.1687G>A (p.Glu563Lys)	PDGFRB	E402K, E499K, E563K	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|PDGFRB-related disorder	VCV001005357	5	149505128	5	150125565	1005357	990800	rs1483057981	NC_000005.10:150125564:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1686C>G (p.Tyr562Ter)	PDGFRB	Y498*, Y401*, Y562*	Basal ganglia calcification, idiopathic, 4	VCV000931386	5	149505129	5	150125566	931386	918934	rs570202484	NC_000005.10:150125565:G:C	single nucleotide variant	nonsense	Uncertain significance	Mar 19, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1686C>T (p.Tyr562=)	PDGFRB		not provided	VCV000739854	5	149505129	5	150125566	739854	749346	rs570202484	NC_000005.10:150125565:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1684T>A (p.Tyr562Asn)	PDGFRB	Y401N, Y498N, Y562N	Myofibromatosis, infantile, 1	VCV003393309	5	149505131	5	150125568	3393309	3552386		NC_000005.10:150125567:A:T	single nucleotide variant	missense variant	Likely pathogenic	Dec 19, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1684T>G (p.Tyr562Asp)	PDGFRB	Y562D, Y498D, Y401D	Infantile myofibromatosis	VCV000973197	5	149505131	5	150125568	973197	961573	rs1760271956	NC_000005.10:150125567:A:C	single nucleotide variant	missense variant	Pathogenic	Aug 10, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1682_1684del (p.Arg561_Tyr562delinsHis)	PDGFRB		Infantile myofibromatosis	VCV000973196	5	149505131 - 149505133	5	150125568 - 150125570	973196	961574	rs1760272027	NC_000005.10:150125567:AAC:	Deletion	inframe_indel	Pathogenic	Aug 10, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1681C>T (p.Arg561Cys)	PDGFRB	R561C, R497C, R400C	Myofibromatosis, infantile, 1|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|not provided	VCV000055848	5	149505134	5	150125571	55848	70502	rs367543286	NC_000005.10:150125570:G:A	single nucleotide variant	missense variant	Pathogenic	Mar 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1679C>T (p.Pro560Leu)	PDGFRB	P560L, P399L, P496L	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|not provided	VCV002925384	5	149505136	5	150125573	2925384	3086265		NC_000005.10:150125572:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1675-4C>T	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002935913	5	149505144	5	150125581	2935913	3095702		NC_000005.10:150125580:G:A	single nucleotide variant	intron variant	Likely benign	Dec 15, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1675-14G>T	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002149183	5	149505154	5	150125591	2149183	1877631		NC_000005.10:150125590:C:A	single nucleotide variant	intron variant	Likely benign	Jun 12, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1675-17T>G	PDGFRB		Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV002144818	5	149505157	5	150125594	2144818	1873220		NC_000005.10:150125593:A:C	single nucleotide variant	intron variant	Likely benign	Aug 20, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1675-166C>T	PDGFRB		not provided	VCV001257191	5	149505306	5	150125743	1257191	1246688	rs10072056	NC_000005.10:150125742:G:A	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1675-187T>C	PDGFRB		not provided	VCV001287672	5	149505327	5	150125764	1287672	1277504	rs1368376	NC_000005.10:150125763:A:G	single nucleotide variant	intron variant	Benign	Feb 7, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1675-293G>A	PDGFRB		not provided	VCV001200941	5	149505433	5	150125870	1200941	1190329	rs114147512	NC_000005.10:150125869:C:T	single nucleotide variant	intron variant	Likely benign	Apr 3, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1674+9C>G	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001583169	5	149506074	5	150126511	1583169	1535407	rs1231443369	NC_000005.10:150126510:G:C	single nucleotide variant	intron variant	Likely benign	May 5, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1663C>G (p.Leu555Val)	PDGFRB	L394V, L491V, L555V	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001945033	5	149506094	5	150126531	1945033	1998732		NC_000005.10:150126530:G:C	single nucleotide variant	missense variant	Likely benign	Apr 6, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1660A>G (p.Met554Val)	PDGFRB	M393V, M554V, M490V	Inborn genetic diseases|not provided|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002074737	5	149506097	5	150126534	2074737	2137831		NC_000005.10:150126533:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1643C>A (p.Ser548Tyr)	PDGFRB	S548Y, S387Y, S484Y	not provided	VCV003602001	5	149506114	5	150126551	3602001	3734663		NC_000005.10:150126550:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	no assertion criteria provided							
NM_002609.4(PDGFRB):c.1642delinsATGCTTATCA (p.Ser548delinsMetLeuIleThr)	PDGFRB		not specified	VCV001334841	5	149506115	5	150126552	1334841	1325762	rs2113898258	NC_000005.10:150126551:A:TGATAAGCAT	Indel	inframe_indel	Uncertain significance	Jan 25, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1636A>G (p.Ile546Val)	PDGFRB	I385V, I482V, I546V	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV003237452	5	149506121	5	150126558	3237452	3396573		NC_000005.10:150126557:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1630C>T (p.Leu544Phe)	PDGFRB	L383F, L480F, L544F	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001423324	5	149506127	5	150126564	1423324	1425603	rs2113898287	NC_000005.10:150126563:G:A	single nucleotide variant	missense variant	Uncertain significance	May 21, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1629G>A (p.Val543=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV001979030	5	149506128	5	150126565	1979030	2038207		NC_000005.10:150126564:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1611_1618delinsTCAGGGTGATCTCA (p.Ile538_Ala540delinsGlnGlyAspLeuThr)	PDGFRB		PDGFRB-related disorder	VCV002630983	5	149506139 - 149506146	5	150126576 - 150126583	2630983	2796738		NC_000005.10:150126575:CCAGGATG:TGAGATCACCCTGA	Indel	inframe_indel	Uncertain significance	Sep 11, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1616T>C (p.Leu539Pro)	PDGFRB	L378P, L475P, L539P	not provided	VCV002412878	5	149506141	5	150126578	2412878	2401605		NC_000005.10:150126577:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1615_1616insGAT (p.Ile538_Leu539insArg)	PDGFRB		Infantile myofibromatosis	VCV000375557	5	149506141 - 149506142	5	150126578 - 150126579	375557	362367	rs1060499541	NC_000005.10:150126578::ATC	Insertion	inframe_insertion	Pathogenic	Dec 1, 2016	no assertion criteria provided							
NM_002609.4(PDGFRB):c.1613T>A (p.Ile538Asn)	PDGFRB	I377N, I474N, I538N	Infantile myofibromatosis	VCV000973198	5	149506144	5	150126581	973198	961575	rs1760301005	NC_000005.10:150126580:A:T	single nucleotide variant	missense variant	Pathogenic	Aug 10, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1610C>A (p.Ala537Asp)	PDGFRB	A473D, A537D, A376D	Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis	VCV000973199	5	149506147	5	150126584	973199	961576	rs1760301176	NC_000005.10:150126583:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 3, 2022	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.1580-8G>A	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002057455	5	149506185	5	150126622	2057455	2116612		NC_000005.10:150126621:C:T	single nucleotide variant	intron variant	Likely benign	Aug 10, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1580-45T>C	PDGFRB		not provided	VCV001216710	5	149506222	5	150126659	1216710	1206690	rs139342112	NC_000005.10:150126658:A:G	single nucleotide variant	intron variant	Likely benign	May 29, 2019	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1579+230C>T	PDGFRB		not provided	VCV001186987	5	149509090	5	150129527	1186987	1176590	rs115603484	NC_000005.10:150129526:G:A	single nucleotide variant	intron variant	Likely benign	Nov 29, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1579+209G>A	PDGFRB		not provided	VCV001280872	5	149509111	5	150129548	1280872	1271591	rs1864971	NC_000005.10:150129547:C:T	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1579+122G>A	PDGFRB		not provided	VCV001329583	5	149509198	5	150129635	1329583	1320268	rs141765057	NC_000005.10:150129634:C:T	single nucleotide variant	intron variant	Likely benign	May 25, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1579+50T>C	PDGFRB		not provided	VCV001241725	5	149509270	5	150129707	1241725	1232502	rs1864972	NC_000005.10:150129706:A:G	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1579+30G>T	PDGFRB		not provided	VCV001253760	5	149509290	5	150129727	1253760	1243697	rs73277741	NC_000005.10:150129726:C:A	single nucleotide variant	intron variant	Benign	Mar 20, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1579+10C>T	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000707151	5	149509310	5	150129747	707151	695283	rs571420039	NC_000005.10:150129746:G:A	single nucleotide variant	intron variant	Benign	Oct 24, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1574C>T (p.Pro525Leu)	PDGFRB	P364L, P461L, P525L	not provided	VCV001209893	5	149509325	5	150129762	1209893	1199937	rs2113902466	NC_000005.10:150129761:G:A	single nucleotide variant	missense variant	Uncertain significance		no assertion criteria provided							
NM_002609.4(PDGFRB):c.1572G>A (p.Val524=)	PDGFRB		not provided	VCV000500601	5	149509327	5	150129764	500601	492025	rs777749769	NC_000005.10:150129763:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Mar 23, 2017	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1567G>A (p.Val523Met)	PDGFRB	V362M, V459M, V523M	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Inborn genetic diseases	VCV001978435	5	149509332	5	150129769	1978435	2041511		NC_000005.10:150129768:C:T	single nucleotide variant	missense variant	Likely benign	Nov 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1566C>T (p.Ile522=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002927536	5	149509333	5	150129770	2927536	3083219		NC_000005.10:150129769:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1563C>T (p.Val521=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV000766215	5	149509336	5	150129773	766215	764968	rs1580804718	NC_000005.10:150129772:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 20, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1562T>G (p.Val521Gly)	PDGFRB	V521G, V360G, V457G	Inborn genetic diseases	VCV002474549	5	149509337	5	150129774	2474549	2460275		NC_000005.10:150129773:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1556AGG[1] (p.Glu520del)	PDGFRB	E359del, E456del, E520del	Inborn genetic diseases	VCV002282307	5	149509338 - 149509340	5	150129775 - 150129777	2282307	2273419		NC_000005.10:150129774:CCTCCT:CCT	Microsatellite	inframe_deletion	Uncertain significance	May 9, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1554G>A (p.Thr518=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis	VCV002925255	5	149509345	5	150129782	2925255	3086138		NC_000005.10:150129781:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 16, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1554G>T (p.Thr518=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000772273	5	149509345	5	150129782	772273	698928	rs371192118	NC_000005.10:150129781:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1553C>T (p.Thr518Met)	PDGFRB	T357M, T454M, T518M	Inborn genetic diseases|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002951939	5	149509346	5	150129783	2951939	3113335		NC_000005.10:150129782:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jun 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1540G>A (p.Val514Met)	PDGFRB	V353M, V450M, V514M	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002952521	5	149509359	5	150129796	2952521	3110135		NC_000005.10:150129795:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1539T>C (p.Ala513=)	PDGFRB		Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV000772148	5	149509360	5	150129797	772148	698929	rs150562879	NC_000005.10:150129796:A:G	single nucleotide variant	synonymous variant	Benign	Feb 2, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1537G>A (p.Ala513Thr)	PDGFRB	A449T, A513T, A352T	Inborn genetic diseases|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV002159961	5	149509362	5	150129799	2159961	1887039		NC_000005.10:150129798:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1536C>T (p.Asn512=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|not provided	VCV001091364	5	149509363	5	150129800	1091364	1072542	rs186555112	NC_000005.10:150129799:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1535A>G (p.Asn512Ser)	PDGFRB	N512S, N351S, N448S	not provided|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002042019	5	149509364	5	150129801	2042019	2102490		NC_000005.10:150129800:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 6, 2022	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.1531C>T (p.Arg511Cys)	PDGFRB	R447C, R350C, R511C	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002929326	5	149509368	5	150129805	2929326	3083699		NC_000005.10:150129804:G:A	single nucleotide variant	missense variant	Uncertain significance	May 15, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1527G>A (p.Thr509=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis	VCV002198615	5	149509372	5	150129809	2198615	1930364		NC_000005.10:150129808:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 6, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1527G>T (p.Thr509=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001644320	5	149509372	5	150129809	1644320	1564361	rs750725462	NC_000005.10:150129808:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1526C>T (p.Thr509Met)	PDGFRB	T348M, T445M, T509M	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001518353	5	149509373	5	150129810	1518353	1508746	rs766614995	NC_000005.10:150129809:G:A	single nucleotide variant	missense variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1520G>A (p.Arg507His)	PDGFRB	R346H, R443H, R507H	not provided|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001282130	5	149509379	5	150129816	1282130	1271985	rs145823245	NC_000005.10:150129815:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1519_1520insTACTGTCGGTGC (p.Val506_Arg507insLeuLeuSerVal)	PDGFRB		Infantile myofibromatosis	VCV000973194	5	149509379 - 149509380	5	150129816 - 150129817	973194	961577	rs1760406652	NC_000005.10:150129816:GCACCGACAGT:GCACCGACAGTAGCACCGACAGT	Insertion	inframe_insertion	Pathogenic	Aug 10, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1505G>A (p.Arg502Gln)	PDGFRB	R502Q, R438Q, R341Q	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|not provided	VCV000473403	5	149509394	5	150129831	473403	454749	rs148974733	NC_000005.10:150129830:C:T	single nucleotide variant	missense variant	Benign	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1504C>T (p.Arg502Trp)	PDGFRB	R502W, R341W, R438W	Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|not provided	VCV000707454	5	149509395	5	150129832	707454	691786	rs142992960	NC_000005.10:150129831:G:A	single nucleotide variant	missense variant	Likely benign	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1497C>T (p.His499=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002928903	5	149509402	5	150129839	2928903	3087166		NC_000005.10:150129838:G:A	single nucleotide variant	synonymous variant	Likely benign	May 20, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1495C>T (p.His499Tyr)	PDGFRB	H338Y, H435Y, H499Y	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV003600499	5	149509404	5	150129841	3600499	3733114		NC_000005.10:150129840:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1494G>A (p.Gln498=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002937893	5	149509405	5	150129842	2937893	3106025		NC_000005.10:150129841:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 3, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1487G>A (p.Arg496His)	PDGFRB	R432H, R496H, R335H	PDGFRB-related disorder|Inborn genetic diseases|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002151826	5	149509412	5	150129849	2151826	1881993		NC_000005.10:150129848:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.1472T>C (p.Val491Ala)	PDGFRB	V491A, V330A, V427A	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000540600	5	149509427	5	150129864	540600	520927	rs540480924	NC_000005.10:150129863:A:G	single nucleotide variant	missense variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1463A>T (p.Glu488Val)	PDGFRB	E327V, E424V, E488V	Inborn genetic diseases	VCV003210840	5	149509436	5	150129873	3210840	3375372		NC_000005.10:150129872:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1456G>A (p.Glu486Lys)	PDGFRB	E325K, E422K, E486K	PDGFRB-related disorder	VCV002635315	5	149509443	5	150129880	2635315	2802215		NC_000005.10:150129879:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1453G>A (p.Glu485Lys)	PDGFRB	E485K, E324K, E421K	Myeloproliferative disorder, chronic, with eosinophilia|not provided|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000473402	5	149509446	5	150129883	473402	455600	rs41287110	NC_000005.10:150129882:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1450G>A (p.Glu484Lys)	PDGFRB	E420K, E323K, E484K	Myofibromatosis, infantile, 1|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Myeloproliferative disorder, chronic, with eosinophilia|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000663275	5	149509449	5	150129886	663275	633636	rs765124485	NC_000005.10:150129885:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 4, 2024	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.1442C>T (p.Thr481Met)	PDGFRB	T320M, T417M, T481M	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002195831	5	149509457	5	150129894	2195831	1926721		NC_000005.10:150129893:G:A	single nucleotide variant	missense variant	Likely benign	Jul 30, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1438G>A (p.Val480Met)	PDGFRB	V319M, V480M, V416M	Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Inborn genetic diseases	VCV002073317	5	149509461	5	150129898	2073317	2123405		NC_000005.10:150129897:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1437C>T (p.Asn479=)	PDGFRB		Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|not provided	VCV000774381	5	149509462	5	150129899	774381	698930	rs371550567	NC_000005.10:150129898:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1433C>T (p.Thr478Ile)	PDGFRB	T414I, T317I, T478I	Inborn genetic diseases	VCV002513716	5	149509466	5	150129903	2513716	2680572		NC_000005.10:150129902:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1427T>G (p.Leu476Arg)	PDGFRB	L315R, L412R, L476R	not provided	VCV002430845	5	149509472	5	150129909	2430845	2404352		NC_000005.10:150129908:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1415A>T (p.Glu472Val)	PDGFRB	E472V, E408V, E311V	Inborn genetic diseases	VCV003305495	5	149509484	5	150129921	3305495	3470358		NC_000005.10:150129920:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1412A>G (p.Glu471Gly)	PDGFRB	E310G, E407G, E471G	not provided	VCV001722816	5	149509487	5	150129924	1722816	1780319		NC_000005.10:150129923:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1411G>A (p.Glu471Lys)	PDGFRB	E310K, E407K, E471K	PDGFRB-related disorder	VCV002635833	5	149509488	5	150129925	2635833	2797654		NC_000005.10:150129924:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1399G>A (p.Gly467Arg)	PDGFRB	G306R, G403R, G467R	Inborn genetic diseases|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002146418	5	149509500	5	150129937	2146418	1873521		NC_000005.10:150129936:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 14, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.1395G>A (p.Leu465=)	PDGFRB		not provided	VCV000796878	5	149509504	5	150129941	796878	782222	rs1580805101	NC_000005.10:150129940:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 14, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1393C>T (p.Leu465=)	PDGFRB		not provided|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000707672	5	149509506	5	150129943	707672	691787	rs116171826	NC_000005.10:150129942:G:A	single nucleotide variant	synonymous variant	Benign	Jan 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1391C>T (p.Thr464Met)	PDGFRB	T464M, T400M, T303M	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Myeloproliferative disorder, chronic, with eosinophilia|not provided	VCV000473401	5	149509508	5	150129945	473401	455602	rs74943037	NC_000005.10:150129944:G:A	single nucleotide variant	missense variant	Benign	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1388C>T (p.Pro463Leu)	PDGFRB	P399L, P463L, P302L	Myeloproliferative disorder, chronic, with eosinophilia|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Myofibromatosis, infantile, 1|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV003591898	5	149509511	5	150129948	3591898	3725053		NC_000005.10:150129947:G:A	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1378G>A (p.Glu460Lys)	PDGFRB	E299K, E396K, E460K	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000813699	5	149509521	5	150129958	813699	801811	rs202179598	NC_000005.10:150129957:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1376G>A (p.Arg459His)	PDGFRB	R459H, R395H, R298H	not provided|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000707673	5	149509523	5	150129960	707673	691788	rs149274963	NC_000005.10:150129959:C:T	single nucleotide variant	missense variant	Benign	Jan 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1368-10C>T	PDGFRB		PDGFRB-related disorder	VCV003053349	5	149509541	5	150129978	3053349	3205808		NC_000005.10:150129977:G:A	single nucleotide variant	intron variant	Likely benign	Aug 30, 2019	no assertion criteria provided							
NM_002609.4(PDGFRB):c.1368-14G>A	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002951838	5	149509545	5	150129982	2951838	3113234		NC_000005.10:150129981:C:T	single nucleotide variant	intron variant	Benign	Dec 8, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1368-15C>T	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001537602	5	149509546	5	150129983	1537602	1649881	rs777941214	NC_000005.10:150129982:G:A	single nucleotide variant	intron variant	Benign	Jan 19, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1368-189A>G	PDGFRB		not provided	VCV001252275	5	149509720	5	150130157	1252275	1242222	rs17110942	NC_000005.10:150130156:T:C	single nucleotide variant	intron variant	Benign	Mar 20, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1367+209G>T	PDGFRB		not provided	VCV001280901	5	149509893	5	150130330	1280901	1271619	rs73277745	NC_000005.10:150130329:C:A	single nucleotide variant	intron variant	Benign	Mar 20, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1367+56G>T	PDGFRB		not provided	VCV001197509	5	149510046	5	150130483	1197509	1186888	rs74846250	NC_000005.10:150130482:C:A	single nucleotide variant	intron variant	Likely benign	Oct 8, 2020	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1367+20A>G	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002939246	5	149510082	5	150130519	2939246	3096423		NC_000005.10:150130518:T:C	single nucleotide variant	intron variant	Likely benign	Dec 12, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1360C>T (p.Leu454Phe)	PDGFRB	L293F, L454F, L390F	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Inborn genetic diseases	VCV002949137	5	149510109	5	150130546	2949137	3109340		NC_000005.10:150130545:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 21, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.1346C>T (p.Ser449Phe)	PDGFRB	S449F, S385F, S288F	Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000581888	5	149510123	5	150130560	581888	562996	rs1312583190	NC_000005.10:150130559:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1332G>A (p.Pro444=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002195268	5	149510137	5	150130574	2195268	1929635		NC_000005.10:150130573:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 7, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1332G>C (p.Pro444=)	PDGFRB		not provided|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002141259	5	149510137	5	150130574	2141259	1872250		NC_000005.10:150130573:C:G	single nucleotide variant	synonymous variant	Likely benign	Jul 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1330C>G (p.Pro444Ala)	PDGFRB	P444A, P283A, P380A	not provided	VCV000546354	5	149510139	5	150130576	546354	536686	rs1211844128	NC_000005.10:150130575:G:C	single nucleotide variant	missense variant	Uncertain significance	May 23, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1316G>C (p.Arg439Pro)	PDGFRB	R278P, R375P, R439P	not provided	VCV001698226	5	149510153	5	150130590	1698226	1690605	rs746042729	NC_000005.10:150130589:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1302C>G (p.Val434=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002183043	5	149510167	5	150130604	2183043	1916978		NC_000005.10:150130603:G:C	single nucleotide variant	synonymous variant	Likely benign	Jul 5, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1279C>T (p.Pro427Ser)	PDGFRB	P427S, P363S, P266S	Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|not provided|Inborn genetic diseases	VCV000766771	5	149510190	5	150130627	766771	698931	rs199873101	NC_000005.10:150130626:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Oct 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1278C>A (p.His426Gln)	PDGFRB	H265Q, H362Q, H426Q	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002921815	5	149510191	5	150130628	2921815	3085306		NC_000005.10:150130627:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1273A>G (p.Ser425Gly)	PDGFRB	S264G, S361G, S425G	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV003600484	5	149510196	5	150130633	3600484	3733099		NC_000005.10:150130632:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1253G>A (p.Arg418Gln)	PDGFRB	R257Q, R354Q, R418Q	Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV002934834	5	149510216	5	150130653	2934834	3102394		NC_000005.10:150130652:C:T	single nucleotide variant	missense variant	Likely benign	Mar 21, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1244-4G>A	PDGFRB		Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV000797250	5	149510229	5	150130666	797250	787436	rs1580805805	NC_000005.10:150130665:C:T	single nucleotide variant	intron variant	Likely benign	Dec 20, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1244-5T>C	PDGFRB		Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis	VCV002184028	5	149510230	5	150130667	2184028	1910258		NC_000005.10:150130666:A:G	single nucleotide variant	intron variant	Likely benign	May 16, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1243+18C>T	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001544814	5	149511524	5	150131961	1544814	1525090	rs199897509	NC_000005.10:150131960:G:A	single nucleotide variant	intron variant	Likely benign	Jun 18, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1243+12G>A	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002103165	5	149511530	5	150131967	2103165	2158469		NC_000005.10:150131966:C:T	single nucleotide variant	intron variant	Likely benign	Nov 7, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1243+4A>T	PDGFRB		not provided	VCV000708187	5	149511538	5	150131975	708187	730342	rs573720818	NC_000005.10:150131974:T:A	single nucleotide variant	intron variant	Benign	Apr 12, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1223C>A (p.Ser408Tyr)	PDGFRB	S247Y, S344Y, S408Y	not provided	VCV001706361	5	149511562	5	150131999	1706361	1704675		NC_000005.10:150131998:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1223C>G (p.Ser408Cys)	PDGFRB	S247C, S344C, S408C	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV000707343	5	149511562	5	150131999	707343	691789	rs200203294	NC_000005.10:150131998:G:C	single nucleotide variant	missense variant	Benign	Nov 19, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1217A>G (p.Gln406Arg)	PDGFRB	Q406R, Q342R, Q245R	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000581169	5	149511568	5	150132005	581169	560213	rs374802057	NC_000005.10:150132004:T:C	single nucleotide variant	missense variant	Likely benign	Nov 4, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1189C>T (p.Arg397Trp)	PDGFRB	R333W, R236W, R397W	Inborn genetic diseases|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002354029	5	149511596	5	150132033	2354029	2340694		NC_000005.10:150132032:G:A	single nucleotide variant	missense variant	Likely benign	Sep 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1176C>T (p.Gly392=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002953253	5	149511609	5	150132046	2953253	3114808		NC_000005.10:150132045:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1165G>A (p.Ala389Thr)	PDGFRB	A228T, A325T, A389T	not provided	VCV001804356	5	149511620	5	150132057	1804356	1861375		NC_000005.10:150132056:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1161G>T (p.Lys387Asn)	PDGFRB	K226N, K323N, K387N	not provided	VCV003337446	5	149511624	5	150132061	3337446	3496108		NC_000005.10:150132060:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1156G>C (p.Val386Leu)	PDGFRB	V386L, V225L, V322L	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002938261	5	149511629	5	150132066	2938261	3103206		NC_000005.10:150132065:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1155C>T (p.Arg385=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002046178	5	149511630	5	150132067	2046178	2096312		NC_000005.10:150132066:G:A	single nucleotide variant	synonymous variant	Benign	Oct 23, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1154G>C (p.Arg385Pro)	PDGFRB	R224P, R321P, R385P	not provided	VCV002504731	5	149511631	5	150132068	2504731	2669698		NC_000005.10:150132067:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1149G>C (p.Leu383=)	PDGFRB		not provided|Myeloproliferative disorder, chronic, with eosinophilia|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000473400	5	149511636	5	150132073	473400	454817	rs2228439	NC_000005.10:150132072:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1145C>T (p.Thr382Ile)	PDGFRB	T221I, T318I, T382I	not provided	VCV003379608	5	149511640	5	150132077	3379608	3538784		NC_000005.10:150132076:G:A	single nucleotide variant	missense variant	Uncertain significance	May 20, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1128-135C>T	LOC132089189|PDGFRB		not provided	VCV001282018	5	149511792	5	150132229	1282018	1273245	rs3733678	NC_000005.10:150132228:G:A	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1128-202T>C	LOC132089189|PDGFRB		not provided	VCV001190776	5	149511859	5	150132296	1190776	1179980	rs3733679	NC_000005.10:150132295:A:G	single nucleotide variant	intron variant	Likely benign	Oct 8, 2020	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1127+271C>T	PDGFRB		not provided	VCV001226977	5	149512042	5	150132479	1226977	1216949	rs11748255	NC_000005.10:150132478:G:A	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1127+34G>T	PDGFRB		not provided	VCV001800909	5	149512279	5	150132716	1800909	1858197		NC_000005.10:150132715:C:A	single nucleotide variant	intron variant	Likely benign	Jan 16, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1127+24C>A	PDGFRB		not provided	VCV001801186	5	149512289	5	150132726	1801186	1858473		NC_000005.10:150132725:G:T	single nucleotide variant	intron variant	Likely benign	Jan 16, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1127+17C>G	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002179200	5	149512296	5	150132733	2179200	1919597		NC_000005.10:150132732:G:C	single nucleotide variant	intron variant	Likely benign	Jun 10, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1127+7A>G	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV002080761	5	149512306	5	150132743	2080761	2132233		NC_000005.10:150132742:T:C	single nucleotide variant	intron variant	Benign	Nov 25, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1127G>A (p.Arg376Gln)	PDGFRB	R215Q, R312Q, R376Q	Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002071426	5	149512313	5	150132750	2071426	2126788		NC_000005.10:150132749:C:T	single nucleotide variant	missense variant	Uncertain significance	May 20, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1126C>T (p.Arg376Trp)	PDGFRB	R215W, R312W, R376W	not provided	VCV001202337	5	149512314	5	150132751	1202337	1190330	rs142621427	NC_000005.10:150132750:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1119G>A (p.Ser373=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV000767332	5	149512321	5	150132758	767332	698932	rs200225593	NC_000005.10:150132757:C:T	single nucleotide variant	synonymous variant	Benign	Dec 31, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1118C>T (p.Ser373Leu)	PDGFRB	S212L, S309L, S373L	not provided	VCV003371136	5	149512322	5	150132759	3371136	3530326		NC_000005.10:150132758:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1114G>A (p.Val372Met)	PDGFRB	V211M, V308M, V372M	Inborn genetic diseases|not provided|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001189742	5	149512326	5	150132763	1189742	1179981	rs371975483	NC_000005.10:150132762:C:T	single nucleotide variant	missense variant	Likely benign	Dec 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1113C>A (p.Asn371Lys)	PDGFRB	N210K, N307K, N371K	not provided	VCV002499234	5	149512327	5	150132764	2499234	2477210		NC_000005.10:150132763:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1109G>A (p.Arg370His)	PDGFRB	R209H, R306H, R370H	Inborn genetic diseases|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002284348	5	149512331	5	150132768	2284348	2268113		NC_000005.10:150132767:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1108C>T (p.Arg370Cys)	PDGFRB	R306C, R370C, R209C	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000772279	5	149512332	5	150132769	772279	698933	rs200684708	NC_000005.10:150132768:G:A	single nucleotide variant	missense variant	Benign	Jan 8, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1106C>T (p.Thr369Met)	PDGFRB	T208M, T369M, T305M	Inborn genetic diseases	VCV002367685	5	149512334	5	150132771	2367685	2350803		NC_000005.10:150132770:G:A	single nucleotide variant	missense variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1096G>A (p.Ala366Thr)	PDGFRB	A302T, A205T, A366T	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002926309	5	149512344	5	150132781	2926309	3093244		NC_000005.10:150132780:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1090G>A (p.Glu364Lys)	PDGFRB	E203K, E300K, E364K	not specified|not provided	VCV001342481	5	149512350	5	150132787	1342481	1334058	rs754790326	NC_000005.10:150132786:C:T	single nucleotide variant	missense variant	Uncertain significance	May 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1089C>T (p.Gly363=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|not provided	VCV002059062	5	149512351	5	150132788	2059062	2116923		NC_000005.10:150132787:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1083C>T (p.Ser361=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001165964	5	149512357	5	150132794	1165964	1154965	rs146064275	NC_000005.10:150132793:G:A	single nucleotide variant	synonymous variant	Benign	Apr 24, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1063C>T (p.Arg355Cys)	PDGFRB	R194C, R291C, R355C	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002158400	5	149512377	5	150132814	2158400	1883382		NC_000005.10:150132813:G:A	single nucleotide variant	missense variant	Benign	Aug 16, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1057G>C (p.Asp353His)	PDGFRB	D289H, D192H, D353H	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002162093	5	149512383	5	150132820	2162093	1884481		NC_000005.10:150132819:C:G	single nucleotide variant	missense variant	Likely benign	Aug 17, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1052T>A (p.Phe351Tyr)	PDGFRB	F190Y, F287Y, F351Y	not provided	VCV002655909	5	149512388	5	150132825	2655909	2825402		NC_000005.10:150132824:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1037C>T (p.Pro346Leu)	PDGFRB	P185L, P282L, P346L	not provided	VCV003365756	5	149512403	5	150132840	3365756	3524963		NC_000005.10:150132839:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1035G>A (p.Pro345=)	PDGFRB		not provided	VCV000719190	5	149512405	5	150132842	719190	721306	rs55889271	NC_000005.10:150132841:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 25, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1034C>T (p.Pro345Leu)	PDGFRB	P184L, P345L, P281L	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002927640	5	149512406	5	150132843	2927640	3083323		NC_000005.10:150132842:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1033C>T (p.Pro345Ser)	PDGFRB	P345S, P184S, P281S	Basal ganglia calcification, idiopathic, 4|Myeloproliferative disorder, chronic, with eosinophilia|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|not provided	VCV000377063	5	149512407	5	150132844	377063	363941	rs2229558	NC_000005.10:150132843:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.1025C>T (p.Ala342Val)	PDGFRB	A181V, A278V, A342V	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001333888	5	149512415	5	150132852	1333888	1324658	rs2113907045	NC_000005.10:150132851:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 5, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1021dup (p.Glu341fs)	PDGFRB	E180fs, E277fs, E341fs	PDGFRB-related disorder	VCV003032332	5	149512418 - 149512419	5	150132855 - 150132856	3032332	3198254		NC_000005.10:150132855:C:CC	Duplication	frameshift variant	Uncertain significance	Jan 16, 2024	no assertion criteria provided							
NM_002609.4(PDGFRB):c.1020C>G (p.Phe340Leu)	PDGFRB	F179L, F276L, F340L	not provided	VCV001723536	5	149512420	5	150132857	1723536	1781022		NC_000005.10:150132856:G:C	single nucleotide variant	missense variant	Uncertain significance	May 11, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1008G>A (p.Leu336=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis	VCV002185246	5	149512432	5	150132869	2185246	1913949		NC_000005.10:150132868:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1001G>A (p.Arg334Gln)	PDGFRB	R173Q, R270Q, R334Q	Inborn genetic diseases	VCV003210839	5	149512439	5	150132876	3210839	3375371		NC_000005.10:150132875:C:T	single nucleotide variant	missense variant	Likely benign	Jan 23, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.1000C>T (p.Arg334Trp)	PDGFRB	R173W, R270W, R334W	not provided	VCV002655910	5	149512440	5	150132877	2655910	2825403		NC_000005.10:150132876:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.994C>T (p.Arg332Trp)	PDGFRB	R268W, R332W, R171W	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002162158	5	149512446	5	150132883	2162158	1884546		NC_000005.10:150132882:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.991C>T (p.His331Tyr)	PDGFRB	H170Y, H267Y, H331Y	Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV001713890	5	149512449	5	150132886	1713890	1773161		NC_000005.10:150132885:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.971C>T (p.Thr324Ile)	PDGFRB	T324I, T163I, T260I	Inborn genetic diseases|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002073339	5	149512469	5	150132906	2073339	2123427		NC_000005.10:150132905:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.968G>A (p.Gly323Asp)	PDGFRB	G162D, G323D, G259D	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001391377	5	149512472	5	150132909	1391377	1390057	rs374208706	NC_000005.10:150132908:C:T	single nucleotide variant	missense variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.963G>A (p.Glu321=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001080893	5	149512477	5	150132914	1080893	1072543	rs773441060	NC_000005.10:150132913:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 29, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.958G>C (p.Gly320Arg)	PDGFRB	G159R, G256R, G320R	Inborn genetic diseases	VCV003416462	5	149512482	5	150132919	3416462	3578977		NC_000005.10:150132918:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.950G>A (p.Arg317Gln)	PDGFRB	R156Q, R317Q, R253Q	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001938797	5	149512490	5	150132927	1938797	2004124		NC_000005.10:150132926:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.949C>T (p.Arg317Trp)	PDGFRB	R156W, R253W, R317W	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002064253	5	149512491	5	150132928	2064253	2128237		NC_000005.10:150132927:G:A	single nucleotide variant	missense variant	Likely benign	Mar 26, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.946G>A (p.Val316Met)	PDGFRB	V316M, V155M, V252M	not specified|not provided|Myeloproliferative disorder, chronic, with eosinophilia|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000285888	5	149512494	5	150132931	285888	270125	rs41287112	NC_000005.10:150132930:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.945C>T (p.Tyr315=)	PDGFRB		not provided|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV000772768	5	149512495	5	150132932	772768	698934	rs56069016	NC_000005.10:150132931:G:A	single nucleotide variant	synonymous variant	Benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.938G>A (p.Ser313Asn)	PDGFRB	S152N, S313N, S249N	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Inborn genetic diseases	VCV001946074	5	149512502	5	150132939	1946074	2002352		NC_000005.10:150132938:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 22, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.937A>G (p.Ser313Gly)	PDGFRB	S249G, S313G, S152G	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|not provided	VCV000639829	5	149512503	5	150132940	639829	633637	rs1580808180	NC_000005.10:150132939:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.936G>A (p.Glu312=)	PDGFRB		not provided	VCV000750230	5	149512504	5	150132941	750230	749347	rs1367367619	NC_000005.10:150132940:C:T	single nucleotide variant	synonymous variant	Likely benign	May 31, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.935-5T>C	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002936098	5	149512510	5	150132947	2936098	3095179		NC_000005.10:150132946:A:G	single nucleotide variant	intron variant	Likely benign	Dec 14, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.935-9C>T	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002937329	5	149512514	5	150132951	2937329	3099690		NC_000005.10:150132950:G:A	single nucleotide variant	intron variant	Likely benign	Dec 19, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.935-15G>A	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002924289	5	149512520	5	150132957	2924289	3082588		NC_000005.10:150132956:C:T	single nucleotide variant	intron variant	Likely benign	Jul 22, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.935-101C>T	PDGFRB		not provided	VCV001278913	5	149512606	5	150133043	1278913	1266199	rs73796323	NC_000005.10:150133042:G:A	single nucleotide variant	intron variant	Benign	Mar 1, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.935-106T>C	PDGFRB		not provided	VCV001210813	5	149512611	5	150133048	1210813	1200811	rs55670260	NC_000005.10:150133047:A:G	single nucleotide variant	intron variant	Likely benign	Mar 6, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.935-131A>C	PDGFRB		not provided	VCV001193869	5	149512636	5	150133073	1193869	1183603	rs56331037	NC_000005.10:150133072:T:G	single nucleotide variant	intron variant	Likely benign	Mar 6, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.935-173A>G	PDGFRB		not provided	VCV001276957	5	149512678	5	150133115	1276957	1266827	rs246396	NC_000005.10:150133114:T:C	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.935-276C>T	PDGFRB		not provided	VCV001283457	5	149512781	5	150133218	1283457	1273398	rs73796324	NC_000005.10:150133217:G:A	single nucleotide variant	intron variant	Benign	Feb 28, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.934+276_934+279del	PDGFRB		not provided	VCV001211641	5	149512870 - 149512873	5	150133307 - 150133310	1211641	1201638	rs201970553	NC_000005.10:150133306:AGAAAG:AG	Deletion	intron variant	Likely benign	May 20, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.934+132C>T	PDGFRB		not provided	VCV001195535	5	149513017	5	150133454	1195535	1183604	rs143166351	NC_000005.10:150133453:G:A	single nucleotide variant	intron variant	Likely benign	Oct 8, 2020	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.934+77T>C	PDGFRB		not provided	VCV001272524	5	149513072	5	150133509	1272524	1261989	rs2240780	NC_000005.10:150133508:A:G	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.921C>T (p.Asn307=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001943247	5	149513162	5	150133599	1943247	1998235		NC_000005.10:150133598:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 9, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.920A>G (p.Asn307Ser)	PDGFRB	N146S, N243S, N307S	not provided	VCV003253537	5	149513163	5	150133600	3253537	3412331		NC_000005.10:150133599:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.899A>G (p.His300Arg)	PDGFRB	H139R, H236R, H300R	not provided	VCV001206371	5	149513184	5	150133621	1206371	1195988	rs546647851	NC_000005.10:150133620:T:C	single nucleotide variant	missense variant	Likely benign		no assertion criteria provided							
NM_002609.4(PDGFRB):c.882G>A (p.Thr294=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002158392	5	149513201	5	150133638	2158392	1883374		NC_000005.10:150133637:C:T	single nucleotide variant	synonymous variant	Benign	Sep 29, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.882G>T (p.Thr294=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001975892	5	149513201	5	150133638	1975892	2023540		NC_000005.10:150133637:C:A	single nucleotide variant	synonymous variant	Likely benign	May 25, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.881C>T (p.Thr294Met)	PDGFRB	T133M, T230M, T294M	Inborn genetic diseases	VCV003416455	5	149513202	5	150133639	3416455	3578971		NC_000005.10:150133638:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.875A>G (p.Asn292Ser)	PDGFRB	N131S, N292S, N228S	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Inborn genetic diseases	VCV001440324	5	149513208	5	150133645	1440324	1461610	rs1175765188	NC_000005.10:150133644:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.869C>T (p.Thr290Ile)	PDGFRB	T129I, T226I, T290I	not provided	VCV001707003	5	149513214	5	150133651	1707003	1705314		NC_000005.10:150133650:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.862A>G (p.Thr288Ala)	PDGFRB	T224A, T288A, T127A	Inborn genetic diseases	VCV002272071	5	149513221	5	150133658	2272071	2254556		NC_000005.10:150133657:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.858G>A (p.Ser286=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV000740421	5	149513225	5	150133662	740421	749348	rs778116813	NC_000005.10:150133661:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 17, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.845A>T (p.Glu282Val)	PDGFRB	E121V, E218V, E282V	not provided	VCV003379610	5	149513238	5	150133675	3379610	3538786		NC_000005.10:150133674:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.844G>A (p.Glu282Lys)	PDGFRB	E121K, E218K, E282K	Inborn genetic diseases|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV002934915	5	149513239	5	150133676	2934915	3102475		NC_000005.10:150133675:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 6, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.843C>T (p.Ala281=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002078103	5	149513240	5	150133677	2078103	2138618		NC_000005.10:150133676:G:A	single nucleotide variant	synonymous variant	Benign	Dec 19, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.841G>A (p.Ala281Thr)	PDGFRB	A217T, A120T, A281T	Inborn genetic diseases	VCV003416460	5	149513242	5	150133679	3416460	3578975		NC_000005.10:150133678:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.817C>T (p.Arg273Cys)	PDGFRB	R209C, R273C, R112C	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002164758	5	149513266	5	150133703	2164758	1898663		NC_000005.10:150133702:G:A	single nucleotide variant	missense variant	Likely benign	Jul 10, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.814A>C (p.Ile272Leu)	PDGFRB	I111L, I208L, I272L	not provided	VCV001695853	5	149513269	5	150133706	1695853	1688262	rs765818881	NC_000005.10:150133705:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.805C>G (p.Pro269Ala)	PDGFRB	P205A, P269A, P108A	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002952092	5	149513278	5	150133715	2952092	3111770		NC_000005.10:150133714:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.799G>A (p.Asp267Asn)	PDGFRB	D106N, D203N, D267N	Inborn genetic diseases	VCV002261271	5	149513284	5	150133721	2261271	2255432		NC_000005.10:150133720:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.783G>A (p.Val261=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000714396	5	149513300	5	150133737	714396	721307	rs142649064	NC_000005.10:150133736:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 18, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.780G>A (p.Pro260=)	PDGFRB		PDGFRB-related disorder	VCV003057699	5	149513303	5	150133740	3057699	3192813		NC_000005.10:150133739:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2019	no assertion criteria provided							
NM_002609.4(PDGFRB):c.779C>T (p.Pro260Leu)	PDGFRB	P196L, P260L, P99L	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002154495	5	149513304	5	150133741	2154495	1889388		NC_000005.10:150133740:G:A	single nucleotide variant	missense variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.772G>A (p.Val258Met)	PDGFRB	V97M, V194M, V258M	Inborn genetic diseases	VCV002541219	5	149513311	5	150133748	2541219	2708878		NC_000005.10:150133747:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.766C>T (p.Arg256Trp)	PDGFRB	R256W, R95W, R192W	Inborn genetic diseases|not provided	VCV000452355	5	149513317	5	150133754	452355	443723	rs147568171	NC_000005.10:150133753:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.760-10G>T	PDGFRB		Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV002006765	5	149513333	5	150133770	2006765	2066000		NC_000005.10:150133769:C:A	single nucleotide variant	intron variant	Likely benign	Jun 14, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.759+41A>G	PDGFRB		not provided	VCV001288085	5	149513403	5	150133840	1288085	1277917	rs56779496	NC_000005.10:150133839:T:C	single nucleotide variant	intron variant	Benign	Mar 1, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.748C>G (p.Pro250Ala)	PDGFRB	P89A, P250A, P186A	Inborn genetic diseases	VCV003416464	5	149513455	5	150133892	3416464	3578979		NC_000005.10:150133891:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.745T>C (p.Tyr249His)	PDGFRB	Y88H, Y185H, Y249H	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001976391	5	149513458	5	150133895	1976391	2034243		NC_000005.10:150133894:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.735C>T (p.Phe245=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001597724	5	149513468	5	150133905	1597724	1570863	rs765554311	NC_000005.10:150133904:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.729C>T (p.Val243=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV001652533	5	149513474	5	150133911	1652533	1664446	rs758566697	NC_000005.10:150133910:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 22, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.726G>C (p.Val242=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000735955	5	149513477	5	150133914	735955	749349	rs149027530	NC_000005.10:150133913:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 31, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.714C>T (p.Ile238=)	PDGFRB		Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|not provided	VCV000770095	5	149513489	5	150133926	770095	698935	rs41287114	NC_000005.10:150133925:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.683G>A (p.Gly228Asp)	PDGFRB	G228D, G164D, G67D	not specified	VCV000191201	5	149513520	5	150133957	191201	189004	rs374239531	NC_000005.10:150133956:C:T	single nucleotide variant	missense variant	Likely benign	Sep 28, 2016	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.671_677del (p.Val224fs)	PDGFRB	V160fs, V224fs, V63fs	not provided	VCV001314610	5	149513526 - 149513532	5	150133963 - 150133969	1314610	1304871	rs2113909312	NC_000005.10:150133962:CGGACCAC:C	Deletion	frameshift variant	Uncertain significance	Apr 9, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.657C>T (p.Asn219=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV000767437	5	149513546	5	150133983	767437	698936	rs745467275	NC_000005.10:150133982:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.646G>C (p.Val216Leu)	PDGFRB	V152L, V55L, V216L	Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV002098421	5	149513557	5	150133994	2098421	2157617		NC_000005.10:150133993:C:G	single nucleotide variant	missense variant	Likely benign	Feb 18, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.646G>A (p.Val216Ile)	PDGFRB	V55I, V216I, V152I	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV001511780	5	149513557	5	150133994	1511780	1459260	rs370817438	NC_000005.10:150133993:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.645C>T (p.Asn215=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002038637	5	149513558	5	150133995	2038637	2101705		NC_000005.10:150133994:G:A	single nucleotide variant	synonymous variant	Benign	Aug 21, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.632-55A>C	PDGFRB		not provided	VCV001234733	5	149513626	5	150134063	1234733	1223848	rs11740355	NC_000005.10:150134062:T:G	single nucleotide variant	intron variant	Benign	Feb 24, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.631+11T>C	PDGFRB	L42P	PDGFRB-related disorder	VCV002629650	5	149514302	5	150134739	2629650	2803107		NC_000005.10:150134738:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 20, 2024	no assertion criteria provided							
NM_002609.4(PDGFRB):c.631+2T>C	PDGFRB	V39A	not provided	VCV000546987	5	149514311	5	150134748	546987	537476	rs1554109533	NC_000005.10:150134747:A:G	single nucleotide variant	missense variant|splice donor variant	Uncertain significance	Apr 1, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.631+1G>A	PDGFRB	V39M	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001017376	5	149514312	5	150134749	1017376	1005988	rs111491260	NC_000005.10:150134748:C:T	single nucleotide variant	missense variant|splice donor variant	Uncertain significance	Mar 25, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.624A>C (p.Arg208Ser)	PDGFRB	D36A, R144S, R208S	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Inborn genetic diseases	VCV002037288	5	149514320	5	150134757	2037288	2097779		NC_000005.10:150134756:T:G	single nucleotide variant	missense variant	Likely benign	Mar 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.615T>C (p.Tyr205=)	PDGFRB	M33T	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001092094	5	149514329	5	150134766	1092094	1072544	rs756283680	NC_000005.10:150134765:A:G	single nucleotide variant	synonymous variant|missense variant	Likely benign	Oct 11, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.598G>A (p.Asp200Asn)	PDGFRB	W27*, D136N, D200N	Inborn genetic diseases	VCV003210844	5	149514346	5	150134783	3210844	3375376		NC_000005.10:150134782:C:T	single nucleotide variant	missense variant|nonsense	Uncertain significance	Dec 22, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.590G>A (p.Arg197Lys)	PDGFRB	R133K, R197K, G25R	Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|not provided	VCV000772509	5	149514354	5	150134791	772509	698937	rs116642123	NC_000005.10:150134790:C:T	single nucleotide variant	missense variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.581T>C (p.Ile194Thr)	PDGFRB	I194T, I130T	not provided|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000707690	5	149514363	5	150134800	707690	691790	rs2229560	NC_000005.10:150134799:A:G	single nucleotide variant	missense variant|synonymous variant	Benign/Likely benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.575C>T (p.Thr192Ile)	PDGFRB	P20S, T128I, T192I	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002415805	5	149514369	5	150134806	2415805	1937146		NC_000005.10:150134805:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.575C>G (p.Thr192Ser)	PDGFRB	T128S, T192S, P20A	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002187709	5	149514369	5	150134806	2187709	1911348		NC_000005.10:150134805:G:C	single nucleotide variant	missense variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.542G>C (p.Gly181Ala)	PDGFRB	G117A, V9L, G181A	Inborn genetic diseases|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002144767	5	149514402	5	150134839	2144767	1873169		NC_000005.10:150134838:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 22, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.541G>A (p.Gly181Ser)	PDGFRB	G117S, G181S	Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Inborn genetic diseases	VCV001134052	5	149514403	5	150134840	1134052	1115666	rs574853772	NC_000005.10:150134839:C:T	single nucleotide variant	missense variant|synonymous variant	Likely benign	Apr 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.530G>A (p.Arg177His)	PDGFRB	R113H, R177H, V5M	not provided	VCV003363361	5	149514414	5	150134851	3363361	3522570		NC_000005.10:150134850:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.529C>G (p.Arg177Gly)	PDGFRB	R113G, R177G, N4K	Inborn genetic diseases	VCV002316765	5	149514415	5	150134852	2316765	2310426		NC_000005.10:150134851:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.529C>T (p.Arg177Cys)	PDGFRB	R177C, R113C	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV001963981	5	149514415	5	150134852	1963981	2013777		NC_000005.10:150134851:G:A	single nucleotide variant	missense variant|synonymous variant	Likely benign	Jul 25, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.518A>G (p.Tyr173Cys)	PDGFRB	M1V, Y109C, Y173C	not provided	VCV003381287	5	149514426	5	150134863	3381287	3540470		NC_000005.10:150134862:T:C	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.511G>T (p.Val171Phe)	PDGFRB	V107F, V171F	Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV002945538	5	149514433	5	150134870	2945538	3105309		NC_000005.10:150134869:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.499G>A (p.Val167Ile)	PDGFRB	V103I, V167I	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001570103	5	149514445	5	150134882	1570103	1623419	rs144857517	NC_000005.10:150134881:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Sep 4, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.486G>A (p.Glu162=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001167104	5	149514458	5	150134895	1167104	1154966	rs147141808	NC_000005.10:150134894:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign	Apr 6, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.484G>A (p.Glu162Lys)	PDGFRB	E162K, E98K	Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000582961	5	149514460	5	150134897	582961	560334	rs1562011077	NC_000005.10:150134896:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 26, 2018	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.483C>T (p.His161=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002945939	5	149514461	5	150134898	2945939	3101819		NC_000005.10:150134897:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Nov 23, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.468G>A (p.Leu156=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002926188	5	149514476	5	150134913	2926188	3093123		NC_000005.10:150134912:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	May 15, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.467T>G (p.Leu156Arg)	PDGFRB	L156R, L92R	not provided	VCV002412876	5	149514477	5	150134914	2412876	2401603		NC_000005.10:150134913:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 28, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.462A>G (p.Pro154=)	PDGFRB		Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV002935476	5	149514482	5	150134919	2935476	3099149		NC_000005.10:150134918:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.461C>G (p.Pro154Arg)	PDGFRB	P154R, P90R	Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Inborn genetic diseases	VCV002933154	5	149514483	5	150134920	2933154	3091826		NC_000005.10:150134919:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.460C>T (p.Pro154Ser)	PDGFRB	P154S, P90S	Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002073601	5	149514484	5	150134921	2073601	2123689		NC_000005.10:150134920:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 20, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.449G>A (p.Arg150Gln)	PDGFRB	R86Q, R150Q	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002946473	5	149514495	5	150134932	2946473	3108133		NC_000005.10:150134931:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.443C>T (p.Pro148Leu)	PDGFRB	P148L, P84L	Inborn genetic diseases	VCV003416457	5	149514501	5	150134938	3416457	3578973		NC_000005.10:150134937:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 20, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.438C>A (p.Thr146=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000731377	5	149514506	5	150134943	731377	734937	rs764023871	NC_000005.10:150134942:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Feb 13, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.433A>G (p.Ile145Val)	PDGFRB	I145V, I81V	not provided	VCV001700495	5	149514511	5	150134948	1700495	1692888	rs1760580023	NC_000005.10:150134947:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 6, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.419C>T (p.Thr140Met)	PDGFRB	T140M, T76M	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Myofibromatosis, infantile, 1|Idiopathic basal ganglia calcification 1|Myeloproliferative disorder, chronic, with eosinophilia|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|not provided	VCV001304805	5	149514525	5	150134962	1304805	1295080	rs138830253	NC_000005.10:150134961:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 2, 2022	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.396C>T (p.Ala132=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000724418	5	149514548	5	150134985	724418	734938	rs751600349	NC_000005.10:150134984:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Apr 9, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.390T>C (p.Asn130=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002089688	5	149514554	5	150134991	2089688	2155358		NC_000005.10:150134990:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jan 26, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.377G>C (p.Gly126Ala)	PDGFRB	G126A, G62A	not provided|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Inborn genetic diseases|not specified	VCV001706178	5	149514567	5	150135004	1706178	1704492		NC_000005.10:150135003:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.377G>A (p.Gly126Asp)	PDGFRB	G62D, G126D	Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000955087	5	149514567	5	150135004	955087	944493	rs371293050	NC_000005.10:150135003:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Jul 25, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.373G>A (p.Val125Met)	PDGFRB	V125M, V61M	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Inborn genetic diseases	VCV002949487	5	149514571	5	150135008	2949487	3108986		NC_000005.10:150135007:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 11, 2024	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.373G>T (p.Val125Leu)	PDGFRB	V125L, V61L	not provided	VCV002655911	5	149514571	5	150135008	2655911	2825404		NC_000005.10:150135007:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.370A>G (p.Thr124Ala)	PDGFRB	T124A, T60A	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002927478	5	149514574	5	150135011	2927478	3083161		NC_000005.10:150135010:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Oct 31, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.365-4G>T	PDGFRB		Myeloproliferative disorder, chronic, with eosinophilia|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000473407	5	149514583	5	150135020	473407	455307	rs139448702	NC_000005.10:150135019:C:A	single nucleotide variant	intron variant	Benign	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.365-5G>C	PDGFRB		Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV001934083	5	149514584	5	150135021	1934083	1989087		NC_000005.10:150135020:C:G	single nucleotide variant	intron variant	Likely benign	Sep 13, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.365-13C>T	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002163327	5	149514592	5	150135029	2163327	1887811		NC_000005.10:150135028:G:A	single nucleotide variant	intron variant	Likely benign	Jul 26, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.365-120T>C	PDGFRB		not provided	VCV001213149	5	149514699	5	150135136	1213149	1203143	rs17652080	NC_000005.10:150135135:A:G	single nucleotide variant	intron variant	Likely benign	Oct 8, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.364+160A>C	PDGFRB		not provided	VCV001225344	5	149514958	5	150135395	1225344	1216611	rs758589	NC_000005.10:150135394:T:G	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.364+44C>T	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|not provided	VCV001221912	5	149515074	5	150135511	1221912	1213474	rs740750	NC_000005.10:150135510:G:A	single nucleotide variant	intron variant	Benign	Sep 5, 2021	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.364+15C>G	PDGFRB		not specified|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV002949902	5	149515103	5	150135540	2949902	3114046		NC_000005.10:150135539:G:C	single nucleotide variant	intron variant	Likely benign	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.360G>T (p.Val120=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002927523	5	149515122	5	150135559	2927523	3083206		NC_000005.10:150135558:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	May 6, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.351C>T (p.Tyr117=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001902175	5	149515131	5	150135568	1902175	1954215		NC_000005.10:150135567:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jun 1, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.344G>A (p.Arg115Gln)	PDGFRB	R115Q, R51Q	Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002155431	5	149515138	5	150135575	2155431	1892912		NC_000005.10:150135574:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Benign	Nov 23, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.342A>C (p.Lys114Asn)	PDGFRB	K114N, K50N	Inborn genetic diseases	VCV003416463	5	149515140	5	150135577	3416463	3578978		NC_000005.10:150135576:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 20, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.341A>C (p.Lys114Thr)	PDGFRB	K50T, K114T	Inborn genetic diseases	VCV002477348	5	149515141	5	150135578	2477348	2453697		NC_000005.10:150135577:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 23, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.338G>A (p.Arg113Gln)	PDGFRB	R49Q, R113Q	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Inborn genetic diseases	VCV002054278	5	149515144	5	150135581	2054278	2112160		NC_000005.10:150135580:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Nov 15, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.337C>T (p.Arg113Trp)	PDGFRB	R49W, R113W	not provided|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002945938	5	149515145	5	150135582	2945938	3101818		NC_000005.10:150135581:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.334G>A (p.Glu112Lys)	PDGFRB	E112K, E48K	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000971582	5	149515148	5	150135585	971582	954093	rs749932332	NC_000005.10:150135584:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Benign	Jan 8, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.331G>A (p.Asp111Asn)	PDGFRB	D111N, D47N	Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV001299791	5	149515151	5	150135588	1299791	1289843	rs558122968	NC_000005.10:150135587:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Aug 5, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.330C>T (p.Thr110=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000728357	5	149515152	5	150135589	728357	734939	rs755333624	NC_000005.10:150135588:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 17, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.314C>T (p.Ser105Phe)	PDGFRB	S105F, S41F	Inborn genetic diseases	VCV002516565	5	149515168	5	150135605	2516565	2674947		NC_000005.10:150135604:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 31, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.285G>A (p.Thr95=)	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002928420	5	149515197	5	150135634	2928420	3090580		NC_000005.10:150135633:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 5, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.277C>A (p.Leu93Ile)	PDGFRB	L93I, L29I	Inborn genetic diseases	VCV002284755	5	149515205	5	150135642	2284755	2264632		NC_000005.10:150135641:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 14, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.269T>A (p.Leu90His)	PDGFRB	L26H, L90H	See cases	VCV001690933	5	149515213	5	150135650	1690933	1683341	rs1373590584	NC_000005.10:150135649:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 4, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.263C>T (p.Thr88Ile)	PDGFRB	T88I, T24I	Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Inborn genetic diseases	VCV000772270	5	149515219	5	150135656	772270	698938	rs147303614	NC_000005.10:150135655:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.259C>T (p.Leu87=)	PDGFRB		Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4	VCV002097459	5	149515223	5	150135660	2097459	2150079		NC_000005.10:150135659:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 7, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.255C>T (p.Leu85=)	PDGFRB		not provided	VCV001210073	5	149515227	5	150135664	1210073	1199938	rs572557907	NC_000005.10:150135663:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign		no assertion criteria provided							
NM_002609.4(PDGFRB):c.252G>A (p.Val84=)	PDGFRB		PDGFRB-related disorder	VCV003041297	5	149515230	5	150135667	3041297	3192458		NC_000005.10:150135666:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	May 10, 2019	no assertion criteria provided							
NM_002609.4(PDGFRB):c.251T>C (p.Val84Ala)	PDGFRB	V20A, V84A	not provided	VCV001311278	5	149515231	5	150135668	1311278	1300659	rs2113912296	NC_000005.10:150135667:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 6, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.250G>A (p.Val84Met)	PDGFRB	V20M, V84M	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002041587	5	149515232	5	150135669	2041587	2091748		NC_000005.10:150135668:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Benign	Mar 10, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.241T>A (p.Phe81Ile)	PDGFRB	F17I, F81I	not provided	VCV001303700	5	149515241	5	150135678	1303700	1293976	rs2113912334	NC_000005.10:150135677:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 16, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.225G>A (p.Lys75=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Infantile myofibromatosis	VCV002106887	5	149515257	5	150135694	2106887	2159596		NC_000005.10:150135693:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Nov 28, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.191G>A (p.Arg64Gln)	PDGFRB	R64Q	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV002927921	5	149515291	5	150135728	2927921	3093546		NC_000005.10:150135727:C:T	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.177G>A (p.Pro59=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV002035687	5	149515305	5	150135742	2035687	2097471		NC_000005.10:150135741:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Dec 12, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.176C>T (p.Pro59Leu)	PDGFRB	P59L	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Inborn genetic diseases	VCV000951630	5	149515306	5	150135743	951630	923949	rs202213873	NC_000005.10:150135742:G:A	single nucleotide variant	5 prime UTR variant|missense variant	Conflicting classifications of pathogenicity	Nov 15, 2022	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.168T>A (p.Gly56=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV001598104	5	149515314	5	150135751	1598104	1660710	rs532483221	NC_000005.10:150135750:A:T	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	May 21, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.165G>A (p.Ser55=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV003600489	5	149515317	5	150135754	3600489	3733104		NC_000005.10:150135753:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant	Uncertain significance	Jul 9, 2024	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.164C>T (p.Ser55Leu)	PDGFRB	S55L	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Inborn genetic diseases|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|not provided	VCV000450614	5	149515318	5	150135755	450614	443724	rs147952898	NC_000005.10:150135754:G:A	single nucleotide variant	5 prime UTR variant|missense variant	Conflicting classifications of pathogenicity	Dec 14, 2023	criteria provided, conflicting classifications							
NM_002609.4(PDGFRB):c.151G>A (p.Val51Ile)	PDGFRB	V51I	not provided	VCV002673033	5	149515331	5	150135768	2673033	2840552		NC_000005.10:150135767:C:T	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Nov 1, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.141C>T (p.Ser47=)	PDGFRB		not provided	VCV000809828	5	149515341	5	150135778	809828	795661	rs754041602	NC_000005.10:150135777:G:A	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Jun 1, 2018	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.136G>A (p.Val46Ile)	PDGFRB	V46I	Inborn genetic diseases	VCV002543705	5	149515346	5	150135783	2543705	2702072		NC_000005.10:150135782:C:T	single nucleotide variant	5 prime UTR variant|missense variant	Likely benign	Jun 6, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.130C>T (p.Leu44Phe)	PDGFRB	L44F	not provided	VCV003342581	5	149515352	5	150135789	3342581	3501813		NC_000005.10:150135788:G:A	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	May 30, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.128T>C (p.Val43Ala)	PDGFRB	V43A	Inborn genetic diseases	VCV002298741	5	149515354	5	150135791	2298741	2288101		NC_000005.10:150135790:A:G	single nucleotide variant	5 prime UTR variant|missense variant	Likely benign	Aug 26, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.121G>A (p.Glu41Lys)	PDGFRB	E41K	Inborn genetic diseases	VCV002241202	5	149515361	5	150135798	2241202	2232791		NC_000005.10:150135797:C:T	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Aug 2, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.111C>A (p.Pro37=)	PDGFRB		PDGFRB-related disorder	VCV003042495	5	149515371	5	150135808	3042495	3207973		NC_000005.10:150135807:G:T	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Dec 19, 2023	no assertion criteria provided							
NM_002609.4(PDGFRB):c.109C>G (p.Pro37Ala)	PDGFRB	P37A	not provided	VCV001708623	5	149515373	5	150135810	1708623	1706977		NC_000005.10:150135809:G:C	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Apr 9, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.103G>A (p.Val35Ile)	PDGFRB	V35I	Inborn genetic diseases	VCV002212988	5	149515379	5	150135816	2212988	2205070		NC_000005.10:150135815:C:T	single nucleotide variant	5 prime UTR variant|missense variant	Likely benign	Apr 21, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.102C>T (p.Val34=)	PDGFRB		Myeloproliferative disorder, chronic, with eosinophilia|not provided|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV000473399	5	149515380	5	150135817	473399	455604	rs17708515	NC_000005.10:150135816:G:A	single nucleotide variant	5 prime UTR variant|synonymous variant	Benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.94G>A (p.Gly32Ser)	PDGFRB	G32S	not provided|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001305172	5	149515388	5	150135825	1305172	1295447	rs761286709	NC_000005.10:150135824:C:T	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Sep 21, 2021	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.91C>T (p.Gln31Ter)	PDGFRB	Q31*	not provided	VCV003365417	5	149515391	5	150135828	3365417	3524624		NC_000005.10:150135827:G:A	single nucleotide variant	5 prime UTR variant|nonsense	Uncertain significance	Dec 13, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.85A>T (p.Ile29Phe)	PDGFRB	I29F	Myeloproliferative disorder, chronic, with eosinophilia|not provided|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV000258780	5	149515397	5	150135834	258780	251822	rs17110944	NC_000005.10:150135833:T:A	single nucleotide variant	5 prime UTR variant|missense variant	Benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.70C>T (p.Leu24Phe)	PDGFRB	L24F	not provided|Inborn genetic diseases	VCV002595325	5	149515412	5	150135849	2595325	2762862		NC_000005.10:150135848:G:A	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Aug 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.51G>A (p.Leu17=)	PDGFRB		PDGFRB-related disorder	VCV003054608	5	149515431	5	150135868	3054608	3219269		NC_000005.10:150135867:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Nov 14, 2023	no assertion criteria provided							
NM_002609.4(PDGFRB):c.48G>A (p.Leu16=)	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002942656	5	149515434	5	150135871	2942656	3097242		NC_000005.10:150135870:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Mar 3, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.43G>A (p.Glu15Lys)	PDGFRB	E15K	Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|not provided	VCV000863739	5	149515439	5	150135876	863739	830538	rs148853962	NC_000005.10:150135875:C:T	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Jun 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.42C>T (p.Gly14=)	PDGFRB		Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4	VCV001106963	5	149515440	5	150135877	1106963	1094134	rs145316660	NC_000005.10:150135876:G:A	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.40+214C>T	PDGFRB		not provided	VCV001258971	5	149516357	5	150136794	1258971	1247182	rs79805903	NC_000005.10:150136793:G:A	single nucleotide variant	intron variant	Benign	Apr 4, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.40+194T>G	PDGFRB		not provided	VCV001195191	5	149516377	5	150136814	1195191	1183605	rs17110946	NC_000005.10:150136813:A:C	single nucleotide variant	intron variant	Likely benign	Feb 3, 2020	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.40+91G>A	PDGFRB		not provided	VCV001267177	5	149516480	5	150136917	1267177	1254500	rs2240781	NC_000005.10:150136916:C:T	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.40+19_40+23del	PDGFRB		Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV001981405	5	149516548 - 149516552	5	150136985 - 150136989	1981405	2045771		NC_000005.10:150136984:TACCTTA:TA	Deletion	intron variant	Likely benign	Jul 11, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.40+16A>G	PDGFRB		Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002053105	5	149516555	5	150136992	2053105	2108402		NC_000005.10:150136991:T:C	single nucleotide variant	intron variant	Likely benign	Jan 21, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.31G>A (p.Ala11Thr)	PDGFRB	A11T	Inborn genetic diseases	VCV002365067	5	149516580	5	150137017	2365067	2356981		NC_000005.10:150137016:C:T	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Uncertain significance	Jun 22, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.22C>G (p.Pro8Ala)	PDGFRB	P8A	not provided	VCV002442717	5	149516589	5	150137026	2442717	2416428		NC_000005.10:150137025:G:C	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.18G>A (p.Ala6=)	PDGFRB		Infantile myofibromatosis|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000754430	5	149516593	5	150137030	754430	764969	rs201570042	NC_000005.10:150137029:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant|intron variant	Likely benign	Oct 9, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.17C>G (p.Ala6Gly)	PDGFRB	A6G	Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV001716096	5	149516594	5	150137031	1716096	1771393		NC_000005.10:150137030:G:C	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Uncertain significance	Sep 27, 2022	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.17C>T (p.Ala6Val)	PDGFRB	A6V	Inborn genetic diseases|Basal ganglia calcification, idiopathic, 4|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Infantile myofibromatosis	VCV001586531	5	149516594	5	150137031	1586531	1562688	rs150173975	NC_000005.10:150137030:G:A	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Likely benign	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.12G>A (p.Pro4=)	PDGFRB		not provided|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Acroosteolysis-keloid-like lesions-premature aging syndrome|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	VCV000772769	5	149516599	5	150137036	772769	698939	rs138641101	NC_000005.10:150137035:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant|intron variant	Benign	Jul 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_002609.4(PDGFRB):c.11C>T (p.Pro4Leu)	PDGFRB	P4L	Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis	VCV002950721	5	149516600	5	150137037	2950721	3111691		NC_000005.10:150137036:G:A	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Benign	Nov 24, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.11C>A (p.Pro4Gln)	PDGFRB	P4Q	PDGFRB-related disorder	VCV002635001	5	149516600	5	150137037	2635001	2801903		NC_000005.10:150137036:G:T	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.5G>A (p.Arg2Gln)	PDGFRB	R2Q	Inborn genetic diseases	VCV003210845	5	149516606	5	150137043	3210845	3375377		NC_000005.10:150137042:C:T	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Uncertain significance	Apr 7, 2021	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.4C>T (p.Arg2Trp)	PDGFRB	R2W	Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4	VCV002940237	5	149516607	5	150137044	2940237	3103877		NC_000005.10:150137043:G:A	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Likely benign	Jun 3, 2023	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.-6-107G>T	PDGFRB		not provided	VCV001272791	5	149516723	5	150137160	1272791	1262256	rs73796328	NC_000005.10:150137159:C:A	single nucleotide variant	intron variant	Benign	Mar 1, 2019	criteria provided, single submitter							
NM_002609.4(PDGFRB):c.-6-158C>T	PDGFRB		not provided	VCV001253658	5	149516774	5	150137211	1253658	1243595	rs67088273	NC_000005.10:150137210:G:A	single nucleotide variant	intron variant	Benign	Mar 20, 2019	criteria provided, single submitter							
NC_000005.9:g.(?_147774340)_(149681936_?)del	ABLIM3|ADRB2|AFAP1L1|ARHGEF37|ARSI|CAMK2A|CDX1|CSF1R|CSNK1A1|FBXO38|GRPEL2|HMGXB3|HTR4|IL17B|MIR143|MIR145|MIR378A|PCYOX1L|PDE6A|PDGFRB|PPARGC1B|SH3TC2|SLC26A2|SLC6A7|TIGD6		not provided	VCV002425319	5	147774340 - 149681936			2425319	1943045			Deletion		Uncertain significance	Mar 27, 2022	criteria provided, single submitter							
GRCh37/hg19 5q32-35.3(chr5:149010383-180719789)	LTC4S|MIR103A1|MIR146A|MGAT1|MGAT4B|MIR378A|MRNIP|MRPL22|MSX2|MAPK9|MAT2B|MED7|MFAP3|MAML1|ADAM19|ADAMTS2|ADRA1B|ANXA6|ARHGEF37|ARL10|ARSI|ATOX1|ATP10B|ATP6V0E1|B4GALT7|BNIP1|BOD1|BTNL3|BTNL8|BTNL9|C1QTNF2|C5orf47|C5orf52|C5orf58|CAMK2A|CANX|CBY3|CCDC69|CCNG1|CCNJL|CD74|CDHR2|CDX1|CLINT1|CLK4|CLTB|CNOT6|CNOT8|COL23A1|CPEB4|CPLX2|CREBRF|CSF1R|CYFIP2|DBN1|DCTN4|DDX41|DOCK2|DOK3|DRD1|DUSP1|EBF1|EFCAB9|EIF4E1B|ERGIC1|F12|FABP6|FAF2|FAM114A2|FAM153A|FAM153B|FAM193B|FAM200C|FAT2|FAXDC2|FBXW11|FGF18|FGFR4|FLT4|FNDC9|FOXI1|G3BP1|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GALNT10|GARIN3|GEMIN5|GFPT2|GLRA1|GM2A|GPRIN1|GPX3|GRIA1|GRK6|GRM6|HAND1|HAVCR1|HAVCR2|HIGD2A|HK3|HMGXB3|HMMR|HNRNPAB|HNRNPH1|HRH2|IL12B|INSYN2B|IRGM|ITK|KCNIP1|KCNMB1|KIAA1191|KIF4B|LARP1|LCP2|LMAN2|LOC100128059|LOC100288254|LSM11|MXD3|MYOZ3|N4BP3|NDST1|NEURL1B|NHP2|NIPAL4|NKX2-5|NMUR2|NOP16|NPM1|NSD1|NUDCD2|OR2V1|OR2V2|OR2Y1|PANK3|PDE6A|PDGFRB|PDLIM7|PFN3|PHYKPL|PPARGC1B|PRELID1|PROP1|PRR7|PTTG1|PWWP2A|RAB24|RACK1|RANBP17|RARS1|RASGEF1C|RBM22|RGS14|RMND5B|RNF130|RNF145|RNF44|RPL26L1|RPS14|RUFY1|SAP30L|SCGB3A1|SFXN1|SGCD|SH3PXD2B|SIMC1|SLC26A2|SLC34A1|SLC36A1|SLC36A2|SLC36A3|SLC6A7|SLIT3|SLU7|SMIM23|SMIM3|SNCB|SNORA74B|SOX30|SPARC|SPATA31J1|SPDL1|SQSTM1|STC2|STK10|SYNPO|TBC1D9B|TCOF1|TENM2|THG1L|THOC3|TIGD6|TIMD4|TLX3|TMED9|TNIP1|TRIM41|TRIM52|TRIM7|TRK-CTT2-3|TRP-TGG3-1|TRT-TGT6-1|TRV-AAC1-4|TRV-CAC1-2|TSPAN17|TTC1|UBLCP1|UBTD2|UIMC1|UNC5A|WWC1|ZFP2|ZFP62|ZNF300|ZNF346|ZNF354A|ZNF354B|ZNF354C|ZNF454|ZNF879		Hunter-McAlpine craniosynostosis	VCV001703528	5	149010383 - 180719789			1703528	1695919			copy number gain		Pathogenic		no assertion criteria provided							
NC_000005.9:g.(?_149503793)_(149516630_?)dup	PDGFRB		Basal ganglia calcification, idiopathic, 4|Infantile myofibromatosis|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Acroosteolysis-keloid-like lesions-premature aging syndrome|Basal ganglia calcification, idiopathic, 4|Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome|Myofibromatosis, infantile, 1|Acroosteolysis-keloid-like lesions-premature aging syndrome	VCV001010852	5	149503793 - 149516630			1010852	986290			Duplication		Uncertain significance	Jun 20, 2018	criteria provided, single submitter							
NC_000005.9:g.149505067_149505080delins[g.149502629_149502780dup]	PDGFRB		Imatinib response	VCV000691863	5	149502629 - 149505080			691863	679578			Complex		drug response	Sep 9, 2019	criteria provided, single submitter							
Single allele	C5orf24|C5orf34|CPLANE1|CRHBP|CSF1R|FAM151B|FAM169A|FAM170A|FAM174A|HOMER1|HSD17B4|HSPA4|LRRC70|P4HA2|PAIP1|PCDHGA2|PCDHGA3|PRKAA1|PRLR|PROB1|SH3RF2|SH3TC2|SRA1|SREK1|SREK1IP1|ZFYVE16|ZMAT2|ZSWIM6|ZNF474|ZNF131|ZNF366|ZNF608|ZNF622|SRFBP1|SRP19|STARD4|STING1|TAF7|TAF9|TARS1|TBCA|TCERG1|STK32A|SUB1|SV2C|TCF7|TENT2|SSBP2|ST8SIA4|SHISAL2B|SHROOM1|SKIC3|SKP1|SKP2|SLC22A5|SLC23A1|SLC25A2|SLC12A2|SLC1A3|SLC22A4|SIL1|PRR16|PTGER4|PURA|RAB3C|RAD1|RAD17|RAD50|PRRC1|PCDHGB6|PSD2|PTCD2|PCDHGA4|PCDHGB7|PCDHGC3|PCDHGA5|PCDHGA6|PCDHA11|PCDHA12|PCDHA13|PCDHGA7|PCDHGB5|PAIP2|PAM|PCDHA2|PARP8|PART1|PCBD2|PCDH1|MACIR|MACROH2A1|MAN2A1|PCDH12|PCDHA1|PCDHA10|LRRTM2|LUCAT1|LVRN|MAP1B|MATR3|IGIP|IK|LYRM7|HSPB3|HTR1A|LYSMD3|HSPA9|IL13|IL17B|IL3|FBXO38|FBXO4|FEM1C|FER|FGF1|FYB1|FCHO2|FCHSD1|HTR4|FAM53C|FAM81B|FBN2|FBXL17|FBXL7|DELE1|CSF2|CSNK1A1|CSNK1G3|CTNNA1|CTXN3|CWC27|CXCL14|CXXC5|CYSTM1|DAB2|DCANP1|DCP2|DDX4|DDX46|CARD6|C7|C5orf64|C9|CAMK4|CAMLG|C5orf46|C5orf63|CAPSL|C6|ACTBL2|ABLIM3|ACOT12|ACSL6|ADAMTS12|ADAMTS19|ADAMTS6|ADGRV1|ADRB2|AFAP1L1|AFF4|AGGF1|AGXT2|ALDH7A1|AMACR|ANKDD1B|ANKH|ANKHD1|ANKHD1-EIF4EBP3|ANKRA2|ANKRD31|ANKRD34B|ANKRD55|ANXA2R|AP3B1|AP3S1|APBB3|APC|ARAP3|ARB2A|ARHGAP26|ARHGEF28|ARHGEF37|ARL14EPL|ARL15|ARRDC3|ARSB|ARSK|ATG10|ATG12|ATP6AP1L|BASP1|BDP1|BHMT|BHMT2|BRD8|BRIX1|BTF3|C1QTNF3|C5orf15|C5orf22|CARTPT|CAST|CATSPER3|CCDC112|CCDC125|CCDC152|CCL28|CCNB1|CCNH|CCNI2|CCNO|CD14|CD180|CDC20B|CDC23|CDC25C|CDC42SE2|CDH10|CDH12|CDH18|CDH6|CDH9|CDK7|CDKL3|CDKN2AIPNL|CDO1|CENPH|CENPK|CEP120|CERT1|CETN3|CHD1|CHSY3|CKMT2|CMYA5|COMMD10|COX7C|DEPDC1B|DHFR|DHX29|DIAPH1|DIMT1|DMGDH|DMXL1|DNAJC18|DNAJC21|DND1|DPYSL3|DROSHA|DTWD2|ECSCR|EDIL3|EFNA5|EGFLAM|EGFLAM-AS2|EGFLAM-AS4|EGR1|EIF4EBP3|ELL2|ELOVL7|EMB|ENC1|EPB41L4A|ERAP1|ERAP2|ERBIN|ERCC8|ESM1|ETF1|F2R|F2RL1|F2RL2|FAM13B|FGF10|FNIP1|FOXD1|FST|FSTL4|FTMT|GAPT|GCNT4|GDF9|GDNF|GDNF-AS1|GFM2|GFRA3|GHR|GIN1|GLRX|GNPDA1|GOLPH3|GPBP1|GPR150|GPR151|GPX8|GRAMD2B|GRPEL2|GRXCR2|GTF2H2|GTF2H2C|GZMA|GZMK|HAPLN1|HARS1|HARS2|HBEGF|HCN1|HDAC3|HEXB|HINT1|HMGCR|HMGCS1|HMGXB3|HMHB1|HNRNPA0|IL31RA|IL4|IL5|IL6ST|IL7R|IL9|IPO11|IQGAP2|IRF1|ISL1|ISOC1|ITGA1|ITGA2|JADE2|JAKMIP2|JMY|KCNN2|KCTD16|KDM3B|KGD4|KIAA0825|KIF20A|KIF2A|KIF3A|KLHL3|LARS1|LEAP2|LECT2|LHFPL2|LIFR|LINC02899|LIX1|LMBRD2|LMNB1|LNPEP|LOX|MAP3K1|MARCHF11|MARCHF3|MARVELD2|MAST4|MBLAC2|MCC|MCCC2|MCIDAS|MCTP1|MEF2C|MEGF10|MIER3|MINAR2|MIR143|MIR145|MIR378A|MIR449A|MIR449B|MIR9-2|MOCS2|MROH2B|MRPS27|MRPS30|MSH3|MTMR12|MTREX|MTRNR2L2|MTX3|MYO10|MYOT|MZB1|NADK2|NAIP|NCRUPAR|NDFIP1|NDUFA2|NDUFAF2|NDUFS4|NEUROG1|NIPBL|NLN|NME5|NNT|NPR3|NR2F1|NR3C1|NREP|NRG2|NSA2|NUDT12|NUP155|OCLN|OSMR|OTP|OTULIN|OXCT1|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHB1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHB16|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB8|PCDHB9|PCDHB@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGC4|PCDHGC5|PCSK1|PCYOX1L|PDE4D|PDE6A|PDE8B|PDGFRB|PDLIM4|PDZD2|PELO|PFDN1|PGGT1B|PHAX|PIK3R1|PITX1|PJA2|PKD2L2|PLAC8L1|PLCXD3|PLK2|PLPP1|POC5|POLK|POLR3G|POU4F3|POU5F2|PPARGC1B|PPIC|PPIP5K2|PPP2CA|PPP2R2B|PPWD1|PRDM6|PRDM9|PRELID2|RAI14|RANBP3L|RAPGEF6|RASA1|RASGRF2|RBM27|REEP2|REEP5|RELL2|RETREG1|RFESD|RGMB|RGS7BP|RHOBTB3|RICTOR|RIMOC1|RIOK2|RNF14|RNF180|RPL37|RPS23|RXFP3|S100Z|SAR1B|SCAMP1|SCARNA18|SCGB3A2|SEC24A|SELENOP|SEMA6A|SEPTIN8|SERF1A|SERF1B|SERINC5|SETD9|SGTB|SLC25A46|SLC25A48|SLC26A2|SLC27A6|SLC30A5|SLC35A4|SLC38A9|SLC45A2|SLC4A9|SLCO4C1|SLCO6A1|SLF1|SMAD5|SMIM15|SMN1|SMN2|SNCAIP|SNHG4|SNX18|SNX2|SNX24|SOWAHA|SPATA24|SPATA9|SPEF2|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SPZ1|TGFBI|THBS4|TICAM2|TIFAB|TIGD6|TMCO6|TMED7|TMED7-TICAM2|TMEM161B|TMEM167A|TMEM171|TMEM232|TMEM174|TMEM267|TNFAIP8|TNPO1|TRAPPC13|TRIM23|TRIM36|TRPC7|TSLP|TSSK1B|TTC23L|TTC33|TXNDC15|UBE2B|UBE2D2|UGT3A1|UGT3A2|UQCRQ|UTP15|VCAN|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR36|WDR41|WDR55|WDR70|WNT8A|XRCC4|YIPF5|YTHDC2|ZBED3|ZCCHC10|ZCCHC9|ZFR		Neurodevelopmental disorder	VCV000635930	5	14685137 - 149511942			635930	623743			Deletion		Uncertain significance	Apr 9, 2019	criteria provided, single submitter							
NC_000005.9:g.(?_86400000)_(154000000_?)del	CCDC69|CCNH|CXXC5|FAM114A2|GPR150|GPR151|HSPA9|LEAP2|MIR9-2|PCDHA2|PCDHB15|PCDHB16|PCDHGB2|PCDHGB3|PPARGC1B|SCGB3A2|SLC36A2|SRP19|ST8SIA4|UQCRQ|VDAC1|ZNF474|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|YTHDC2|ZCCHC10|ZMAT2|ZNF300|WDR36|WDR55|WNT8A|YIPF5|STARD4|TAF7|TCERG1|TNFAIP8|TNIP1|TRIM36|SMAD5|SMIM3|SNCAIP|SNHG4|SNX2|SNX24|SOWAHA|STING1|STK32A|SYNPO|TCF7|TCOF1|TGFBI|TICAM2|TIFAB|SEC24A|SEMA6A|SEPTIN8|SLC22A4|SH3RF2|SH3TC2|SHROOM1|SIL1|SKIC3|SLC12A2|SLC22A5|SLC23A1|SLC25A2|SKP1|SLC36A3|SLC4A9|SLC6A7|SLCO4C1|SLCO6A1|SLF1|SPARC|SPATA24|SPATA9|PPIC|PRR16|PRRC1|PDLIM4|PFDN1|PGGT1B|PCDHGB7|PCDHGC3|PCDHGC5|PDGFRB|PHAX|PITX1|RAD50|RAPGEF6|RFESD|RGMB|PPIP5K2|PPP2CA|PPP2R2B|PRDM6|PRELID2|PROB1|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA2|PCDHA7|PCDHGA3|PCDHGA4|PCDHB8|PCDHB9|PSD2|PURA|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGC4|PCSK1|PCYOX1L|PDE6A|PCDHA3|PCDHA4|MZB1|NDFIP1|NDST1|NDUFA2|NEUROG1|NME5|NMUR2|PAIP2|PAM|PCBD2|PCDHA5|PCDHA6|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|LECT2|MACROH2A1|MAN2A1|LIX1|MACIR|MARCHF3|JAKMIP2|KCNN2|KCTD16|MATR3|MBLAC2|MCC|MCTP1|MEF2C|LYRM7|LYSMD3|PCDHB1|MYOT|MYOZ3|PCDH1|PCDH12|HBEGF|HDAC3|GRAMD2B|GRIA1|GRPEL2|GRXCR2|HAND1|HARS2|HARS1|HTR4|IGIP|IK|IL13|IL17B|IL3|IL4|IL5|IL9|IRF1|IRGM|FAM13B|FAT2|FAM170A|FAM174A|DIAPH1|DMXL1|DPYSL3|DTWD2|ECSCR|EFNA5|FAM53C|FAM81B|FGF1|FNIP1|FSTL4|FTMT|G3BP1|GALNT10|GDF9|ISOC1|JADE2|CCNI2|CD14|GPX3|CDC42SE2|CDKN2AIPNL|CDO1|CDX1|CEP120|CHD1|CHSY3|COMMD10|CSF1R|CDKL3|CYSTM1|DCANP1|DNAJC18|DND1|ADRB2|AFAP1L1|CD74|CDC23|CDC25C|ARRDC3|ARSI|ANKHD1|ANKHD1-EIF4EBP3|ANXA6|DCP2|DCTN4|APBB3|ARSK|ATG12|ALDH7A1|AP3S1|EGR1|DDX46|DELE1|CETN3|AFF4|ABLIM3|ACSL6|ADAMTS19|ADGRV1|APC|ARAP3|ARB2A|ARHGAP26|ARHGEF37|ARL14EPL|ATOX1|BRD8|C5orf15|C5orf24|C5orf46|C5orf63|CAMK2A|CAMK4|CAMLG|CAST|CATSPER3|CCDC112|CSF2|CSNK1A1|CSNK1G3|CTNNA1|CTXN3|CXCL14|EIF4EBP3|ELL2|EPB41L4A|ERAP1|ERAP2|ETF1|FBN2|FBXL17|FBXO38|FCHSD1|FEM1C|FER|GFRA3|GIN1|GLRA1|GLRX|GM2A|GNPDA1|HINT1|HMGXB3|HMHB1|HNRNPA0|HSD17B4|HSPA4|KDM3B|KIAA0825|KIF20A|KIF3A|KLHL3|LARS1|LMNB1|LNPEP|LOX|LRRTM2|LUCAT1|LVRN|MEGF10|MFAP3|MINAR2|MIR143|MIR145|MIR378A|NR2F1|NR3C1|NREP|NRG2|NUDT12|P4HA2|PCDHA1|PCDHA10|PCDHA11|PCDHA12|PCDHA13|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PJA2|PKD2L2|PLAC8L1|POLR3G|POU4F3|POU5F2|RASA1|RBM22|RBM27|REEP2|REEP5|RELL2|RHOBTB3|RIOK2|RNF14|RPS14|SAP30L|SAR1B|SLC25A46|SLC25A48|SLC26A2|SLC27A6|SLC35A4|SLC36A1|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SRA1|SRFBP1|TIGD6|TMCO6|TMED7|TMED7-TICAM2|TMEM161B|TMEM232|TRPC7|TSLP|TSSK1B|TXNDC15|UBE2B|UBE2D2|ZNF608		Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	VCV000457359	5	86400000 - 154000000			457359	455090			Deletion		Pathogenic	Dec 3, 2021	criteria provided, single submitter							
GRCh37/hg19 5p15.1-q35.2(chr5:17628741-176575720)x1	DHFR|DHX29|DIAPH1|DIMT1|DMGDH|DMXL1|DNAJC18|ABLIM3|ACOT12|ACSL6|ACTBL2|ADAM19|ADAMTS12|ADAMTS19|ADAMTS6|ADGRV1|ADRA1B|ADRB2|AFAP1L1|AFF4|AGGF1|AGXT2|ALDH7A1|AMACR|ANKDD1B|ANKHD1|ANKHD1-EIF4EBP3|ANKRA2|ANKRD31|ANKRD34B|ANKRD55|ANXA2R|ANXA6|AP3B1|AP3S1|APBB3|APC|ARAP3|ARB2A|ARHGAP26|ARHGEF28|ARHGEF37|ARL10|ARL14EPL|ARL15|ARRDC3|ARSB|ARSI|ARSK|ATG10|ATG12|ATOX1|ATP10B|ATP6AP1L|ATP6V0E1|BDP1|BHMT|BHMT2|BNIP1|BOD1|BRD8|BRIX1|BTF3|C1QTNF2|C1QTNF3|C5orf15|C5orf22|C5orf24|C5orf34|C5orf46|C5orf47|C5orf52|C5orf58|C5orf63|C6|C7|C9|CAMK2A|CAMK4|CAMLG|CAPSL|CARD6|CARTPT|CAST|CATSPER3|CCDC112|CCDC125|CCDC152|CCDC69|CCL28|CCNB1|CCNG1|CCNH|CCNI2|CCNJL|CCNO|CD14|CD180|CD74|CDC20B|CDC23|CDC25C|CDC42SE2|CDH10|CDH12|CDH18|CDH6|CDH9|CDHR2|CDK7|CDKL3|CDKN2AIPNL|CDO1|CDX1|CENPH|CENPK|CEP120|CERT1|CETN3|CHD1|CHSY3|CKMT2|CLINT1|CLTB|CMYA5|CNOT8|COMMD10|COX7C|CPEB4|CPLANE1|CPLX2|CREBRF|CRHBP|CSF1R|CSF2|CSNK1A1|CSNK1G3|CTNNA1|CTXN3|CWC27|CXCL14|CXXC5|CYFIP2|CYSTM1|DAB2|DCANP1|DCP2|DCTN4|DDX4|DDX46|DELE1|DEPDC1B|DNAJC21|DND1|DOCK2|DPYSL3|DRD1|DROSHA|DTWD2|DUSP1|EBF1|ECSCR|EDIL3|EFCAB9|EFNA5|EGFLAM|EGFLAM-AS2|EGFLAM-AS4|EGR1|EIF4E1B|EIF4EBP3|ELL2|ELOVL7|EMB|ENC1|EPB41L4A|ERAP1|ERAP2|ERBIN|ERCC8|ERGIC1|ESM1|ETF1|F2R|F2RL1|F2RL2|FABP6|FAF2|FAM114A2|FAM13B|FAM151B|FAM153B|FAM169A|FAM170A|FAM174A|FAM200C|FAM53C|FAM81B|FAT2|FAXDC2|FBN2|FBXL17|FBXO38|FBXO4|FBXW11|FCHO2|FCHSD1|FEM1C|FER|FGF1|FGF10|FGF18|FGFR4|FNDC9|FNIP1|FOXD1|FOXI1|FST|FSTL4|FTMT|FYB1|G3BP1|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GALNT10|GAPT|GARIN3|GCNT4|GDF9|GDNF|GDNF-AS1|GEMIN5|GFM2|GFRA3|GHR|GIN1|GLRA1|GLRX|GM2A|GNPDA1|GOLPH3|GPBP1|GPR150|GPR151|GPRIN1|GPX3|GPX8|GRAMD2B|GRIA1|GRPEL2|GRXCR2|GTF2H2|GTF2H2C|GZMA|GZMK|HAND1|HAPLN1|HARS1|HARS2|HAVCR1|HAVCR2|HBEGF|HCN1|HDAC3|HEXB|HIGD2A|HINT1|HK3|HMGCR|HMGCS1|HMGXB3|HMHB1|HMMR|HNRNPA0|HOMER1|HRH2|HSD17B4|HSPA4|HSPA9|HSPB3|HTR1A|HTR4|IGIP|IK|IL12B|IL13|IL17B|IL3|IL31RA|IL4|IL5|IL6ST|IL7R|IL9|INSYN2B|IPO11|IQGAP2|IRF1|IRGM|ISL1|ISOC1|ITGA1|ITGA2|ITK|JADE2|JAKMIP2|JMY|KCNIP1|KCNMB1|KCNN2|KCTD16|KDM3B|KGD4|KIAA0825|KIAA1191|KIF20A|KIF2A|KIF3A|KIF4B|KLHL3|LARP1|LARS1|LCP2|LEAP2|LECT2|LHFPL2|LIFR|LINC02899|LINC03122|LIX1|LMBRD2|LMNB1|LNPEP|LOC100128059|LOC100288254|LOX|LRRC70|LRRTM2|LSM11|LUCAT1|LVRN|LYRM7|LYSMD3|MACIR|MACROH2A1|MAN2A1|MAP1B|MAP3K1|MARCHF3|MARVELD2|MAST4|MAT2B|MATR3|MBLAC2|MCC|MCCC2|MCIDAS|MCTP1|MED7|MEF2C|MEGF10|MFAP3|MIER3|MINAR2|MIR103A1|MIR143|MIR145|MIR146A|MIR378A|MIR449A|MIR449B|MIR9-2|MOCS2|MROH2B|MRPL22|MRPS27|MRPS30|MSH3|MSX2|MTMR12|MTREX|MTRNR2L2|MTX3|MYOT|MYOZ3|MZB1|NADK2|NAIP|NCRUPAR|NDFIP1|NDST1|NDUFA2|NDUFAF2|NDUFS4|NEURL1B|NEUROG1|NIPAL4|NIPBL|NKX2-5|NLN|NME5|NMUR2|NNT|NOP16|NPM1|NPR3|NR2F1|NR3C1|NREP|NRG2|NSA2|NSD1|NUDCD2|NUDT12|NUP155|OCLN|OSMR|OTP|OXCT1|P4HA2|PAIP1|PAIP2|PAM|PANK3|PARP8|PART1|PCBD2|PCDH1|PCDH12|PCDHA1|PCDHA10|PCDHA11|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHB1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHB16|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB8|PCDHB9|PCDHB@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCSK1|PCYOX1L|PDE4D|PDE6A|PDE8B|PDGFRB|PDLIM4|PDZD2|PELO|PFDN1|PGGT1B|PHAX|PIK3R1|PITX1|PJA2|PKD2L2|PLAC8L1|PLCXD3|PLK2|PLPP1|POC5|POLK|POLR3G|POU4F3|POU5F2|PPARGC1B|PPIC|PPIP5K2|PPP2CA|PPP2R2B|PPWD1|PRDM6|PRDM9|PRELID2|PRKAA1|PRLR|PROB1|PRR16|PRRC1|PSD2|PTCD2|PTGER4|PTTG1|PURA|PWWP2A|RAB3C|RAD1|RAD17|RAD50|RAI14|RANBP17|RANBP3L|RAPGEF6|RARS1|RASA1|RASGRF2|RBM22|RBM27|REEP2|REEP5|RELL2|RFESD|RGMB|RGS7BP|RHOBTB3|RICTOR|RIMOC1|RIOK2|RNF14|RNF145|RNF180|RNF44|RPL26L1|RPL37|RPS14|RPS23|RXFP3|S100Z|SAP30L|SAR1B|SCAMP1|SCARNA18|SCGB3A2|SEC24A|SELENOP|SEMA6A|SEPTIN8|SERF1A|SERF1B|SERINC5|SETD9|SFXN1|SGCD|SGTB|SH3PXD2B|SH3RF2|SH3TC2|SHISAL2B|SHROOM1|SIL1|SIMC1|SKIC3|SKP1|SKP2|SLC12A2|SLC1A3|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A46|SLC25A48|SLC26A2|SLC27A6|SLC30A5|SLC35A4|SLC36A1|SLC36A2|SLC36A3|SLC38A9|SLC45A2|SLC4A9|SLC6A7|SLCO4C1|SLCO6A1|SLF1|SLIT3|SLU7|SMAD5|SMIM15|SMIM23|SMIM3|SMN1|SMN2|SNCAIP|SNCB|SNHG4|SNORA74B|SNX18|SNX2|SNX24|SOWAHA|SOX30|SPARC|SPATA24|SPATA9|SPDL1|SPEF2|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SPZ1|SRA1|SREK1|SREK1IP1|SRFBP1|SRP19|SSBP2|ST8SIA4|STARD4|STC2|STING1|STK10|STK32A|SUB1|SV2C|SYNPO|TAF7|TAF9|TARS1|TBCA|TCERG1|TCF7|TCOF1|TENM2|TENT2|TGFBI|THBS4|THG1L|THOC3|TICAM2|TIFAB|TIGD6|TIMD4|TLX3|TMCO6|TMED7|TMED7-TICAM2|TMEM161B|TMEM167A|TMEM171|TMEM174|TMEM232|TMEM267|TNFAIP8|TNIP1|TNPO1|TRAPPC13|TRIM23|TRIM36|TRPC7|TSLP|TSPAN17|TSSK1B|TTC1|TTC23L|TTC33|TXNDC15|UBE2B|UBE2D2|UBLCP1|UBTD2|UGT3A1|UGT3A2|UIMC1|UNC5A|UQCRQ|UTP15|VCAN|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR36|WDR41|WDR55|WDR70|WNT8A|WWC1|XRCC4|YIPF5|YTHDC2|ZBED3|ZCCHC10|ZCCHC9|ZFR|ZFYVE16|ZMAT2|ZNF131|ZNF300|ZNF346|ZNF366|ZNF474|ZNF608|ZSWIM6		See cases	VCV000442431	5	17628741 - 176575720			442431	436093			copy number loss		Pathogenic	Feb 1, 2016	no assertion criteria provided							
GRCh37/hg19 5p15.33-q35.3(chr5:113577-180719789)	ABLIM3|ACOT12|ACSL6|ACTBL2|ADAM19|ADAMTS12|ADAMTS16|ADAMTS19|ADAMTS2|ADAMTS6|ADCY2|ADGRV1|ADRA1B|ADRB2|AFAP1L1|AFF4|AGGF1|AGXT2|AHRR|ALDH7A1|AMACR|ANKDD1B|ANKH|ANKHD1|ANKHD1-EIF4EBP3|ANKRA2|ANKRD31|ANKRD33B|ANKRD34B|ANKRD55|ANXA2R|ANXA6|AP3B1|AP3S1|APBB3|APC|ARAP3|ARB2A|ARHGAP26|ARHGEF28|ARHGEF37|ARL10|ARL14EPL|ARL15|ARRDC3|ARSB|ARSI|ARSK|ATG10|ATG12|ATOX1|ATP10B|ATP6AP1L|ATP6V0E1|ATPSCKMT|B4GALT7|BASP1|BDP1|BHMT|BHMT2|BNIP1|BOD1|BRD8|BRD9|BRIX1|BTF3|BTNL3|BTNL8|BTNL9|C1QTNF2|C1QTNF3|C5orf15|C5orf22|C5orf24|C5orf34|C5orf46|C5orf47|C5orf52|C5orf58|C5orf60|C5orf63|C6|C7|C9|CAMK2A|CAMK4|CAMLG|CANX|CAPSL|CARD6|CARTPT|CAST|CATSPER3|CBY3|CCDC112|CCDC125|CCDC127|CCDC152|CCDC69|CCL28|CCNB1|CCNG1|CCNH|CCNI2|CCNJL|CCNO|CCT5|CD14|CD180|CD74|CDC20B|CDC23|CDC25C|CDC42SE2|CDH10|CDH12|CDH18|CDH6|CDH9|CDHR2|CDK7|CDKL3|CDKN2AIPNL|CDO1|CDX1|CENPH|CENPK|CEP120|CEP72|CERT1|CETN3|CFAP90|CHD1|CHSY3|CKMT2|CLINT1|CLK4|CLPTM1L|CLTB|CMBL|CMYA5|CNOT6|CNOT8|COL23A1|COMMD10|COX7C|CPEB4|CPLANE1|CPLX2|CREBRF|CRHBP|CSF1R|CSF2|CSNK1A1|CSNK1G3|CTNNA1|CTNND2|CTXN3|CWC27|CXCL14|CXXC5|CYFIP2|CYSTM1|DAB2|DAP|DBN1|DCANP1|DCP2|DCTN4|DDX4|DDX41|DDX46|DELE1|DEPDC1B|DHFR|DHX29|DIAPH1|DIMT1|DMGDH|DMXL1|DNAH5|DNAJC18|DNAJC21|DND1|DOCK2|DOK3|DPYSL3|DRD1|DROSHA|DTWD2|DUSP1|EBF1|ECSCR|EDIL3|EFCAB9|EFNA5|EGFLAM|EGFLAM-AS2|EGFLAM-AS4|EGR1|EIF4E1B|EIF4EBP3|ELL2|ELOVL7|EMB|ENC1|EPB41L4A|ERAP1|ERAP2|ERBIN|ERCC8|ERGIC1|ESM1|ETF1|EXOC3|EXOC3-AS1|F12|F2R|F2RL1|F2RL2|FABP6|FAF2|FAM114A2|FAM13B|FAM151B|FAM153A|FAM153B|FAM169A|FAM170A|FAM174A|FAM193B|FAM200C|FAM53C|FAM81B|FASTKD3|FAT2|FAXDC2|FBN2|FBXL17|FBXL7|FBXO38|FBXO4|FBXW11|FCHO2|FCHSD1|FEM1C|FER|FGF1|FGF10|FGF18|FGFR4|FLT4|FNDC9|FNIP1|FOXD1|FOXI1|FST|FSTL4|FTMT|FYB1|G3BP1|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GALNT10|GAPT|GARIN3|GCNT4|GDF9|GDNF|GDNF-AS1|GEMIN5|GFM2|GFPT2|GFRA3|GHR|GIN1|GLRA1|GLRX|GM2A|GNPDA1|GOLPH3|GPBP1|GPR150|GPR151|GPRIN1|GPX3|GPX8|GRAMD2B|GRIA1|GRK6|GRM6|GRPEL2|GRXCR2|GTF2H2|GTF2H2C|GZMA|GZMK|HAND1|HAPLN1|HARS1|HARS2|HAVCR1|HAVCR2|HBEGF|HCN1|HDAC3|HEXB|HIGD2A|HINT1|HK3|HMGCR|HMGCS1|HMGXB3|HMHB1|HMMR|HNRNPA0|HNRNPAB|HNRNPH1|HOMER1|HRH2|HSD17B4|HSPA4|HSPA9|HSPB3|HTR1A|HTR4|ICE1|IGIP|IK|IL12B|IL13|IL17B|IL3|IL31RA|IL4|IL5|IL6ST|IL7R|IL9|INSYN2B|IPO11|IQGAP2|IRF1|IRGM|IRX1|IRX2|IRX2-DT|IRX4|ISL1|ISOC1|ITGA1|ITGA2|ITK|JADE2|JAKMIP2|JMY|KCNIP1|KCNMB1|KCNN2|KCTD16|KDM3B|KGD4|KIAA0825|KIAA1191|KIF20A|KIF2A|KIF3A|KIF4B|KLHL3|LARP1|LARS1|LCP2|LEAP2|LECT2|LHFPL2|LIFR|LINC01194|LINC02899|LINC03122|LIX1|LMAN2|LMBRD2|LMNB1|LNPEP|LOC100128059|LOC100288254|LOX|LPCAT1|LRRC14B|LRRC70|LRRTM2|LSM11|LTC4S|LUCAT1|LVRN|LYRM7|LYSMD3|MACIR|MACROH2A1|MAML1|MAN2A1|MAP1B|MAP3K1|MAPK9|MARCHF11|MARCHF3|MARCHF6|MARVELD2|MAST4|MAT2B|MATR3|MBLAC2|MCC|MCCC2|MCIDAS|MCTP1|MED10|MED7|MEF2C|MEGF10|MFAP3|MGAT1|MGAT4B|MIER3|MINAR2|MIR103A1|MIR143|MIR145|MIR146A|MIR378A|MIR449A|MIR449B|MIR9-2|MOCS2|MRNIP|MROH2B|MRPL22|MRPL36|MRPS27|MRPS30|MSH3|MSX2|MTMR12|MTREX|MTRNR2L2|MTRR|MTX3|MXD3|MYO10|MYOT|MYOZ3|MZB1|N4BP3|NADK2|NAIP|NCRUPAR|NDFIP1|NDST1|NDUFA2|NDUFAF2|NDUFS4|NDUFS6|NEURL1B|NEUROG1|NHP2|NIPAL4|NIPBL|NKD2|NKX2-5|NLN|NME5|NMUR2|NNT|NOP16|NPM1|NPR3|NR2F1|NR3C1|NREP|NRG2|NSA2|NSD1|NSUN2|NUDCD2|NUDT12|NUP155|OCLN|OR2V1|OR2V2|OR2Y1|OSMR|OTP|OTULIN|OTULIN-DT|OTULINL|OXCT1|P4HA2|PAIP1|PAIP2|PAM|PANK3|PARP8|PART1|PCBD2|PCDH1|PCDH12|PCDHA1|PCDHA10|PCDHA11|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHB1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHB16|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB8|PCDHB9|PCDHB@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCSK1|PCYOX1L|PDCD6|PDE4D|PDE6A|PDE8B|PDGFRB|PDLIM4|PDLIM7|PDZD2|PELO|PFDN1|PFN3|PGGT1B|PHAX|PHYKPL|PIK3R1|PITX1|PJA2|PKD2L2|PLAC8L1|PLCXD3|PLEKHG4B|PLK2|PLPP1|POC5|POLK|POLR3G|POU4F3|POU5F2|PPARGC1B|PPIC|PPIP5K2|PPP2CA|PPP2R2B|PPWD1|PRDM6|PRDM9|PRELID1|PRELID2|PRKAA1|PRLR|PROB1|PROP1|PRR16|PRR7|PRRC1|PSD2|PTCD2|PTGER4|PTTG1|PURA|PWWP2A|RAB24|RAB3C|RACK1|RAD1|RAD17|RAD50|RAI14|RANBP17|RANBP3L|RAPGEF6|RARS1|RASA1|RASGEF1C|RASGRF2|RBM22|RBM27|REEP2|REEP5|RELL2|RETREG1|RFESD|RGMB|RGS14|RGS7BP|RHOBTB3|RICTOR|RIMOC1|RIOK2|RMND5B|RNF130|RNF14|RNF145|RNF180|RNF44|ROPN1L|RPL26L1|RPL37|RPS14|RPS23|RUFY1|RXFP3|S100Z|SAP30L|SAR1B|SCAMP1|SCARNA18|SCGB3A1|SCGB3A2|SDHA|SEC24A|SELENOP|SEMA5A|SEMA6A|SEPTIN8|SERF1A|SERF1B|SERINC5|SETD9|SFXN1|SGCD|SGTB|SH3PXD2B|SH3RF2|SH3TC2|SHISAL2B|SHROOM1|SIL1|SIMC1|SKIC3|SKP1|SKP2|SLC12A2|SLC12A7|SLC1A3|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A46|SLC25A48|SLC26A2|SLC27A6|SLC30A5|SLC34A1|SLC35A4|SLC36A1|SLC36A2|SLC36A3|SLC38A9|SLC45A2|SLC4A9|SLC6A18|SLC6A19|SLC6A3|SLC6A7|SLC9A3|SLCO4C1|SLCO6A1|SLF1|SLIT3|SLU7|SMAD5|SMIM15|SMIM23|SMIM3|SMN1|SMN2|SNCAIP|SNCB|SNHG4|SNORA74B|SNX18|SNX2|SNX24|SOWAHA|SOX30|SPARC|SPATA24|SPATA9|SPDL1|SPEF2|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SPZ1|SQSTM1|SRA1|SRD5A1|SREK1|SREK1IP1|SRFBP1|SRP19|SSBP2|ST8SIA4|STARD4|STC2|STING1|STK10|STK32A|SUB1|SV2C|SYNPO|TAF7|TAF9|TARS1|TAS2R1|TBC1D9B|TBCA|TCERG1|TCF7|TCOF1|TENM2|TENT2|TENT4A|TERT|TGFBI|THBS4|THG1L|THOC3|TICAM2|TIFAB|TIGD6|TIMD4|TLX3|TMCO6|TMED7|TMED7-TICAM2|TMED9|TMEM161B|TMEM167A|TMEM171|TMEM174|TMEM232|TMEM267|TNFAIP8|TNIP1|TNPO1|TPPP|TRAPPC13|TRIM23|TRIM36|TRIM41|TRIM52|TRIM7|TRIO|TRIP13|TRK-CTT2-3|TRP-TGG3-1|TRPC7|TRT-TGT6-1|TRV-AAC1-4|TRV-CAC1-2|TSLP|TSPAN17|TSSK1B|TTC1|TTC23L|TTC33|TXNDC15|UBE2B|UBE2D2|UBE2QL1|UBLCP1|UBTD2|UGT3A1|UGT3A2|UIMC1|UNC5A|UQCRQ|UTP15|VCAN|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR36|WDR41|WDR55|WDR70|WNT8A|WWC1|XRCC4|YIPF5|YTHDC2|ZBED3|ZCCHC10|ZCCHC9|ZDHHC11|ZDHHC11B|ZFP2|ZFP62|ZFR|ZFYVE16|ZMAT2|ZNF131|ZNF300|ZNF346|ZNF354A|ZNF354B|ZNF354C|ZNF366|ZNF454|ZNF474|ZNF608|ZNF622|ZNF879|ZSWIM6		See cases	VCV000441920	5	113577 - 180719789			441920	435582			copy number gain		Pathogenic	Jul 14, 2015	no assertion criteria provided							
GRCh37/hg19 5p15.33-q35.3(chr5:113577-180719789)x3	ABLIM3|ACOT12|ACSL6|ACTBL2|ADAM19|ADAMTS12|ADAMTS16|ADAMTS19|ADAMTS2|ADAMTS6|ADCY2|ADGRV1|ADRA1B|ADRB2|AFAP1L1|AFF4|AGGF1|AGXT2|AHRR|ALDH7A1|AMACR|ANKDD1B|ANKH|ANKHD1|ANKHD1-EIF4EBP3|ANKRA2|ANKRD31|ANKRD33B|ANKRD34B|ANKRD55|ANXA2R|ANXA6|AP3B1|AP3S1|APBB3|APC|ARAP3|ARB2A|ARHGAP26|ARHGEF28|ARHGEF37|ARL10|ARL14EPL|ARL15|ARRDC3|ARSB|ARSI|ARSK|ATG10|ATG12|ATOX1|ATP10B|ATP6AP1L|ATP6V0E1|ATPSCKMT|B4GALT7|BASP1|BDP1|BHMT|BHMT2|BNIP1|BOD1|BRD8|BRD9|BRIX1|BTF3|BTNL3|BTNL8|BTNL9|C1QTNF2|C1QTNF3|C5orf15|C5orf22|C5orf24|C5orf34|C5orf46|C5orf47|C5orf52|C5orf58|C5orf60|C5orf63|C6|C7|C9|CAMK2A|CAMK4|CAMLG|CANX|CAPSL|CARD6|CARTPT|CAST|CATSPER3|CBY3|CCDC112|CCDC125|CCDC127|CCDC152|CCDC69|CCL28|CCNB1|CCNG1|CCNH|CCNI2|CCNJL|CCNO|CCT5|CD14|CD180|CD74|CDC20B|CDC23|CDC25C|CDC42SE2|CDH10|CDH12|CDH18|CDH6|CDH9|CDHR2|CDK7|CDKL3|CDKN2AIPNL|CDO1|CDX1|CENPH|CENPK|CEP120|CEP72|CERT1|CETN3|CFAP90|CHD1|CHSY3|CKMT2|CLINT1|CLK4|CLPTM1L|CLTB|CMBL|CMYA5|CNOT6|CNOT8|COL23A1|COMMD10|COX7C|CPEB4|CPLANE1|CPLX2|CREBRF|CRHBP|CSF1R|CSF2|CSNK1A1|CSNK1G3|CTNNA1|CTNND2|CTXN3|CWC27|CXCL14|CXXC5|CYFIP2|CYSTM1|DAB2|DAP|DBN1|DCANP1|DCP2|DCTN4|DDX4|DDX41|DDX46|DELE1|DEPDC1B|DHFR|DHX29|DIAPH1|DIMT1|DMGDH|DMXL1|DNAH5|DNAJC18|DNAJC21|DND1|DOCK2|DOK3|DPYSL3|DRD1|DROSHA|DTWD2|DUSP1|EBF1|ECSCR|EDIL3|EFCAB9|EFNA5|EGFLAM|EGFLAM-AS2|EGFLAM-AS4|EGR1|EIF4E1B|EIF4EBP3|ELL2|ELOVL7|EMB|ENC1|EPB41L4A|ERAP1|ERAP2|ERBIN|ERCC8|ERGIC1|ESM1|ETF1|EXOC3|EXOC3-AS1|F12|F2R|F2RL1|F2RL2|FABP6|FAF2|FAM114A2|FAM13B|FAM151B|FAM153A|FAM153B|FAM169A|FAM170A|FAM174A|FAM193B|FAM200C|FAM53C|FAM81B|FASTKD3|FAT2|FAXDC2|FBN2|FBXL17|FBXL7|FBXO38|FBXO4|FBXW11|FCHO2|FCHSD1|FEM1C|FER|FGF1|FGF10|FGF18|FGFR4|FLT4|FNDC9|FNIP1|FOXD1|FOXI1|FST|FSTL4|FTMT|FYB1|G3BP1|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GALNT10|GAPT|GARIN3|GCNT4|GDF9|GDNF|GDNF-AS1|GEMIN5|GFM2|GFPT2|GFRA3|GHR|GIN1|GLRA1|GLRX|GM2A|GNPDA1|GOLPH3|GPBP1|GPR150|GPR151|GPRIN1|GPX3|GPX8|GRAMD2B|GRIA1|GRK6|GRM6|GRPEL2|GRXCR2|GTF2H2|GTF2H2C|GZMA|GZMK|HAND1|HAPLN1|HARS1|HARS2|HAVCR1|HAVCR2|HBEGF|HCN1|HDAC3|HEXB|HIGD2A|HINT1|HK3|HMGCR|HMGCS1|HMGXB3|HMHB1|HMMR|HNRNPA0|HNRNPAB|HNRNPH1|HOMER1|HRH2|HSD17B4|HSPA4|HSPA9|HSPB3|HTR1A|HTR4|ICE1|IGIP|IK|IL12B|IL13|IL17B|IL3|IL31RA|IL4|IL5|IL6ST|IL7R|IL9|INSYN2B|IPO11|IQGAP2|IRF1|IRGM|IRX1|IRX2|IRX2-DT|IRX4|ISL1|ISOC1|ITGA1|ITGA2|ITK|JADE2|JAKMIP2|JMY|KCNIP1|KCNMB1|KCNN2|KCTD16|KDM3B|KGD4|KIAA0825|KIAA1191|KIF20A|KIF2A|KIF3A|KIF4B|KLHL3|LARP1|LARS1|LCP2|LEAP2|LECT2|LHFPL2|LIFR|LINC01194|LINC02899|LINC03122|LIX1|LMAN2|LMBRD2|LMNB1|LNPEP|LOC100128059|LOC100288254|LOX|LPCAT1|LRRC14B|LRRC70|LRRTM2|LSM11|LTC4S|LUCAT1|LVRN|LYRM7|LYSMD3|MACIR|MACROH2A1|MAML1|MAN2A1|MAP1B|MAP3K1|MAPK9|MARCHF11|MARCHF3|MARCHF6|MARVELD2|MAST4|MAT2B|MATR3|MBLAC2|MCC|MCCC2|MCIDAS|MCTP1|MED10|MED7|MEF2C|MEGF10|MFAP3|MGAT1|MGAT4B|MIER3|MINAR2|MIR103A1|MIR143|MIR145|MIR146A|MIR378A|MIR449A|MIR449B|MIR9-2|MOCS2|MRNIP|MROH2B|MRPL22|MRPL36|MRPS27|MRPS30|MSH3|MSX2|MTMR12|MTREX|MTRNR2L2|MTRR|MTX3|MXD3|MYO10|MYOT|MYOZ3|MZB1|N4BP3|NADK2|NAIP|NCRUPAR|NDFIP1|NDST1|NDUFA2|NDUFAF2|NDUFS4|NDUFS6|NEURL1B|NEUROG1|NHP2|NIPAL4|NIPBL|NKD2|NKX2-5|NLN|NME5|NMUR2|NNT|NOP16|NPM1|NPR3|NR2F1|NR3C1|NREP|NRG2|NSA2|NSD1|NSUN2|NUDCD2|NUDT12|NUP155|OCLN|OR2V1|OR2V2|OR2Y1|OSMR|OTP|OTULIN|OTULIN-DT|OTULINL|OXCT1|P4HA2|PAIP1|PAIP2|PAM|PANK3|PARP8|PART1|PCBD2|PCDH1|PCDH12|PCDHA1|PCDHA10|PCDHA11|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHB1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHB16|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB8|PCDHB9|PCDHB@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCSK1|PCYOX1L|PDCD6|PDE4D|PDE6A|PDE8B|PDGFRB|PDLIM4|PDLIM7|PDZD2|PELO|PFDN1|PFN3|PGGT1B|PHAX|PHYKPL|PIK3R1|PITX1|PJA2|PKD2L2|PLAC8L1|PLCXD3|PLEKHG4B|PLK2|PLPP1|POC5|POLK|POLR3G|POU4F3|POU5F2|PPARGC1B|PPIC|PPIP5K2|PPP2CA|PPP2R2B|PPWD1|PRDM6|PRDM9|PRELID1|PRELID2|PRKAA1|PRLR|PROB1|PROP1|PRR16|PRR7|PRRC1|PSD2|PTCD2|PTGER4|PTTG1|PURA|PWWP2A|RAB24|RAB3C|RACK1|RAD1|RAD17|RAD50|RAI14|RANBP17|RANBP3L|RAPGEF6|RARS1|RASA1|RASGEF1C|RASGRF2|RBM22|RBM27|REEP2|REEP5|RELL2|RETREG1|RFESD|RGMB|RGS14|RGS7BP|RHOBTB3|RICTOR|RIMOC1|RIOK2|RMND5B|RNF130|RNF14|RNF145|RNF180|RNF44|ROPN1L|RPL26L1|RPL37|RPS14|RPS23|RUFY1|RXFP3|S100Z|SAP30L|SAR1B|SCAMP1|SCARNA18|SCGB3A1|SCGB3A2|SDHA|SEC24A|SELENOP|SEMA5A|SEMA6A|SEPTIN8|SERF1A|SERF1B|SERINC5|SETD9|SFXN1|SGCD|SGTB|SH3PXD2B|SH3RF2|SH3TC2|SHISAL2B|SHROOM1|SIL1|SIMC1|SKIC3|SKP1|SKP2|SLC12A2|SLC12A7|SLC1A3|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A46|SLC25A48|SLC26A2|SLC27A6|SLC30A5|SLC34A1|SLC35A4|SLC36A1|SLC36A2|SLC36A3|SLC38A9|SLC45A2|SLC4A9|SLC6A18|SLC6A19|SLC6A3|SLC6A7|SLC9A3|SLCO4C1|SLCO6A1|SLF1|SLIT3|SLU7|SMAD5|SMIM15|SMIM23|SMIM3|SMN1|SMN2|SNCAIP|SNCB|SNHG4|SNORA74B|SNX18|SNX2|SNX24|SOWAHA|SOX30|SPARC|SPATA24|SPATA9|SPDL1|SPEF2|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SPZ1|SQSTM1|SRA1|SRD5A1|SREK1|SREK1IP1|SRFBP1|SRP19|SSBP2|ST8SIA4|STARD4|STC2|STING1|STK10|STK32A|SUB1|SV2C|SYNPO|TAF7|TAF9|TARS1|TAS2R1|TBC1D9B|TBCA|TCERG1|TCF7|TCOF1|TENM2|TENT2|TENT4A|TERT|TGFBI|THBS4|THG1L|THOC3|TICAM2|TIFAB|TIGD6|TIMD4|TLX3|TMCO6|TMED7|TMED7-TICAM2|TMED9|TMEM161B|TMEM167A|TMEM171|TMEM174|TMEM232|TMEM267|TNFAIP8|TNIP1|TNPO1|TPPP|TRAPPC13|TRIM23|TRIM36|TRIM41|TRIM52|TRIM7|TRIO|TRIP13|TRK-CTT2-3|TRP-TGG3-1|TRPC7|TRT-TGT6-1|TRV-AAC1-4|TRV-CAC1-2|TSLP|TSPAN17|TSSK1B|TTC1|TTC23L|TTC33|TXNDC15|UBE2B|UBE2D2|UBE2QL1|UBLCP1|UBTD2|UGT3A1|UGT3A2|UIMC1|UNC5A|UQCRQ|UTP15|VCAN|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR36|WDR41|WDR55|WDR70|WNT8A|WWC1|XRCC4|YIPF5|YTHDC2|ZBED3|ZCCHC10|ZCCHC9|ZDHHC11|ZDHHC11B|ZFP2|ZFP62|ZFR|ZFYVE16|ZMAT2|ZNF131|ZNF300|ZNF346|ZNF354A|ZNF354B|ZNF354C|ZNF366|ZNF454|ZNF474|ZNF608|ZNF622|ZNF879|ZSWIM6		See cases	VCV000441919	5	113577 - 180719789			441919	435581			copy number gain		Pathogenic	Dec 2, 2014	no assertion criteria provided							
GRCh37/hg19 5q15-35.3(chr5:94844077-178830410)x3	ARL10|ARL14EPL|ARSI|ARSK|CSF1R|CSF2|CSNK1A1|FAM200C|ATG12|CSNK1G3|CTNNA1|FAM53C|HINT1|HK3|LARP1|LARS1|NMUR2|NOP16|PCDHB16|PDLIM4|PDLIM7|PFDN1|RELL2|SLC36A1|SLC36A2|SLC36A3|SYNPO|TAF7|ZNF346|ZNF354A|ZNF454|ZNF474|ZNF354B|ZNF354C|TCF7|TNFAIP8|TNIP1|TRIM36|TRPC7|TSLP|TSPAN17|TSSK1B|TIFAB|TMED7-TICAM2|ZNF608|ZNF879|SLC4A9|SLC6A7|SLCO4C1|SLCO6A1|SLIT3|SLU7|SMIM3|SNCAIP|SNX24|SOWAHA|SMAD5|SMIM23|SNCB|SNHG4|SNORA74B|SNX2|TCERG1|TMED9|TMEM232|RFESD|RHOBTB3|RIOK2|RMND5B|RNF14|RNF145|RNF44|RPL26L1|RPS14|SAP30L|SAR1B|SCGB3A2|PITX1|PJA2|PKD2L2|PPARGC1B|PPIC|PHAX|PHYKPL|PCDHB5|PCDHB6|PLAC8L1|POU4F3|PFN3|PGGT1B|RGMB|RGS14|PCDHB2|PCDHB7|PCDHB8|PCDHB@|PCDHGA1|NREP|NRG2|PCDH1|PCDH12|PCDHA1|PCDHGA10|PCDHB9|PCDHB3|PCDHB4|NPM1|NR3C1|PANK3|MACROH2A1|MAN2A1|MARCHF3|MCC|MED7|MAT2B|MATR3|LECT2|LIX1|LMAN2|LSM11|LVRN|PCBD2|PCDHA10|PCDHA11|HNRNPAB|HRH2|HSD17B4|HTR4|IGIP|IK|HMHB1|HMMR|HSPA4|HSPA9|HNRNPA0|LCP2|LEAP2|LYRM7|FAT2|FAXDC2|FBN2|FTMT|G3BP1|GALNT10|GARIN3|GDF9|GEMIN5|FBXL17|FBXO38|FOXI1|FSTL4|FGFR4|FNDC9|FNIP1|MACIR|CXCL14|CXXC5|CYFIP2|CTXN3|CYSTM1|DBN1|DCANP1|DTWD2|DCP2|DCTN4|DND1|DOCK2|DOK3|ATP6V0E1|B4GALT7|ATOX1|ATP10B|DPYSL3|DRD1|BNIP1|BOD1|BRD8|C1QTNF2|C5orf15|C5orf24|C5orf46|C5orf47|C5orf52|C5orf58|C5orf63|CCDC69|CCNG1|HMGXB3|ABLIM3|ACSL6|ADAM19|ADAMTS19|ADAMTS2|ADRA1B|ADRB2|AFAP1L1|AFF4|ALDH7A1|ANKHD1|ANKHD1-EIF4EBP3|ANXA6|AP3S1|APBB3|APC|ARAP3|ARHGAP26|ARHGEF37|CAMK2A|CAMK4|CAMLG|CAST|CATSPER3|CCDC112|CCNI2|CCNJL|CD14|CD74|CDC23|CDC25C|CDC42SE2|CDHR2|CDKL3|CDKN2AIPNL|CDO1|CDX1|CEP120|CHD1|CHSY3|CLINT1|CLK4|CLTB|CNOT8|COL23A1|COMMD10|CPEB4|CPLX2|CREBRF|DDX41|DDX46|DELE1|DIAPH1|DMXL1|DNAJC18|DUSP1|EBF1|ECSCR|EFCAB9|EFNA5|EGR1|EIF4E1B|EIF4EBP3|ELL2|EPB41L4A|ERAP1|ERAP2|ERGIC1|ETF1|F12|FABP6|FAF2|FAM114A2|FAM13B|FAM153A|FAM153B|FAM170A|FAM174A|FAM193B|FBXW11|FCHSD1|FEM1C|FER|FGF1|FGF18|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GFRA3|GIN1|GLRA1|GLRX|GM2A|GNPDA1|GPR150|GPR151|GPRIN1|GPX3|GRAMD2B|GRIA1|GRK6|GRM6|GRPEL2|GRXCR2|HAND1|HARS1|HARS2|HAVCR1|HAVCR2|HBEGF|HDAC3|HIGD2A|IL12B|IL13|IL17B|IL3|IL4|IL5|IL9|INSYN2B|IRF1|IRGM|ISOC1|ITK|JADE2|JAKMIP2|KCNIP1|KCNMB1|KCNN2|KCTD16|KDM3B|KIAA1191|KIF20A|KIF3A|KIF4B|KLHL3|LMNB1|LNPEP|LOC100128059|LOC100288254|LOX|LRRTM2|MEGF10|MFAP3|MINAR2|MIR103A1|MIR143|MIR145|MIR146A|MIR378A|MRPL22|MSX2|MXD3|MYOT|MYOZ3|MZB1|N4BP3|NDFIP1|NDST1|NDUFA2|NEURL1B|NEUROG1|NHP2|NIPAL4|NKX2-5|NME5|NSD1|NUDCD2|NUDT12|P4HA2|PAIP2|PAM|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHB1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCSK1|PCYOX1L|PDE6A|PDGFRB|PPIP5K2|PPP2CA|PPP2R2B|PRDM6|PRELID1|PRELID2|PROB1|PROP1|PRR16|PRR7|PRRC1|PSD2|PTTG1|PURA|PWWP2A|RAB24|RAD50|RANBP17|RAPGEF6|RARS1|RBM22|RBM27|REEP2|REEP5|SEC24A|SEMA6A|SEPTIN8|SFXN1|SGCD|SH3PXD2B|SH3RF2|SH3TC2|SHROOM1|SIL1|SIMC1|SKIC3|SKP1|SLC12A2|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A46|SLC25A48|SLC26A2|SLC27A6|SLC34A1|SLC35A4|SOX30|SPARC|SPATA24|SPATA9|SPDL1|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SRA1|SRFBP1|SRP19|ST8SIA4|STARD4|STC2|STING1|STK10|STK32A|TCOF1|TENM2|TGFBI|THG1L|THOC3|TICAM2|TIGD6|TIMD4|TLX3|TMCO6|TMED7|TTC1|TXNDC15|UBE2B|UBE2D2|UBLCP1|UBTD2|UIMC1|UNC5A|UQCRQ|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR36|WDR55|WNT8A|WWC1|YIPF5|YTHDC2|ZCCHC10|ZFP2|ZMAT2|ZNF300		not provided	VCV000425542	5	94844077 - 178830410			425542	413876			copy number gain		Likely benign	Jan 31, 2017	criteria provided, single submitter							
GRCh37/hg19 5q21.3-35.3(chr5:106716357-180687338)x3	HRH2|HSD17B4|HSPA4|HSPA9|RNF145|RNF44|RPL26L1|RPS14|HTR4|IGIP|IK|RUFY1|SAR1B|SCGB3A1|SCGB3A2|SEC24A|SGCD|SAP30L|SH3PXD2B|SH3RF2|SH3TC2|IL13|IL17B|INSYN2B|IRF1|IRGM|IL3|IL4|JADE2|JAKMIP2|IL5|IL9|ISOC1|ITK|SEMA6A|SEPTIN8|SFXN1|IL12B|SHROOM1|SIL1|SIMC1|ABLIM3|ACSL6|ADAM19|ADAMTS19|ADAMTS2|ADRA1B|ADRB2|AFAP1L1|AFF4|ALDH7A1|ANKHD1|ANKHD1-EIF4EBP3|ANXA6|AP3S1|APBB3|APC|ARAP3|ARHGAP26|ARHGEF37|ARL10|ARL14EPL|ARSI|ATG12|ATOX1|ATP10B|ATP6V0E1|B4GALT7|BNIP1|BOD1|BRD8|BTNL3|BTNL8|BTNL9|C1QTNF2|C5orf15|C5orf24|C5orf46|C5orf47|C5orf52|C5orf58|C5orf60|C5orf63|CAMK2A|CAMK4|CAMLG|CANX|CATSPER3|CBY3|CCDC112|CCDC69|CCNG1|CCNI2|CCNJL|CD14|CD74|CDC23|CDC25C|CDC42SE2|CDHR2|CDKL3|CDKN2AIPNL|CDO1|CDX1|CEP120|CHSY3|CLINT1|CLK4|CLTB|CNOT6|CNOT8|COL23A1|COMMD10|CPEB4|CPLX2|CREBRF|CSF1R|CSF2|CSNK1A1|CSNK1G3|CTNNA1|CTXN3|CXCL14|CXXC5|CYFIP2|CYSTM1|DBN1|DCANP1|DCP2|DCTN4|DDX41|DDX46|DELE1|DIAPH1|DMXL1|DNAJC18|DND1|DOCK2|DOK3|DPYSL3|DRD1|DTWD2|DUSP1|EBF1|ECSCR|EFCAB9|EFNA5|EGR1|EIF4E1B|EIF4EBP3|EPB41L4A|ERGIC1|ETF1|F12|FABP6|FAF2|FAM114A2|FAM13B|FAM153A|FAM153B|FAM170A|FAM193B|FAM200C|FAM53C|FAT2|FAXDC2|FBN2|FBXL17|FBXO38|FBXW11|FCHSD1|FEM1C|FER|FGF1|FGF18|FGFR4|FLT4|FNDC9|FNIP1|FOXI1|FSTL4|FTMT|G3BP1|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GALNT10|GARIN3|GDF9|GEMIN5|GFPT2|GFRA3|GLRA1|GM2A|GNPDA1|GPR151|GPRIN1|GPX3|GRAMD2B|GRIA1|GRK6|GRM6|GRPEL2|GRXCR2|HAND1|HARS1|HARS2|HAVCR1|HAVCR2|HBEGF|HDAC3|HIGD2A|HINT1|HK3|HMGXB3|HMHB1|HMMR|HNRNPA0|HNRNPAB|HNRNPH1|KCNIP1|KCNMB1|KCNN2|KCTD16|KDM3B|KIAA1191|KIF20A|KIF3A|KIF4B|KLHL3|LARP1|LARS1|LCP2|LEAP2|LECT2|LMAN2|LMNB1|LOC100128059|LOC100288254|LOX|LRRTM2|LSM11|LTC4S|LVRN|LYRM7|MACROH2A1|MAML1|MAN2A1|MAPK9|MARCHF3|MAT2B|MATR3|MCC|MED7|MEGF10|MFAP3|MGAT1|MGAT4B|MINAR2|MIR103A1|MIR143|MIR145|MIR146A|MIR378A|MRNIP|MRPL22|MSX2|MXD3|MYOT|MYOZ3|MZB1|N4BP3|NDFIP1|NDST1|NDUFA2|NEURL1B|NEUROG1|NHP2|NIPAL4|NKX2-5|NME5|NMUR2|NOP16|NPM1|NR3C1|NREP|NRG2|NSD1|NUDCD2|OR2V1|OR2V2|OR2Y1|P4HA2|PAIP2|PANK3|PCBD2|PCDH1|PCDH12|PCDHA1|PCDHA10|PCDHA11|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHB1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHB16|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB8|PCDHB9|PCDHB@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCYOX1L|PDE6A|PDGFRB|PDLIM4|PDLIM7|PFDN1|PFN3|PGGT1B|PHAX|PHYKPL|PITX1|PJA2|PKD2L2|PLAC8L1|POU4F3|PPARGC1B|PPIC|PPP2CA|PPP2R2B|PRDM6|PRELID1|PRELID2|PROB1|PROP1|PRR16|PRR7|PRRC1|PSD2|PTTG1|PURA|PWWP2A|RAB24|RACK1|RAD50|RANBP17|RAPGEF6|RARS1|RASGEF1C|RBM22|RBM27|REEP2|REEP5|RELL2|RGS14|RMND5B|RNF130|RNF14|SKP1|SLC12A2|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A46|SLC25A48|SLC26A2|SLC27A6|SLC34A1|SLC35A4|SLC36A1|SLC36A2|SLC36A3|SLC4A9|SLC6A7|SLIT3|SLU7|SMAD5|SMIM23|SMIM3|SNCAIP|SNCB|SNHG4|SNORA74B|SNX2|SNX24|SOWAHA|SOX30|SPARC|SPATA24|SPDL1|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SQSTM1|SRA1|SRFBP1|SRP19|STARD4|STC2|STING1|STK10|STK32A|SYNPO|TAF7|TBC1D9B|TCERG1|TCF7|TCOF1|TENM2|TGFBI|THG1L|THOC3|TICAM2|TIFAB|TIGD6|TIMD4|TLX3|TMCO6|TMED7|TMED7-TICAM2|TMED9|TMEM232|TNFAIP8|TNIP1|TRIM36|TRIM41|TRIM52|TRIM7|TRK-CTT2-3|TRP-TGG3-1|TRPC7|TRT-TGT6-1|TRV-AAC1-4|TRV-CAC1-2|TSLP|TSPAN17|TSSK1B|TTC1|TXNDC15|UBE2B|UBE2D2|UBLCP1|UBTD2|UIMC1|UNC5A|UQCRQ|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR36|WDR55|WNT8A|WWC1|YIPF5|YTHDC2|ZCCHC10|ZFP2|ZFP62|ZMAT2|ZNF300|ZNF346|ZNF354A|ZNF354B|ZNF354C|ZNF454|ZNF474|ZNF608|ZNF879		See cases	VCV000394550	5	106716357 - 180687338			394550	381443			copy number gain		Pathogenic		no assertion criteria provided							
N666Y	PDGFRB		OCULAR PTERYGIUM-DIGITAL KELOID DYSPLASIA SYNDROME	VCV003602096					3602096	3734768			single nucleotide variant		Pathogenic	Feb 3, 2025	no assertion criteria provided							
NM_002609.4(PDGFRB):c.724G>T (p.Val242Leu)	PDGFRB	V178L, V242L, V81L	not provided	VCV003361890					3361890	3521100			single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2023	criteria provided, single submitter							
